[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 9149
1. Afulani PA, Altman M, Musana J, Sudhinaraset M: Conceptualizing pathways linking women's empowerment and prematurity in developing countries. BMC Pregnancy Childbirth; 2017 Nov 08;17(Suppl 2):338

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Conceptualizing pathways linking women's empowerment and prematurity in developing countries.
  • RESULTS: There is limited evidence supporting a direct link between women's empowerment and prematurity.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMC Health Serv Res. 2011 Aug 24;11:203 [21864335.001]
  • [Cites] Int Perspect Sex Reprod Health. 2012 Mar;38(1):23-33 [22481146.001]
  • [Cites] Soc Sci Med. 2004 Nov;59(10):2003-12 [15351468.001]
  • [Cites] Matern Child Health J. 2016 Jan;20(1):1-10 [26227738.001]
  • [Cites] Lancet. 2002 Apr 20;359(9315):1423-9 [11978358.001]
  • [Cites] Acta Obstet Gynecol Scand. 2004 May;83(5):455-60 [15059158.001]
  • [Cites] N Engl J Med. 2010 Feb 11;362(6):529-35 [20147718.001]
  • [Cites] J Perinat Neonatal Nurs. 2010 Jan-Mar;24(1):74-80 [20147834.001]
  • [Cites] PLoS One. 2012;7(8):e44536 [22952992.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2007 Mar;131(1):45-51 [16797827.001]
  • [Cites] Nurs Res. 2008 Nov-Dec;57(6):383-94 [19018213.001]
  • [Cites] J Health Care Poor Underserved. 2011 Nov;22(4):1315-30 [22080712.001]
  • [Cites] Am J Obstet Gynecol. 2005 Mar;192(3):882-6 [15746686.001]
  • [Cites] Lancet. 2012 Jun 9;379(9832):2151-61 [22579125.001]
  • [Cites] Am J Epidemiol. 2010 Jul 15;172(2):127-34 [20576757.001]
  • [Cites] Lancet. 2013 May 18;381(9879):1736-46 [23683640.001]
  • [Cites] BMC Pregnancy Childbirth. 2009 Aug 11;9:34 [19671156.001]
  • [Cites] Soc Work Public Health. 2011;26(1):3-16 [21213184.001]
  • [Cites] Pediatrics. 2006 Nov;118(5):e1414-27 [17043133.001]
  • [Cites] Am J Clin Nutr. 1992 Aug;56(2):365-70 [1636615.001]
  • [Cites] Stud Fam Plann. 2002 Dec;33(4):299-308 [12553187.001]
  • [Cites] Am J Obstet Gynecol. 2012 Feb;206(2):113-8 [22177186.001]
  • [Cites] BMC Pregnancy Childbirth. 2010 Feb 23;10 Suppl 1:S2 [20233383.001]
  • [Cites] Matern Child Health J. 2014 Jan;18(1):307-15 [23576403.001]
  • [Cites] Lancet. 2008 Jan 12;371(9607):164-75 [18191687.001]
  • [Cites] Pediatr Res. 2013 Dec;74 Suppl 1:17-34 [24366461.001]
  • [Cites] Iran J Nurs Midwifery Res. 2013 May;18(3):218-21 [23983758.001]
  • [Cites] Am J Obstet Gynecol. 2012 Feb;206(2):119-23 [22177191.001]
  • [Cites] Curr Opin Obstet Gynecol. 2007 Apr;19(2):113-9 [17353678.001]
  • [Cites] Nurs Adm Q. 2009 Jan-Mar;33(1):32-7 [19092521.001]
  • [Cites] Health Policy Plan. 2014 Aug;29(5):580-8 [23894074.001]
  • [Cites] Am J Epidemiol. 2009 Jun 1;169(11):1319-26 [19363098.001]
  • [Cites] Lancet. 2015 Jan 31;385(9966):430-40 [25280870.001]
  • [Cites] Health Care Women Int. 2015;36(1):57-69 [24028632.001]
  • [Cites] Soc Sci Med Med Anthropol. 1981 Jan;15B(1):45-50 [7209605.001]
  • [Cites] Am J Obstet Gynecol. 2010 Aug;203(2):89-100 [20417491.001]
  • [Cites] PLoS One. 2012;7(9):e44931 [23028688.001]
  • [Cites] Adv Pract Nurs Q. 1995 Winter;1(3):58-64 [9447031.001]
  • [Cites] Pediatr Res. 2013 Dec;74 Suppl 1:35-49 [24366462.001]
  • [Cites] Am J Obstet Gynecol. 2011 Nov;205(5):456.e1-6 [22035950.001]
  • [Cites] Iran J Nurs Midwifery Res. 2014 Sep;19(5):451-5 [25400671.001]
  • [Cites] Clin Obstet Gynecol. 2014 Sep;57(3):579-606 [24979355.001]
  • [Cites] Bull World Health Organ. 2007 Oct;85(10):812-9 [18038064.001]
  • [Cites] Krankenpfl Soins Infirm. 2014;107(3):13-4, 65, 89 [24683788.001]
  • [Cites] Int J Environ Res Public Health. 2013 Jun 05;10(6):2296-335 [23739649.001]
  • [Cites] Am J Obstet Gynecol. 2012 May;206(5):415.e1-7 [22542115.001]
  • [Cites] J Clin Nurs. 2010 Jun;19(11-12):1729-37 [20579207.001]
  • [Cites] Curr Opin Psychiatry. 2012 Mar;25(2):141-8 [22262028.001]
  • [Cites] J Pediatr Psychol. 2007 May;32(4):463-74 [17041248.001]
  • [Cites] Semin Fetal Neonatal Med. 2016 Apr;21(2):74-9 [26740166.001]
  • [Cites] J Matern Fetal Neonatal Med. 2006 Dec;19(12):773-82 [17190687.001]
  • [Cites] Health Psychol. 1992;11(1):32-40 [1559532.001]
  • [Cites] SAGE Open Med. 2013 Oct 08;1:2050312113508388 [26770687.001]
  • [Cites] Women Health. 2001;32(1-2):119-35 [11459366.001]
  • [Cites] PLoS One. 2016 Apr 22;11(4):e0154110 [27105309.001]
  • [Cites] Psychodyn Psychiatry. 2013 Summer;41(2):329-49 [23713623.001]
  • [Cites] Pan Afr Med J. 2015 Feb 05;20:108 [26090056.001]
  • [Cites] Reprod Health. 2013;10 Suppl 1:S3 [24625189.001]
  • [Cites] Acta Obstet Gynecol Scand. 2008;87(6):590-600 [18568457.001]
  • [Cites] Soc Sci Med. 2014 Aug;114:169-77 [24929918.001]
  • [Cites] Soc Sci Med. 2014 Aug;115:111-20 [24955875.001]
  • [Cites] Afr J Reprod Health. 2012 Sep;16(3):123-9 [23437506.001]
  • [Cites] Lancet. 2008 Jan 5;371(9606):75-84 [18177778.001]
  • [Cites] Am J Public Health. 2007 Oct;97(10):1794-802 [17761566.001]
  • [Cites] Br J Obstet Gynaecol. 1983 May;90(5):385-6 [6849844.001]
  • [Cites] BMC Med. 2015 Jun 11;13:124 [26063042.001]
  • [Cites] J Adv Nurs. 2012 Jul;68(7):1482-93 [22092499.001]
  • [Cites] Obstet Gynecol. 2003 Nov;102(5 Pt 1):1051-7 [14672486.001]
  • [Cites] Newsl Womens Glob Netw Reprod Rights. 1991 Jul-Sep;(36):22-4 [12284530.001]
  • [Cites] Paediatr Perinat Epidemiol. 2006 May;20(3):188-200 [16629693.001]
  • [Cites] Reprod Health. 2013;10 Suppl 1:S4 [24625215.001]
  • [Cites] Ann Med. 2008;40(3):167-95 [18382883.001]
  • [Cites] Reprod Health. 2013;10 Suppl 1:S2 [24625129.001]
  • [Cites] Acta Obstet Gynecol Scand. 2011 Dec;90(12):1307-16 [21446927.001]
  • [Cites] J Health Care Poor Underserved. 2013 Feb;24(1):152-70 [23377725.001]
  • [Cites] PLoS One. 2010 Jun 23;5(6):e11190 [20585646.001]
  • [Cites] Lancet. 2005 Mar 5-11;365(9462):891-900 [15752534.001]
  • [Cites] J Med Ethics. 2006 May;32(5):287-91 [16648280.001]
  • [Cites] Acta Obstet Gynecol Scand. 2015 Jul;94(7):766-75 [25846179.001]
  • [Cites] Stud Fam Plann. 1999 Dec;30(4):302-14 [10674326.001]
  • [Cites] BJOG. 2016 Jul;123(8):1289-99 [26956568.001]
  • [Cites] Semin Reprod Med. 2008 Sep;26(5):423-35 [18825610.001]
  • [Cites] Pediatr Rep. 2015 Mar 27;7(1):5615 [25918622.001]
  • [Cites] BMC Pregnancy Childbirth. 2015 Jul 24;15:154 [26205512.001]
  • [Cites] Int J Prev Med. 2012 Sep;3(9):628-36 [23024852.001]
  • [Cites] Soc Sci Med. 2005 Jun;60(11):2641-55 [15814188.001]
  • [Cites] Soc Sci Med. 2006 Dec;63(12):3030-45 [16997438.001]
  • [Cites] Semin Perinatol. 2010 Dec;34(6):371-86 [21094412.001]
  • [Cites] BMC Pregnancy Childbirth. 2014 Mar 03;14:94 [24589139.001]
  • [Cites] Matern Child Health J. 2010 Jan;14(1):20-35 [19037715.001]
  • [Cites] PLoS One. 2015 Feb 19;10(2):e0117996 [25695737.001]
  • [Cites] Lancet. 2015 Apr 18;385(9977):1555-66 [25467575.001]
  • [Cites] J Health Soc Behav. 2002 Jun;43(2):189-206 [12096699.001]
  • [Cites] Soc Sci Med. 2010 Aug;71(3):634-42 [20621752.001]
  • [Cites] BMC Public Health. 2005 Dec 22;5:140 [16372911.001]
  • [Cites] Lancet. 2012 Jun 9;379(9832):2162-72 [22682464.001]
  • [Cites] Soc Sci Med. 2004 Dec;59(12):2585-95 [15474211.001]
  • [Cites] BMC Pregnancy Childbirth. 2007 Dec 06;7:29 [18053268.001]
  • [Cites] Semin Perinatol. 2011 Aug;35(4):234-9 [21798403.001]
  • [Cites] Soc Sci Med. 1994 Apr;38(8):1091-110 [8042057.001]
  • [Cites] Int Fam Plan Perspect. 2006 Mar;32(1):17-27 [16723298.001]
  • [Cites] Acta Paediatr. 2014 Jul;103(7):727-31 [24766486.001]
  • [Cites] BMC Health Serv Res. 2012 Feb 15;12:40 [22335834.001]
  • [Cites] Trop Med Int Health. 2004 Mar;9(3):390-8 [14996369.001]
  • [Cites] Lancet. 2007 Oct 13;370(9595):1358-69 [17933651.001]
  • [Cites] Reprod Health. 2013 Aug 20;10:40 [23962135.001]
  • [Cites] Iran J Nurs Midwifery Res. 2014 Jan;19(1):94-100 [24554967.001]
  • [Cites] BMC Pediatr. 2015 Mar 04;15:15 [25884634.001]
  • [Cites] PLoS One. 2012;7(5):e37037 [22623976.001]
  • [Cites] Lancet. 2015 Apr 25;385(9978):1672-84 [25467577.001]
  • [Cites] Stud Fam Plann. 1996 Nov-Dec;27(6):328-40 [8986031.001]
  • [Cites] Obstet Gynecol. 2007 Aug;110(2 Pt 1):330-9 [17666608.001]
  • [Cites] Health Policy Plan. 2013 Mar;28(2):176-84 [22522771.001]
  • [Cites] J Nurse Midwifery. 1998 Jan-Feb;43(1):46-54 [9489291.001]
  • [Cites] Reprod Health. 2013;10 Suppl 1:S6 [24625252.001]
  • [Cites] Stud Fam Plann. 2014 Mar;45(1):19-41 [24615573.001]
  • [Cites] Arch Womens Ment Health. 2016 Apr;19(2):259-69 [26260037.001]
  • [Cites] Midwifery. 2014 Feb;30(2):262-8 [23790959.001]
  • [Cites] Matern Child Health J. 2014 Feb;18(2):478-87 [23430295.001]
  • [Cites] BMJ. 2003 Aug 9;327(7410):313 [12907483.001]
  • [Cites] Soc Sci Med. 2013 Jun;86:26-34 [23608091.001]
  • [Cites] Qual Health Res. 2012 Oct;22(10):1369-82 [22829487.001]
  • [Cites] Reprod Health. 2013;10 Suppl 1:S5 [24625233.001]
  • [Cites] Saudi Med J. 2003 Jul;24(7):748-53 [12883607.001]
  • [Cites] Paediatr Child Health. 2011 Dec;16(10):638-42 [23204904.001]
  • [Cites] Am J Clin Nutr. 2005 May;81(5):1218S-1222S [15883455.001]
  • [Cites] Life Sci. 2011 Sep 26;89(13-14):417-21 [21821056.001]
  • [Cites] Biomed Res Int. 2015;2015:450309 [26413524.001]
  • (PMID = 29143627.001).
  • [ISSN] 1471-2393
  • [Journal-full-title] BMC pregnancy and childbirth
  • [ISO-abbreviation] BMC Pregnancy Childbirth
  • [Language] eng
  • [Grant] United States / NCATS NIH HHS / TR / UL1 TR000124
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Autonomy / Developing countries / Empowerment / Framework / Model / Prematurity / Preterm / Stress / Women
  •  go-up   go-down


2. Chen J, Peng P, Du Y, Ren Y, Chen L, Rao Y, Wang W: Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing. BMC Infect Dis; 2017 Apr 24;17(1):300
Hazardous Substances Data Bank. ISONIAZID .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
  • BACKGROUND: Emergence of multidrug- and extensively drug-resistant tuberculosis (M/XDR-TB) is a major hurdle for TB control programs especially in developing countries like China.

  • Genetic Alliance. consumer health - Tuberculosis.
  • Hazardous Substances Data Bank. RIFAMPIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS One. 2016 Apr 07;11(4):e0152694 [27054344.001]
  • [Cites] PLoS One. 2015 Mar 23;10(3):e0119628 [25799046.001]
  • [Cites] Emerg Infect Dis. 2011 Mar;17(3):558-60 [21392462.001]
  • [Cites] BMC Bioinformatics. 2012 Jun 18;13:134 [22708584.001]
  • [Cites] J Infect. 2010 Jul;61(2):150-4 [20452372.001]
  • [Cites] Antimicrob Agents Chemother. 2006 Aug;50(8):2640-9 [16870753.001]
  • [Cites] BMC Microbiol. 2012 May 30;12:90 [22646308.001]
  • [Cites] Braz J Infect Dis. 2012 Mar-Apr;16(2):136-41 [22552454.001]
  • [Cites] N Engl J Med. 2012 Jun 7;366(23):2161-70 [22670902.001]
  • [Cites] J Clin Biochem Nutr. 2008 May;42(3):228-34 [18545645.001]
  • [Cites] J Clin Microbiol. 2006 Dec;44(12 ):4459-63 [17035488.001]
  • [Cites] J Clin Microbiol. 2006 Sep;44(9):3409-12 [16954287.001]
  • [Cites] Infect Drug Resist. 2013 Nov 28;6:207-13 [24399879.001]
  • [Cites] J Clin Microbiol. 2007 Aug;45(8):2635-40 [17537937.001]
  • [Cites] Emerg Infect Dis. 2015 Jun;21(6):1002-11 [25988954.001]
  • [Cites] Diagn Microbiol Infect Dis. 2012 Oct;74(2):207-9 [22819240.001]
  • [Cites] PLoS One. 2015 Mar 04;10(3):e0117421 [25738956.001]
  • [Cites] PLoS One. 2012;7(6):e39754 [22761889.001]
  • [Cites] PLoS One. 2014 Mar 05;9(3):e90569 [24599230.001]
  • [Cites] BMC Med. 2016 Mar 23;14:31 [27005572.001]
  • [Cites] Antimicrob Agents Chemother. 2015 Jan;59(1):414-20 [25367911.001]
  • [Cites] Antimicrob Agents Chemother. 2008 Aug;52(8):2937-9 [18559646.001]
  • [Cites] Antimicrob Agents Chemother. 2009 Oct;53(10):4498-500 [19687244.001]
  • [Cites] J Clin Microbiol. 2014 Feb;52(2):475-82 [24478476.001]
  • [Cites] Chemotherapy. 2007;53(6):397-401 [17934259.001]
  • [Cites] Tuber Lung Dis. 2000;80(1):47-56 [10897383.001]
  • [Cites] PLoS Med. 2009 Feb 10;6(2):e2 [19209951.001]
  • [Cites] Antimicrob Agents Chemother. 2015 Mar;59(3):1519-24 [25534742.001]
  • [Cites] PLoS One. 2015 Mar 27;10(3):e0120470 [25816236.001]
  • [Cites] J Clin Microbiol. 2010 Jan;48(1):229-37 [19864480.001]
  • [Cites] Antimicrob Agents Chemother. 2010 Mar;54(3):1075-81 [20008778.001]
  • [Cites] J Clin Microbiol. 2003 May;41(5):2209-12 [12734282.001]
  • [Cites] BMC Infect Dis. 2014 Apr 13;14:200 [24725975.001]
  • [Cites] Tuberculosis (Edinb). 2014 May;94(3):277-81 [24751554.001]
  • [Cites] Antimicrob Agents Chemother. 2011 May;55(5):2032-41 [21300839.001]
  • (PMID = 28438132.001).
  • [ISSN] 1471-2334
  • [Journal-full-title] BMC infectious diseases
  • [ISO-abbreviation] BMC Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antitubercular Agents; 0 / Bacterial Proteins; 0 / Fluoroquinolones; V83O1VOZ8L / Isoniazid; VJT6J7R4TR / Rifampin
  • [Keywords] NOTNLM ; Fluoroquinolone / Isoniazid / MDR-TB / Mycobacterium tuberculosis / Pre-XDR-TB / Rifampicin
  •  go-up   go-down


3. Bhatt-Mehta V, MacArthur RB, Löbenberg R, Cies JJ, Cernak I, Ii RHP: An Algorithm to Identify Compounded Non-Sterile Products that Can Be Formulated on a Commercial Scale or Imported to Promote Safer Medication Use in Children. Pharmacy (Basel); 2015 Nov 11;3(4):284-294

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Moreover, the developed algorithm aids in prioritizing useful APIs with finished oral liquid dosage forms available from other countries with direct importation opportunities to North America and beyond.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] JAMA Pediatr. 2014 Feb;168(2):130-6 [24322269.001]
  • [Cites] Clin Ther. 2012 Nov;34(11):S11-24 [23149009.001]
  • [Cites] Drug Dev Ind Pharm. 2007 Sep;33(9):909-26 [17891577.001]
  • [Cites] Adv Drug Deliv Rev. 2014 Jun;73:102-26 [24189013.001]
  • [Cites] Mol Pharm. 2013 Nov 4;10 (11):4378-90 [24094040.001]
  • [Cites] Pharm Res. 2005 Jan;22(1):11-23 [15771225.001]
  • [Cites] Pharm Res. 1995 Mar;12(3):413-20 [7617530.001]
  • [Cites] AAPS PharmSciTech. 2015 Feb;16(1):217-21 [25409918.001]
  • [Cites] AAPS J. 2012 Sep;14(3):462-72 [22528504.001]
  • [Cites] Br J Clin Pharmacol. 2010 Nov;70(5):694-702 [21039763.001]
  • [Cites] Mol Pharm. 2009 Jan-Feb;6(1):60-73 [19183105.001]
  • [Cites] Hypertension. 2014 May;63(5):1116-35 [24591341.001]
  • [Cites] Drug Dev Ind Pharm. 2007 Oct;33(10):1043-57 [17963112.001]
  • [Cites] ISRN Pharm. 2012;2012:436763 [23326686.001]
  • [Cites] Pediatrics. 2014 Mar;133(3):563-7 [24567009.001]
  • [Cites] Int J Pharm. 2014 Aug 5;469(2):251-3 [24602991.001]
  • [Cites] Mol Pharm. 2006 Nov-Dec;3(6):631-43 [17140251.001]
  • [Cites] Eur J Pharm Biopharm. 2000 Jul;50(1):3-12 [10840189.001]
  • [Cites] Am J Health Syst Pharm. 1996 Oct 1;53(19):2304-9 [8893069.001]
  • (PMID = 28975916.001).
  • [ISSN] 2226-4787
  • [Journal-full-title] Pharmacy (Basel, Switzerland)
  • [ISO-abbreviation] Pharmacy (Basel)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; compounded medications / formulation development / patient safety / pediatric
  •  go-up   go-down


Advertisement
4. He L, Yin F, Zhong Z, Ding Z: The impact of local government investment on the carbon emissions reduction effect: An empirical analysis of panel data from 30 provinces and municipalities in China. PLoS One; 2017;12(7):e0180946
Hazardous Substances Data Bank. CARBON .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of the limited number of studies on the effect of LGI on carbon emissions, most focus on its direct effect.
  • Using a cointegration test, a panel data model and clustering analysis based on Chinese data between 2000 and 2013, this study measures the direct role of LGI in carbon dioxide (CO2) emissions reduction.
  • Moreover, the current study can benefit countries similar to China that aim to objectively identify the impacts of their LGI on carbon emissions, and such countries can use it as a reference in the formulation of investment policies based on their economic and industrial characteristics.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Environ Sci Pollut Res Int. 2015 Oct;22(20):16022-30 [26062459.001]
  • [Cites] Environ Sci Pollut Res Int. 2016 Jan;23(2):1203-13 [26351068.001]
  • [Cites] Environ Sci Pollut Res Int. 2016 Jul;23 (14 ):14646-55 [27072031.001]
  • (PMID = 28727783.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Air Pollutants; 7440-44-0 / Carbon
  •  go-up   go-down


5. Norris T, Manktelow BN, Smith LK, Draper ES: Causes and temporal changes in nationally collected stillbirth audit data in high-resource settings. Semin Fetal Neonatal Med; 2017 Jun;22(3):118-128

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Few high-income countries have an active national programme of stillbirth audit.
  • Variation in the classification of stillbirth, cause of death and frequency of risk factor groups limit our ability to draw meaningful conclusions as to the true scale of the burden and the changing epidemiology of stillbirths in high-income countries.
  • International standardization of these would facilitate direct comparisons between countries.
  • The observed declines in stillbirth rates over the period of perinatal audit, a possible consequence of recommendations for improved antenatal care, should serve to incentivise other countries to implement similar audit programmes.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Crown Copyright © 2017. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 28214157.001).
  • [ISSN] 1878-0946
  • [Journal-full-title] Seminars in fetal & neonatal medicine
  • [ISO-abbreviation] Semin Fetal Neonatal Med
  • [Language] eng
  • [Grant] United Kingdom / Department of Health / / CDF-2013-06-018
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; High income country / National perinatal audit / Stillbirth
  •  go-up   go-down


6. Walton-Roberts M, Runnels V, Rajan SI, Sood A, Nair S, Thomas P, Packer C, MacKenzie A, Tomblin Murphy G, Labonté R, Bourgeault IL: Causes, consequences, and policy responses to the migration of health workers: key findings from India. Hum Resour Health; 2017 Apr 05;15(1):28
MedlinePlus Health Information. consumer health - Choosing a Doctor or Health Care Service.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: This study sought to better understand the drivers of skilled health professional migration, its consequences, and the various strategies countries have employed to mitigate its negative impacts.
  • The study was conducted in four countries-Jamaica, India, the Philippines, and South Africa-that have historically been "sources" of health workers migrating to other countries.
  • Research suggests that shortages of skilled health workers in India must be examined in relation to domestic policies on training, recruitment, and retention rather than viewed as a direct consequence of the international migration of health workers.
  • [MeSH-major] Delivery of Health Care / standards. Emigration and Immigration. Health Personnel. Health Policy. Health Services Accessibility. Motivation. Professional Practice Location

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 2011 Feb 12;377(9765):587-98 [21227499.001]
  • [Cites] Hum Resour Health. 2009 Feb 27;7:18 [19250542.001]
  • [Cites] Health Aff (Millwood). 2006 Mar-Apr;25(2):380-93 [16610096.001]
  • [Cites] Hum Resour Health. 2006 May 27;4:12 [16729892.001]
  • [Cites] N Engl J Med. 2014 Mar 6;370(10):950-7 [24597868.001]
  • [Cites] BMJ. 2005 Nov 19;331(7526):1157-8 [16293815.001]
  • [Cites] BMC Med Educ. 2014 Dec 17;14:266 [25515419.001]
  • [Cites] Lancet. 2015 Aug 8;386(9993):517-8 [26293428.001]
  • [Cites] J Nurs Manag. 2012 May;20(4):534-50 [22591155.001]
  • [Cites] Lancet. 2011 Feb 19;377(9766):668-79 [21227490.001]
  • [Cites] Int J Epidemiol. 2006 Dec;35(6):1530-1 [17092948.001]
  • [Cites] Lancet Glob Health. 2015 Dec;3(12):e729-30 [26566742.001]
  • [Cites] Hum Resour Health. 2012 Aug 13;10:19 [22888906.001]
  • [Cites] Econ Hum Biol. 2011 Mar;9(2):172-83 [21288783.001]
  • [Cites] Bull World Health Organ. 2004 Aug;82(8):595-600 [15375449.001]
  • [Cites] Hum Resour Health. 2009 Feb 02;7:5 [19187559.001]
  • [Cites] Health Serv Res. 2007 Jun;42(3 Pt 2):1429-36 [17489924.001]
  • [Cites] Hum Resour Health. 2015 Dec 03;13:92 [26635007.001]
  • [Cites] Hum Resour Health. 2010 Nov 25;8:27 [21108833.001]
  • [Cites] Int Nurs Rev. 2006 Dec;53(4):277-83 [17083416.001]
  • [Cites] Res Nurs Health. 2000 Aug;23(4):334-40 [10940958.001]
  • [Cites] Nurs Manag (Harrow). 2007 Mar;13(10 ):26-30 [17396451.001]
  • [Cites] J Public Health (Oxf). 2013 Mar;35(1):157-63 [23097260.001]
  • [Cites] Lancet. 2011 Feb 5;377(9764):505-15 [21227492.001]
  • [Cites] Soc Sci Med. 2015 Jan;124:374-82 [25445935.001]
  • (PMID = 28381289.001).
  • [ISSN] 1478-4491
  • [Journal-full-title] Human resources for health
  • [ISO-abbreviation] Hum Resour Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Causes / Consequences / Doctors / Health worker migration / Human resources for health / India / Nurses / Policy responses
  •  go-up   go-down


7. Örmeci N, Malhan S, Balık İ, Ergör G, Razavi H, Robbins S: Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey. Hepatol Int; 2017 Nov;11(6):509-516

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Direct costs in US dollars (USD) including diagnostic, laboratory, and healthcare costs were provided by experts in the country.
  • RESULTS: Cumulative total direct and indirect costs (2015-2030) for the WHO Targets scenario were estimated to be 10.8 billion USD, or a 1.5 % increase compared with Base 2016.
  • However, by the following decade, due to a marked decline in DALYs, cumulative direct and indirect costs were estimated to be 45 % less when compared with Base 2016.
  • Treating HCV infection in the country is cost-effective if healthcare and indirect costs are taken into consideration.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2014 Apr 17;370(16):1483-93 [24725238.001]
  • [Cites] Turk J Gastroenterol. 2013;24(4):349-55 [24254268.001]
  • [Cites] N Engl J Med. 2014 Apr 24;370(17):1604-14 [24720679.001]
  • [Cites] Turk J Gastroenterol. 2012;23(5):574-9 [23161304.001]
  • [Cites] Infection. 1994 Nov-Dec;22(6):411-4 [7698839.001]
  • [Cites] Ann Intern Med. 2015 Mar 17;162(6):397-406 [25775312.001]
  • [Cites] Eur J Health Econ. 2012 Oct;13(5):663-76 [22815098.001]
  • [Cites] J Med Econ. 2012;15(5):887-96 [22458755.001]
  • [Cites] Hepatology. 2013 Jun;57(6):2164-70 [23280550.001]
  • [Cites] N Engl J Med. 2014 May 15;370(20):1889-98 [24725239.001]
  • [Cites] PLoS One. 2015 Jun 24;10(6):e0125214 [26107467.001]
  • [Cites] Hepatology. 2015 May;61(5):1471-8 [25706754.001]
  • [Cites] N Engl J Med. 2014 Apr 24;370(17):1594-603 [24720703.001]
  • [Cites] Rand Health Q. 2013 Mar 1;3(1):6 [28083286.001]
  • [Cites] Bull World Health Organ. 1994;72(3):429-45 [8062401.001]
  • [Cites] Clin Gastroenterol Hepatol. 2017 Jun;15(6):827-837.e8 [27650326.001]
  • [Cites] Hepatol Res. 2004 Jun;29(2):75-80 [15163428.001]
  • [Cites] N Engl J Med. 2014 May 15;370(20):1879-88 [24720702.001]
  • [Cites] J Gastroenterol Hepatol. 2014 Aug;29 Suppl 1:1-9 [25055928.001]
  • [Cites] Turk J Med Sci. 2014;44(5):824-31 [25539553.001]
  • [Cites] Liver Int. 2017 Feb;37(2):159-172 [27748564.001]
  • [Cites] Gastroenterology. 2015 Sep;149(3):649-59 [25985734.001]
  • (PMID = 29027109.001).
  • [ISSN] 1936-0541
  • [Journal-full-title] Hepatology international
  • [ISO-abbreviation] Hepatol Int
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Cost-effectiveness / Economic impact / HCV / Treatment / WHO Targets
  •  go-up   go-down


8. Jayasekara H, De Silva A, Amarasinghe A: Costing of immunization service provision in Kalutara district, Sri Lanka: a cross-sectional study. WHO South East Asia J Public Health; 2016 Sep;5(2):149-154

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • With the rising cost of the National Immunization Programme (NIP) in Sri Lanka, immunization costing studies could help programme managers to ensure sustainable immunization financing in the country.
  • Cost estimates were made for direct capital and recurrent costs.
  • The majority of these costs were direct recurrent costs (93.4%).
  • Vaccines (84.3%) and staff salaries (6.4%) were the main components of direct recurrent costs, while cold-chain equipment (5.3%) was the main contributor to direct capital cost.
  • Studies exploring the costing of the NIP in the country would be beneficial, to ensure sustainable immunization financing.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28607243.001).
  • [ISSN] 2304-5272
  • [Journal-full-title] WHO South-East Asia journal of public health
  • [ISO-abbreviation] WHO South East Asia J Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


9. Protty MB, Hayes J: Dawn of the direct-acting oral anticoagulants: trends in oral anticoagulant prescribing in Wales 2009-2015. J Clin Pharm Ther; 2017 Apr;42(2):132-134
MedlinePlus Health Information. consumer health - Blood Thinners.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dawn of the direct-acting oral anticoagulants: trends in oral anticoagulant prescribing in Wales 2009-2015.
  • These include warfarin and the newer direct-acting OACs (DOACs).
  • In this commentary, we report the prescribing patterns for OACs in Wales, as a representative country within the UK.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2016 John Wiley & Sons Ltd.
  • (PMID = 28000318.001).
  • [ISSN] 1365-2710
  • [Journal-full-title] Journal of clinical pharmacy and therapeutics
  • [ISO-abbreviation] J Clin Pharm Ther
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anticoagulants
  • [Keywords] NOTNLM ; NOAC / direct-acting oral anticoagulants / direct oral anticoagulants / prescribing
  •  go-up   go-down


10. Shimizu T, Miyake T, Kitamura N, Tani M, Endo Y: Endotoxin adsorption: Direct hemoperfusion with the polymyxin B-immobilized fiber column (PMX). Transfus Apher Sci; 2017 Oct;56(5):682-688

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endotoxin adsorption: Direct hemoperfusion with the polymyxin B-immobilized fiber column (PMX).
  • Toraymyxin<sup>®</sup> is a medical device developed to adsorb circulating endotoxins in the blood using direct hemoperfusion therapy for patients with septic shock.
  • Toraymyxin is currently available for use in the clinical setting in 14 countries worldwide.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28923774.001).
  • [ISSN] 1473-0502
  • [Journal-full-title] Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
  • [ISO-abbreviation] Transfus. Apher. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; PMX-DHP / Toraymyxin / hemoperfusion / lipopolysaccharide / septic shock
  •  go-up   go-down


11. Yagi M, Ames CP, Keefe M, Hosogane N, Smith JS, Shaffrey CI, Schwab F, Lafage V, Shay Bess R, Matsumoto M, Watanabe K, International Spine Study Group (ISSG): A cost-effectiveness comparisons of adult spinal deformity surgery in the United States and Japan. Eur Spine J; 2017 Aug 23;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The purposes of this study were to compare the direct cost and cost-effectiveness of surgery for ASD in the United States (US) and Japan (JP).
  • Data analysis included preoperative and postoperative demographic, radiographic, health-related quality of life (HRQOL), and direct cost for surgery.
  • CONCLUSION: Retrospective analysis comparing the direct costs and cost-effectiveness of ASD surgery in the US vs JP demonstrated that the total direct costs and cost/QALY were substantially higher in the US than JP.
  • Variations in patient cohort, healthcare costs, revision frequencies, and HRQOL improvement influenced the cost/QALY differential between these countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28836012.001).
  • [ISSN] 1432-0932
  • [Journal-full-title] European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
  • [ISO-abbreviation] Eur Spine J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Adult spinal deformity / Complication / Cost / Cost-effectiveness / QALY
  •  go-up   go-down


12. Zonneveld R, Kanhai HHH, Lamers M, Brand A, Zijlmans WCWR, Schonewille H: D antibodies in pregnant women in multiethnic Suriname: the observational RheSuN study. Transfusion; 2017 Oct;57(10):2490-2495
MedlinePlus Health Information. consumer health - Rh Incompatibility.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In high-income countries, the risk of D immunization has been reduced by routine antenatal and postpartum administration of RhIG from 13% to less than 0.5%.
  • In less-resourced countries, such as Suriname, red blood cell (RBC) antibody screening during pregnancy and prophylactic RhIG administration are not routine.
  • The direct antiglobulin test was positive in 11 of 13 tested D+ newborns.
  • CONCLUSION: D immunization risk in Suriname women is comparable to the pre-anti-D prophylaxis era in high-income countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 AABB.
  • (PMID = 28703855.001).
  • [ISSN] 1537-2995
  • [Journal-full-title] Transfusion
  • [ISO-abbreviation] Transfusion
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Observational Study
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RHO(D) antibody; 0 / Rho(D) Immune Globulin
  •  go-up   go-down


13. Filippitzi ME, Brinch Kruse A, Postma M, Sarrazin S, Maes D, Alban L, Nielsen LR, Dewulf J: Review of transmission routes of 24 infectious diseases preventable by biosecurity measures and comparison of the implementation of these measures in pig herds in six European countries. Transbound Emerg Dis; 2017 Nov 09;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Review of transmission routes of 24 infectious diseases preventable by biosecurity measures and comparison of the implementation of these measures in pig herds in six European countries.
  • Furthermore, it aimed to identify the level of implementation of these measures in different European countries and discuss the observed variations to identify potentials for improvement.
  • First, a literature review was performed to show which direct and indirect transmission routes of 24 infectious pig diseases can be prevented through different biosecurity measures.
  • The quantitative analysis indicated that at the level of internal, external and overall biosecurity, Denmark had a significantly distinct profile with higher external biosecurity scores and less variation than the rest of the countries.
  • The qualitative analysis identified differences in applied policies, legislation, disease status, pig farm density, farming culture and habits between countries that can be used for shaping country-specific biosecurity advice to attain improved prevention and control of important pig diseases in European pig farms.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Blackwell Verlag GmbH.
  • (PMID = 29124908.001).
  • [ISSN] 1865-1682
  • [Journal-full-title] Transboundary and emerging diseases
  • [ISO-abbreviation] Transbound Emerg Dis
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Europe / biosecurity / disease prevention / measures / pig production / transmission routes
  •  go-up   go-down


14. Landi A, Law J, Hockman D, Logan M, Crawford K, Chen C, Kundu J, Ebensen T, Guzman CA, Deschatelets L, Krishnan L, Tyrrell DLJ, Houghton M: Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes. Vaccine; 2017 Dec 15;35(50):6949-6956

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In spite of recent advances in the development of direct acting antivirals, there is still a need for a prophylactic vaccine to limit the virus spread and protect at-risk populations, especially in developing countries, where the cost of the new treatments may severely limit access.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 29089195.001).
  • [ISSN] 1873-2518
  • [Journal-full-title] Vaccine
  • [ISO-abbreviation] Vaccine
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Adjuvant / Archaeosomes / HCV rE1E2 glycoproteins / Vaccine / c-di-AMP
  •  go-up   go-down


15. Labonté R, Runnels V, Crooks VA, Johnston R, Snyder J: What does the development of medical tourism in Barbados hold for health equity? an exploratory qualitative case study. Glob Health Res Policy; 2017;2:5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Background: Although the global growth of privatized health care services in the form of medical tourism appears to generate economic benefits, there is debate about medical tourism's impacts on health equity in countries that receive medical tourists.
  • Studies of the processes of economic globalization in relation to social determinants of health suggest that medical tourism's impacts on health equity can be both direct and indirect.
  • Informants pointed to the direct ways in which the domestic population might access more health care through medical tourism and how privately-provided medical tourism in Barbados could provide health benefits indirectly to the Barbadian populations.
  • Conclusions: In clarifying the direct and indirect pathways by which medical tourism can impact health equity, these findings have implications for health system stakeholders and decision-makers in Barbados and other countries attempting both to build a medical tourism industry and to protect health equity.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Equity Health. 2015 Feb 03;14:15 [25643761.001]
  • [Cites] J Epidemiol Community Health. 2003 Apr;57(4):254-8 [12646539.001]
  • [Cites] Glob Health Action. 2015 Apr 10;8:27348 [25865122.001]
  • [Cites] BMJ. 2005 Nov 19;331(7526):1157-8 [16293815.001]
  • [Cites] Bull World Health Organ. 2002;80(2):158-63 [11953795.001]
  • [Cites] Soc Sci Med. 2004 Dec;59(11):2313-23 [15450706.001]
  • [Cites] Global Health. 2011 May 04;7:12 [21539751.001]
  • [Cites] Int J Equity Health. 2013 Jan 05;12:2 [23289812.001]
  • [Cites] Lancet. 1971 Feb 27;1(7696):405-12 [4100731.001]
  • [Cites] Int J Health Serv. 2015;45(2):334-52 [25813504.001]
  • [Cites] Lancet. 2009 Jan 24;373(9660):325-31 [19167061.001]
  • [Cites] J Law Med Ethics. 2013 Spring;41(1):286-300 [23581671.001]
  • [Cites] Lancet. 2010 Aug 28;376(9742):671-2 [20879077.001]
  • [Cites] Maturitas. 2012 Dec;73(4):300-4 [23007007.001]
  • [Cites] J Public Health Policy. 2010 Jul;31(2):185-98 [20535101.001]
  • [Cites] Indian J Med Ethics. 2008 Jan-Mar;5(1):4-5 [18630244.001]
  • [Cites] Int J Health Serv. 1992;22(3):429-45 [1644507.001]
  • (PMID = 29202073.001).
  • [ISSN] 2397-0642
  • [Journal-full-title] Global health research and policy
  • [ISO-abbreviation] Glob Health Res Policy
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Access to health care / Barbados / Health equity / Medical tourism / Population health
  •  go-up   go-down


16. Bhaskarabhatla A, Chatterjee C, Anurag P, Pennings E: Mitigating regulatory impact: the case of partial price controls on metformin in India. Health Policy Plan; 2017 03 01;32(2):194-204
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Low- and middle-income countries use direct price controls to improve access to essential drugs.
  • But such price controls have little meaning if they are not designed and implemented well, and the extent to which firms coordinate in these countries to weaken price controls has been largely overlooked.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28207048.001).
  • [ISSN] 1460-2237
  • [Journal-full-title] Health policy and planning
  • [ISO-abbreviation] Health Policy Plan
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


17. Asselah T, Hassanein T, Waked I, Mansouri A, Dusheiko G, Gane E: Eliminating Hepatitis C within Low Income Countries - the need to cure Genotypes 4, 5, 6. J Hepatol; 2017 Dec 08;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Eliminating Hepatitis C within Low Income Countries - the need to cure Genotypes 4, 5, 6.
  • HCV anti-viral drug development has been remarkable and this revolution led to several direct-acting antiviral agents achieving an HCV cure after only 8-12 weeks of treatment duration.
  • Because the earliest in vitro assays utilised the GT 1b and 2 replicons, the initial classes of direct acting antivirals (protease inhibitors, non-nucleotide polymerase inhibitors) were genotype 1-specific, albiet had an effect on other less prevalent genotypes.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017. Published by Elsevier B.V.
  • (PMID = 29229584.001).
  • [ISSN] 1600-0641
  • [Journal-full-title] Journal of hepatology
  • [ISO-abbreviation] J. Hepatol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Chronic hepatitis C / Direct-acting antivirals / HCV elimination / Screening
  •  go-up   go-down


18. Glatz T, Höppner J: Is There a Rationale for Structural Quality Assurance in Esophageal Surgery? Visc Med; 2017 May;33(2):135-139
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, recent database analyses reveal that the perioperative mortality of esophagectomy remains high in these countries, indicating a discrepancy between surgical quality in baseline hospitals and specialized centers.
  • Usually, direct outcome measures do not provide enough statistical power to actually identify differences in surgical quality between hospitals, making structural quality measures the only feasible parameter to compare the quality of e- sophageal surgery among different centers.
  • Several analyses from different countries have shown a strong correlation between hospital volume and postoperative mortality.
  • Data from countries in which esophageal surgery has been centralized indicate beneficial effects of a centralized health care system on postoperative mortality after esophagectomy.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Esophagus. 2015 Jul;28(5):468-75 [24697876.001]
  • [Cites] Gesundheitswesen. 2016 Apr 6;:null [27050140.001]
  • [Cites] J Surg Oncol. 2014 Oct;110(5):599-610 [25146593.001]
  • [Cites] Dtsch Arztebl Int. 2014 Aug 18;111(33-34):556-63 [25220065.001]
  • [Cites] Langenbecks Arch Surg. 2017 Mar;402(2):323-331 [28083680.001]
  • [Cites] J Surg Oncol. 2014 Mar;109(3):287-93 [24277235.001]
  • [Cites] Ann Surg. 2015 Jul;262(1):79-85 [24979602.001]
  • [Cites] Ann Surg Oncol. 2009 Jul;16(7):1789-98 [19370377.001]
  • [Cites] Eur J Surg Oncol. 2010 Nov;36(11):1035-43 [20846818.001]
  • [Cites] Lancet Oncol. 2015 Sep;16(9):1090-8 [26254683.001]
  • [Cites] Dis Esophagus. 2017 Jan 1;30(1):1-6 [26727414.001]
  • [Cites] J Clin Oncol. 2009 Oct 1;27(28):4671-8 [19720926.001]
  • [Cites] Ann Surg. 2016 Oct 17;:null [27759620.001]
  • [Cites] Surg Endosc. 2017 Jun;31(6):2491-2497 [27660245.001]
  • [Cites] Dis Esophagus. 2004;17(4):310-4 [15569369.001]
  • [Cites] CA Cancer J Clin. 2009 May-Jun;59(3):192-211 [19414631.001]
  • [Cites] Ann Surg. 2014 Aug;260(2):244-51 [24368634.001]
  • [Cites] Ann Surg Oncol. 2015 Aug;22(8):2615-23 [25605511.001]
  • [Cites] Ann Surg. 2012 Jul;256(1):95-103 [22668811.001]
  • [Cites] Eur J Surg Oncol. 2015 Oct;41(10):1300-7 [26253194.001]
  • [Cites] Dig Surg. 2012;29(5):374-83 [23128369.001]
  • [Cites] J Am Coll Surg. 2004 Apr;198(4):626-32 [15051016.001]
  • [Cites] Z Evid Fortbild Qual Gesundhwes. 2014;108(8-9):487-94 [25523847.001]
  • [Cites] Br J Surg. 2013 Jan;100(1):83-94 [23180474.001]
  • [Cites] J Gastrointest Surg. 2012 May;16(5):1055-63 [22089950.001]
  • [Cites] Updates Surg. 2016 Jun;68(2):129-33 [27240756.001]
  • [Cites] Updates Surg. 2013 Dec;65(4):271-5 [23943409.001]
  • [Cites] Ann Surg. 2016 Nov;264(5):823-830 [27429033.001]
  • [Cites] Ann Surg Oncol. 2014 Dec;21(13):4068-74 [25005073.001]
  • [Cites] J Surg Oncol. 2009 Jun 15;99(8):481-7 [19466737.001]
  • [Cites] J Clin Oncol. 2011 May 1;29(13):1715-21 [21444866.001]
  • [Cites] N Engl J Med. 2012 May 31;366(22):2074-84 [22646630.001]
  • [Cites] Semin Thorac Cardiovasc Surg. 2014 Winter;26(4):287-94 [25837540.001]
  • [Cites] Ann Surg Oncol. 2010 Nov;17(11):2824-31 [20559740.001]
  • [Cites] Chirurg. 2007 Nov;78(11):1028-36 [17928975.001]
  • [Cites] Ann Surg. 2016 Dec;264(6):1082-1090 [26978570.001]
  • [Cites] Dig Dis Sci. 2015 Dec;60(12):3536-44 [26177703.001]
  • [Cites] N Engl J Med. 2006 Jul 6;355(1):11-20 [16822992.001]
  • [Cites] J Gastrointest Surg. 2013 Jul;17(7):1193-201 [23636882.001]
  • (PMID = 28560229.001).
  • [ISSN] 2297-4725
  • [Journal-full-title] Visceral medicine
  • [ISO-abbreviation] Visc Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; Esophageal cancer / Esophagectomy / Hospital volume / Structural quality
  •  go-up   go-down


19. Stickel F, Datz C, Hampe J, Bataller R: Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. Gut Liver; 2017 Mar 15;11(2):173-188
Genetic Alliance. consumer health - Liver Disease.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • While alcohol consumption is slightly decreasing in several European countries, it is rising in others and remains high in many countries around the world.
  • The pathophysiology of ALD is still incompletely understood but relates largely to the direct toxic effects of alcohol and its main intermediate, acetaldehyde.
  • Still, many countries are restrictive in allocating donor livers for ALD patients.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Hepatol. 2002 Jan;36(1):47-52 [11804663.001]
  • [Cites] Hepatology. 2012 Jun;55(6):1931-41 [22278680.001]
  • [Cites] Hepatology. 2010 Jan;51(1):307-28 [20034030.001]
  • [Cites] Scand J Gastroenterol. 2013 May;48(5):585-91 [23506154.001]
  • [Cites] Transplantation. 2013 Mar 15;95(5):755-60 [23370710.001]
  • [Cites] World J Gastroenterol. 2010 Feb 28;16(8):966-72 [20180235.001]
  • [Cites] Nat Rev Genet. 2015 May;16(5):299-311 [25854182.001]
  • [Cites] Semin Liver Dis. 2015 Nov;35(4):361-74 [26676812.001]
  • [Cites] Clin Nutr. 2006 Apr;25(2):285-94 [16707194.001]
  • [Cites] Hepatology. 1983 Sep-Oct;3(5):701-6 [6618437.001]
  • [Cites] Adv Clin Chem. 2013;59:155-201 [23461136.001]
  • [Cites] J Affect Disord. 2015 Oct 1;185:47-59 [26143404.001]
  • [Cites] Gut. 2015 Dec;64(12):1949-60 [25731872.001]
  • [Cites] Hepatology. 2005 Aug;42(2):343-52 [16025520.001]
  • [Cites] Alcohol Clin Exp Res. 2003 Nov;27(11):1765-72 [14634492.001]
  • [Cites] J Hepatol. 2011 Apr;54(4):760-4 [21126790.001]
  • [Cites] Gastroenterology. 2014 May;146(5):1231-9.e1-6 [24440674.001]
  • [Cites] Hepatology. 2009 Feb;49(2):646-57 [19177575.001]
  • [Cites] Am J Gastroenterol. 2008 Nov;103(11):2747-56 [18721242.001]
  • [Cites] Addict Behav. 2012 Apr;37(4):561-4 [22244707.001]
  • [Cites] J Clin Gastroenterol. 2013 Sep;47(8):727-33 [23751845.001]
  • [Cites] Clin Gastroenterol Hepatol. 2005 Jul;3(7):705-13 [16206505.001]
  • [Cites] N Engl J Med. 2015 Apr 23;372(17):1619-28 [25901427.001]
  • [Cites] J Hepatol. 2017 Jan;66(1):195-211 [27575312.001]
  • [Cites] Hepatology. 2002 Mar;35(3):635-8 [11870378.001]
  • [Cites] Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002235 [16625556.001]
  • [Cites] Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002148 [15846629.001]
  • [Cites] J Hepatol. 2004 Jan;40(1):60-8 [14672615.001]
  • [Cites] BMC Med. 2014 Sep 18;12 :145 [25242656.001]
  • [Cites] Eur Neuropsychopharmacol. 2013 Feb;23(2):89-97 [22920734.001]
  • [Cites] Lancet. 1984 Aug 4;2(8397):241-4 [6146805.001]
  • [Cites] Mol Med. 2011;17 (11-12):1285-94 [21863215.001]
  • [Cites] Alcohol Clin Exp Res. 2011 Mar;35(3):566-70 [21143253.001]
  • [Cites] Exp Mol Pathol. 2015 Dec;99(3):596-610 [26342547.001]
  • [Cites] Am J Transplant. 2016 Mar;16(3):841-9 [26710309.001]
  • [Cites] Virchows Arch. 2011 May;458(5):511-23 [21442288.001]
  • [Cites] Gastroenterology. 2013 Jun;144(6):1252-61 [23622135.001]
  • [Cites] Gut. 1997 Dec;41(6):845-50 [9462221.001]
  • [Cites] J Hepatol. 2005 May;42(5):700-6 [15826720.001]
  • [Cites] Hepatology. 2007 Jun;45(6):1348-54 [17518367.001]
  • [Cites] Gastroenterology. 1984 Apr;86(4):632-6 [6698365.001]
  • [Cites] Am J Transplant. 2010 Jan;10(1):138-48 [19951276.001]
  • [Cites] Cochrane Database Syst Rev. 2002;(2):CD002800 [12076451.001]
  • [Cites] Hepatology. 2005 Jun;41(6):1407-32 [15880505.001]
  • [Cites] Joint Bone Spine. 2017 Mar;84(2):189-196 [27238189.001]
  • [Cites] N Engl J Med. 2011 Nov 10;365(19):1790-800 [22070476.001]
  • [Cites] BMJ. 2010 Mar 11;340:c1240 [20223873.001]
  • [Cites] Nat Rev Cardiol. 2015 Oct;12(10):576-87 [26099843.001]
  • [Cites] Liver Transpl. 2006 May;12(5):813-20 [16528710.001]
  • [Cites] Gastroenterology. 2016 Apr;150(4):903-10.e8 [26764182.001]
  • [Cites] Aliment Pharmacol Ther. 2016 Mar;43(5):562-74 [26806124.001]
  • [Cites] Cancer Epidemiol. 2015 Dec;39 Suppl 1:S67-74 [26115567.001]
  • [Cites] Addiction. 2016 Jul;111(7):1203-13 [26948693.001]
  • [Cites] J Hepatol. 2014 May;60(5):1026-31 [24378529.001]
  • [Cites] Arch Toxicol. 2012 Sep;86(9):1337-48 [22367091.001]
  • [Cites] Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50 [15508101.001]
  • [Cites] Hepatology. 2005 Feb;41(2):336-44 [15660387.001]
  • [Cites] J Hepatol. 2015 Sep;63(3):609-21 [25872168.001]
  • [Cites] Lancet. 2006 Jan 7;367 (9504):52-6 [16399153.001]
  • [Cites] Liver Transpl. 2007 Nov;13(11 Suppl 2):S65-8 [17969090.001]
  • [Cites] J Hepatol. 2012 Aug;57(2):399-420 [22633836.001]
  • [Cites] Adv Exp Med Biol. 2015;815:113-30 [25427904.001]
  • [Cites] World J Gastroenterol. 2010 Mar 21;16(11):1377-84 [20238405.001]
  • [Cites] Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1:S51-9 [26189980.001]
  • [Cites] Gut. 2011 Feb;60(2):255-60 [20940288.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Aug 15;18(4):357-73 [12940921.001]
  • [Cites] Nat Rev Cancer. 2007 Aug;7(8):599-612 [17646865.001]
  • [Cites] J Hepatol. 1990 Jul;11(1):92-101 [2204661.001]
  • [Cites] Radiol Technol. 2013 Jul-Aug;84(6):577-92; quiz 593-5 [23861518.001]
  • [Cites] J Hepatol. 2004 Jul;41(1):25-30 [15246203.001]
  • [Cites] Metabolism. 2013 Dec;62(12):1850-7 [24035445.001]
  • [Cites] Aliment Pharmacol Ther. 2013 May;37(9):845-54 [23489011.001]
  • [Cites] Gastroenterology. 2009 Sep;137(3):856-64, 864.e1 [19524577.001]
  • [Cites] Dig Liver Dis. 2009 Jan;41(1):67-70 [18602355.001]
  • [Cites] J Hepatol. 2016 Sep;65(3):618-30 [27155530.001]
  • [Cites] World J Gastroenterol. 2014 Sep 14;20(34):11929-34 [25232227.001]
  • [Cites] J Hepatol. 2016 Apr;64(4):957-67 [26592352.001]
  • [Cites] Med Toxicol. 1987 Jan-Feb;2(1):1-9 [3547003.001]
  • [Cites] J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S7-10 [17567472.001]
  • [Cites] J Gastrointestin Liver Dis. 2013 Jun;22(2):189-97 [23799218.001]
  • [Cites] Hepatology. 2004 Mar;39(3):826-34 [14999703.001]
  • [Cites] J Biol Chem. 2010 Feb 26;285(9):6706-15 [20034933.001]
  • [Cites] Alcohol Clin Exp Res. 2001 May;25(5 Suppl ISBRA):254S-261S [11391080.001]
  • [Cites] Alcohol Clin Exp Res. 1995 Jun;19(3):635-41 [7573786.001]
  • [Cites] Lancet. 1995 Oct 14;346(8981):987-90 [7475591.001]
  • [Cites] Addiction. 2005 Oct;100(10):1477-86 [16185209.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2015 Jul 1;309(1):G30-41 [25930080.001]
  • [Cites] Alcohol Alcohol. 2009 Mar-Apr;44(2):199-203 [19054785.001]
  • [Cites] Nat Rev Gastroenterol Hepatol. 2014 May;11(5):300-7 [24393837.001]
  • [Cites] Scand J Gastroenterol. 2011 Sep;46(9):1127-32 [21591871.001]
  • [Cites] Hepatology. 2016 Oct;64(4):1343-55 [26940353.001]
  • [Cites] Hepatology. 2015 Jun;61(6):1945-56 [25645722.001]
  • [Cites] Nat Genet. 2015 Dec;47(12):1443-8 [26482880.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2014 May 15;306(10):G819-23 [24699333.001]
  • [Cites] Lancet. 2016 Mar 5;387(10022):978-87 [26777270.001]
  • [Cites] J Hepatol. 2013 Jul;59(1):160-8 [23511777.001]
  • [Cites] Cochrane Database Syst Rev. 2012 May 16;(5):CD008344 [22592729.001]
  • [Cites] Nat Protoc. 2013 Mar;8(3):627-37 [23449255.001]
  • [Cites] N Engl J Med. 2011 Nov 10;365(19):1781-9 [22070475.001]
  • [Cites] Hepatology. 1997 Jan;25(1):108-11 [8985274.001]
  • [Cites] Lancet. 2011 Apr 16;377(9774):1297-9 [21334738.001]
  • [Cites] Gastroenterology. 2011 Nov;141(5):1572-85 [21920463.001]
  • [Cites] J Hepatol. 2012 Jun;56(6):1299-304 [22314431.001]
  • [Cites] Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15078-83 [26575631.001]
  • [Cites] J Hepatol. 1989 Jul;9(1):105-13 [2671116.001]
  • [Cites] Hepatology. 2005 Feb;41(2):353-8 [15660383.001]
  • [Cites] Liver Int. 2015 Sep;35(9):2072-8 [25645300.001]
  • [Cites] Hepatology. 2002 Apr;35(4):868-75 [11915033.001]
  • [Cites] Alcohol Clin Exp Res. 2001 Apr;25(4):502-7 [11329488.001]
  • [Cites] Am J Gastroenterol. 2005 Nov;100(11):2583-91 [16279916.001]
  • [Cites] N Engl J Med. 1991 Jun 27;324(26):1852-7 [1904133.001]
  • [Cites] Alcohol Clin Exp Res. 2001 Aug;25(8):1181-7 [11505049.001]
  • [Cites] Hepatology. 2009 Jan;49(1):278-86 [19065677.001]
  • [Cites] World J Gastroenterol. 2015 Oct 21;21(39):11044-52 [26494961.001]
  • [Cites] Alcohol Alcohol. 2008 Sep-Oct;43(5):559-63 [18621800.001]
  • [Cites] Gut. 2007 Dec;56(12):1743-6 [17627961.001]
  • [Cites] Nat Rev Gastroenterol Hepatol. 2015 Jul;12 (7):387-400 [26055245.001]
  • [Cites] Alcohol Clin Exp Res. 1996 Dec;20(9):1528-33 [8986199.001]
  • [Cites] Proteins. 2013 Mar;81(3):406-14 [23042597.001]
  • [Cites] Lancet. 2009 Jun 27;373(9682):2223-33 [19560604.001]
  • [Cites] Gastroenterology. 1978 Aug;75(2):193-9 [352788.001]
  • [Cites] Gastroenterology. 2011 Feb;140(2):488-496.e4 [20682324.001]
  • [Cites] J Hepatol. 1998 Apr;28(4):615-21 [9566830.001]
  • [Cites] Proc Soc Exp Biol Med. 2000 Sep;224(4):302-8 [10964266.001]
  • [Cites] JAMA. 2013 Sep 11;310(10):1033-41 [24026598.001]
  • [Cites] PLoS Med. 2015 Dec 22;12(12):e1001924 [26694529.001]
  • [Cites] Alcohol Clin Exp Res. 2015 Mar;39(3):566-74 [25702770.001]
  • [Cites] Aliment Pharmacol Ther. 2014 Apr;39(7):721-32 [24612165.001]
  • [Cites] J Clin Invest. 2003 Nov;112(9):1383-94 [14597764.001]
  • [Cites] Alcohol Clin Exp Res. 2015 May;39(5):905-10 [25866234.001]
  • [Cites] BMJ. 2006 Mar 4;332(7540):519-22 [16428251.001]
  • [ErratumIn] Gut Liver. 2017 May 15;11(3):447 [28452211.001]
  • (PMID = 28274107.001).
  • [ISSN] 2005-1212
  • [Journal-full-title] Gut and liver
  • [ISO-abbreviation] Gut Liver
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones
  • [Keywords] NOTNLM ; Carcinoma, hepatocellular / Corticosteroid therapy / Hepatitis, alcoholic / Liver transplantation / Malnutrition / PNPLA3
  •  go-up   go-down


20. Linnemayr S, Ryan GW, Liu J, Palar K: Value for Money in Donor HIV Funding. Rand Health Q; 2012;1(4):2
HIV InSite. treatment guidelines - Malaria and HIV .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Countries with the highest burden of human immunodeficiency virus (HIV) disease are heavily reliant on donor funding from such sources as the U.S.
  • To meet the continued need for more HIV services in developing countries, existing resources need to be better leveraged, i.e., to provide improved value for the money.
  • The authors' assessment of available input and output data suggests that current spending allocations across direct and indirect services are not based on increasing value for money.
  • Finally, given projections that funding for HIV will likely not increase, particularly for low-income countries facing the highest HIV burden, an explicit emphasis on improving value for money by finding ways to better leverage existing monies is imperative.

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28083209.001).
  • [Journal-full-title] Rand health quarterly
  • [ISO-abbreviation] Rand Health Q
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Dore GJ, Hatzakis A, Negro F, Waked I: Estimating HCV disease burden-volume 4 (editorial). J Viral Hepat; 2017 Oct;24 Suppl 2:4-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The advent of interferon-free, direct acting antiviral-based (DAA) therapies, with short duration (8-12 weeks), high efficacy, excellent tolerability and ease of delivery (once daily oral dosing), is one of the major advances in clinical medicine in recent decades, and provides the opportunity to address this growing global HCV burden.
  • In May 2014, January 2015 and December 2015, three supplements were published in the Journal of Viral Hepatitis presenting data from 47 countries on the historical epidemiology of HCV, the current HCV-related morbidity and mortality and potential strategies to manage the HCV disease burden in the future.
  • The countries included in those manuscripts were from multiple regions including North and South America, Europe, Asia, the Middle East, Africa and Oceania.
  • In this supplement, data from an additional 17 countries are presented, following a similar pattern as in the previous manuscripts.
  • These countries represent a mixture of high-, middle- and low-income countries that hail from five geographical regions: Africa, Asia, Europe, Middle East and South America.
  • Expert advisory panels were convened in each country to identify the best data sources to use and to review the assumptions and outputs from the model.
  • In the countries considered in the current analyses, there is a wide variance in the availability of robust data.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 John Wiley & Sons Ltd.
  • (PMID = 29105284.001).
  • [ISSN] 1365-2893
  • [Journal-full-title] Journal of viral hepatitis
  • [ISO-abbreviation] J. Viral Hepat.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; diagnosis / disease burden / epidemiology / hepatitis C / hepatitis C virus / prevalence / strategy / sustained viral response / therapies / total infections / treatment
  •  go-up   go-down


22. Rogers C, Dantas JAR: Access to contraception and sexual and reproductive health information post-abortion: a systematic review of literature from low- and middle-income countries. J Fam Plann Reprod Health Care; 2017 Oct;43(4):309-318
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Access to contraception and sexual and reproductive health information post-abortion: a systematic review of literature from low- and middle-income countries.
  • AIM: This systematic literature review documented, analysed and critiqued the accessibility of contraception and sexual and reproductive health (SRH) information for women living in low- and middle-income countries who have undergone medical or surgical abortion.
  • METHODOLOGY: This review systematically collated relevant and recent empirical evidence regarding women's access to contraception and SRH information post-abortion within low- and middle-income countries.
  • The Ovid (MEDLINE), ProQuest, Science Direct, Web of Science, PUBMED and CINAHL databases were searched and studies that met edibility criteria were assessed for validity and analysis.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
  • (PMID = 28209623.001).
  • [ISSN] 2045-2098
  • [Journal-full-title] The journal of family planning and reproductive health care
  • [ISO-abbreviation] J Fam Plann Reprod Health Care
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; contraception / family planning / post-abortion care (PAC) / sexual and reproductive health (SRH) / sexual and reproductive health and rights (SRHR)
  •  go-up   go-down


23. Kobayashi LC, Glymour MM, Kahn K, Payne CF, Wagner RG, Montana L, Mateen FJ, Tollman SM, Berkman LF: Childhood deprivation and later-life cognitive function in a population-based study of older rural South Africans. Soc Sci Med; 2017 Oct;190:20-28

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Linear regression models adjusted for age, sex, and country of birth were used to estimate the total and direct effects of each childhood risk factor, and the indirect effects mediated by years of education.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28837862.001).
  • [ISSN] 1873-5347
  • [Journal-full-title] Social science & medicine (1982)
  • [ISO-abbreviation] Soc Sci Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Aging / Cognitive aging / Cognitive function / Education / Rural / Self-rated health / Socioeconomic conditions / South Africa
  •  go-up   go-down


24. Veenema TG, Thornton CP, Lavin RP, Bender AK, Seal S, Corley A: Climate Change-Related Water Disasters' Impact on Population Health. J Nurs Scholarsh; 2017 Nov;49(6):625-634

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Direct health impact was characterized by four major categories: weather-related morbidity and mortality, waterborne diseases/water-related illness, vector-borne and zoonotic diseases, and psychiatric/mental health effects.
  • Flooding as an event was overrepresented in this analysis (60%), and the majority of the research reviewed was conducted in high-income or upper middle-/high-income countries (62%), despite the fact that low-income countries bear a disproportionate share of the burden on morbidity and mortality from CCRWDs.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Sigma Theta Tau International.
  • (PMID = 28834176.001).
  • [ISSN] 1547-5069
  • [Journal-full-title] Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing
  • [ISO-abbreviation] J Nurs Scholarsh
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Climate change / disasters / public health
  •  go-up   go-down


25. Collineau L, Rojo-Gimeno C, Léger A, Backhans A, Loesken S, Nielsen EO, Postma M, Emanuelson U, Beilage EG, Sjölund M, Wauters E, Stärk KDC, Dewulf J, Belloc C, Krebs S: Herd-specific interventions to reduce antimicrobial usage in pig production without jeopardising technical and economic performance. Prev Vet Med; 2017 Sep 01;144:167-178

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The objective of this study was to assess, across four countries, the technical and economic impact of herd-specific interventions aiming at reducing antimicrobial usage in pig production while implementing alternative measures.
  • A median reduction of 47.0% of antimicrobial usage was achieved across four countries when expressed in terms of treatment incidence from birth to slaughter, corresponding to a 30.5% median reduction of antimicrobial expenditures.
  • It was more influenced by a change in feed conversion ratio and daily weight gain than by a change in antimicrobial expenditures or intervention direct net cost.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier B.V. All rights reserved.
  • (PMID = 28716198.001).
  • [ISSN] 1873-1716
  • [Journal-full-title] Preventive veterinary medicine
  • [ISO-abbreviation] Prev. Vet. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Antibiotics / Compliance / Margin over feed cost / Net farm profit / Preventive measures / Technical performance
  •  go-up   go-down


26. Alves-Silva JM, Romane A, Efferth T, Salgueiro L: North African Medicinal Plants Traditionally Used in Cancer Therapy. Front Pharmacol; 2017;8:383

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Truthfully, herbalists and botanists in North African countries prescribe several plants for cancer treatment.
  • <b>Method:</b> The research was conducted on several popular search engines including PubMed, Science Direct, Scopus and Web of Science.
  • <b>Results:</b> This review on plants traditionally used by herbalists in North Africa highlights that Morocco and Algeria are the countries with most surveys on the use of medicinal plants in folk medicine.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Sci. 2016 Oct;107(10 ):1363-1372 [27486911.001]
  • [Cites] Mol Biol Rep. 2014 Sep;41(9):6247-52 [24973886.001]
  • [Cites] Anticancer Res. 2007 Jul-Aug;27(4A):2053-8 [17649821.001]
  • [Cites] J Ethnopharmacol. 2007 Mar 1;110(1):105-17 [17052873.001]
  • [Cites] Life Sci. 2013 Nov 13;93(21):783-90 [24044882.001]
  • [Cites] Ultrason Sonochem. 2016 Jul;31:449-55 [26964971.001]
  • [Cites] Biosci Biotechnol Biochem. 2005 Mar;69(3):653-8 [15785001.001]
  • [Cites] Biomed Pharmacother. 2017 Jun;90:479-491 [28391170.001]
  • [Cites] Asian Pac J Cancer Prev. 2013;14(3):1829-32 [23679282.001]
  • [Cites] PLoS One. 2013 Sep 09;8(9):e72882 [24039814.001]
  • [Cites] Forsch Komplementmed. 2009 Apr;16(2):79-90 [19420953.001]
  • [Cites] Int J Prev Med. 2016 Apr 14;7:66 [27141285.001]
  • [Cites] Lung Cancer. 2011 May;72(2):154-9 [21354647.001]
  • [Cites] J Ethnopharmacol. 2013 Feb 13;145(3):746-57 [23228916.001]
  • [Cites] Biochem Pharmacol. 2011 Sep 1;82(5):464-75 [21679698.001]
  • [Cites] Oncotarget. 2015 Dec 1;6(38):41324-38 [26510914.001]
  • [Cites] Food Chem Toxicol. 2011 Jun;49(6):1270-5 [21385597.001]
  • [Cites] Food Chem Toxicol. 2012 Jun;50(6):1817-25 [22433985.001]
  • [Cites] PLoS One. 2011;6(5):e20164 [21629786.001]
  • [Cites] Int J Med Sci. 2015 Oct 03;12(10):825-31 [26516311.001]
  • [Cites] J Assoc Physicians India. 2001 Nov;49:1057-61 [11868855.001]
  • [Cites] Front Cell Dev Biol. 2014 Feb 20;2:3 [25364712.001]
  • [Cites] Food Nutr Res. 2015 Dec 22;59:29884 [26699938.001]
  • [Cites] Fitoterapia. 2012 Sep;83(6):1115-9 [22579841.001]
  • [Cites] Bioresour Technol. 2008 Dec;99(18):9004-8 [18538563.001]
  • [Cites] J Ethnopharmacol. 2010 Sep 15;131(2):321-5 [20600755.001]
  • [Cites] Drug Des Devel Ther. 2015 Jun 18;9:3119-24 [26124636.001]
  • [Cites] Avicenna J Phytomed. 2013 Spring;3(2):152-8 [25050269.001]
  • [Cites] Biochim Biophys Acta. 2014 Jan;1845(1):42-52 [24295567.001]
  • [Cites] Phytomedicine. 2002 Jan;9(1):69-74 [11924767.001]
  • [Cites] J Ethnopharmacol. 2015 Dec 4;175:147-52 [26386381.001]
  • [Cites] Oncogene. 2006 Mar 9;25(10):1463-73 [16331273.001]
  • [Cites] Pharm Biol. 2014 Feb;52(2):243-54 [24102093.001]
  • [Cites] Planta Med. 2016 Mar;82(4):312-21 [26848703.001]
  • [Cites] Asian Pac J Cancer Prev. 2014;15(2):983-7 [24568529.001]
  • [Cites] Iran J Pharm Res. 2015 Spring;14(2):539-46 [25901162.001]
  • [Cites] Ann N Y Acad Sci. 2009 Aug;1171:59-76 [19723038.001]
  • [Cites] Cell Death Dis. 2013 Jun 06;4:e660 [23744360.001]
  • [Cites] Pharmacognosy Res. 2015 Apr-Jun;7(2):193-7 [25829794.001]
  • [Cites] Food Chem Toxicol. 2009 Nov;47(11):2768-75 [19699773.001]
  • [Cites] Life Sci. 2005 Aug 5;77(12 ):1319-30 [15916774.001]
  • [Cites] J Med Food. 2013 Dec;16(12):1121-30 [24328702.001]
  • [Cites] Fitoterapia. 2000 Jun;71(3):278-307 [10844168.001]
  • [Cites] J Ethnopharmacol. 2015 Dec 4;175:626-37 [26440857.001]
  • [Cites] Cell Cycle. 2016;15(2):196-212 [26825227.001]
  • [Cites] Oncol Rep. 2014 Aug;32(2):821-8 [24890449.001]
  • [Cites] J Ayub Med Coll Abbottabad. 2008 Apr-Jun;20(2):25-7 [19385451.001]
  • [Cites] PLoS One. 2014 Jul 11;9(7):e102110 [25013907.001]
  • [Cites] J Ethnopharmacol. 2013 Jul 9;148(2):395-402 [23643544.001]
  • [Cites] Food Chem Toxicol. 2013 May;55:470-5 [23380204.001]
  • [Cites] Res Commun Mol Pathol Pharmacol. 2001;110(3-4):239-51 [12760491.001]
  • [Cites] Toxicol Int. 2012 Sep;19(3):287-94 [23293468.001]
  • [Cites] J Ethnopharmacol. 2014 May 28;154(1):76-87 [24685583.001]
  • [Cites] Aging Male. 2016 Jun;19(2):134-42 [26791805.001]
  • [Cites] Food Chem Toxicol. 2014 Jul;69:76-85 [24705020.001]
  • [Cites] Cancer Metastasis Rev. 2005 Jun;24(2):315-27 [15986140.001]
  • [Cites] Toxicol Lett. 2013 Oct 23;223(1):60-72 [24012840.001]
  • [Cites] J Ethnopharmacol. 2016 Dec 24;194:196-218 [27592312.001]
  • [Cites] Br J Pharmacol. 2010 Oct;161(3):541-54 [20880395.001]
  • [Cites] Eur J Clin Pharmacol. 2009 Dec;65(12):1175-8 [19809809.001]
  • [Cites] J Ethnopharmacol. 2006 May 24;105(3):358-67 [16414225.001]
  • [Cites] J Ethnopharmacol. 2003 Jun;86(2-3):149-58 [12738079.001]
  • [Cites] Pharmazie. 2005 Jul;60(7):544-7 [16076084.001]
  • [Cites] Anticancer Res. 2005 Nov-Dec;25(6B):4255-9 [16309225.001]
  • [Cites] Expert Opin Investig Drugs. 2013 Mar;22(3):369-77 [23256895.001]
  • [Cites] Braz J Med Biol Res. 2007 Jun;40(6):839-47 [17581684.001]
  • [Cites] Planta Med. 2010 Jan;76(1):86-7 [19644796.001]
  • [Cites] Mutat Res. 2011 Jan 10;706(1-2):28-35 [21040738.001]
  • [Cites] Phytother Res. 2001 May;15(3):257-9 [11351364.001]
  • [Cites] Biochem Pharmacol. 2010 May 1;79(9):1251-60 [20026309.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1392-8 [15298963.001]
  • [Cites] Cell Biol Int. 2005 Aug;29(8):687-94 [15936223.001]
  • [Cites] Biomed Res Int. 2013;2013:417928 [24288678.001]
  • [Cites] J Ethnopharmacol. 2015 May 26;166:250-60 [25797117.001]
  • [Cites] J Ethnopharmacol. 2016 Jul 21;188:96-110 [27174082.001]
  • [Cites] Z Naturforsch C. 2007 Sep-Oct;62(9-10):656-60 [18069236.001]
  • [Cites] J Tradit Complement Med. 2016 May 21;7(2):195-204 [28417090.001]
  • [Cites] Planta Med. 2002 Apr;68(4):297-301 [11988850.001]
  • [Cites] Chem Biol Interact. 2007 Nov 20;170(2):135-43 [17850779.001]
  • [Cites] PLoS One. 2016 Apr 13;11(4):e0153496 [27073921.001]
  • [Cites] J Ethnopharmacol. 1997 Nov;58(3):149-55 [9421250.001]
  • [Cites] Biomed Res Int. 2014;2014:135048 [24900952.001]
  • [Cites] J Ethnopharmacol. 1997 Oct;58(2):125-9 [9406901.001]
  • [Cites] FEBS Lett. 2001 Oct 12;506(3):225-30 [11602250.001]
  • [Cites] Saudi J Biol Sci. 2011 Oct;18(4):353-9 [23961147.001]
  • [Cites] Food Chem Toxicol. 2016 Oct;96:145-54 [27498339.001]
  • [Cites] Food Chem Toxicol. 1999 Aug;37(8):831-8 [10506006.001]
  • [Cites] Int J Mol Med. 2003 Jan;11(1):23-6 [12469212.001]
  • [Cites] Nat Prod Res. 2015;29(5):474-9 [25141946.001]
  • [Cites] Phytother Res. 2004 May;18(5):395-8 [15174000.001]
  • [Cites] Biochim Biophys Acta. 2014 Jan;1843(1):150-62 [23466868.001]
  • [Cites] Chem Biodivers. 2010 Jan;7(1):129-39 [20087986.001]
  • [Cites] Nutr Cancer. 2016;68(1):131-43 [26771897.001]
  • [Cites] Asian Pac J Cancer Prev. 2013;14(10):5783-8 [24289578.001]
  • [Cites] Am J Chin Med. 2011;39(6):1075-91 [22083982.001]
  • [Cites] Food Chem Toxicol. 2009 Jan;47(1):129-33 [19010375.001]
  • [Cites] Toxicol Lett. 2012 Sep 3;213(2):151-9 [22732633.001]
  • [Cites] Lipids Health Dis. 2011 Sep 21;10:161 [21936887.001]
  • [Cites] Integr Cancer Ther. 2014 Jul;13(4):351-67 [24363284.001]
  • [Cites] Phytomedicine. 2013 Oct 15;20(13):1211-8 [23860409.001]
  • [Cites] Food Chem Toxicol. 2011 Feb;49(2):342-7 [21075159.001]
  • [Cites] Asian Pac J Cancer Prev. 2011;12(12):3299-304 [22471470.001]
  • [Cites] Pharm Biol. 2013 Dec;51(12):1508-14 [23862683.001]
  • [Cites] BMC Complement Altern Med. 2012 May 28;12:69 [22640402.001]
  • [Cites] PLoS One. 2010 Aug 12;5(8):e12124 [20711342.001]
  • [Cites] Epilepsy Res. 2011 Jan;93(1):39-43 [21112742.001]
  • [Cites] Cancer Biol Ther. 2009 Feb;8(3):272-8 [19197146.001]
  • [Cites] J Exp Clin Cancer Res. 2013 May 20;32:30 [23688286.001]
  • [Cites] Cell Mol Biol (Noisy-le-grand). 2016 Sep 30;62(11):108-114 [27755961.001]
  • [Cites] Phytomedicine. 2010 Feb;17 (2):157-60 [19576744.001]
  • [Cites] Iran J Basic Med Sci. 2013 Jan;16(1):27-38 [23638290.001]
  • [Cites] Can J Physiol Pharmacol. 1997 Dec;75(12):1356-61 [9534946.001]
  • [Cites] J Altern Complement Med. 2009 Jun;15(6):639-44 [19500003.001]
  • [Cites] Biomed Res Int. 2015;2015:914645 [26557712.001]
  • [Cites] J Ethnopharmacol. 2007 May 30;112(1):199-202 [17324542.001]
  • [Cites] Food Chem Toxicol. 2013 May;55:202-8 [23333573.001]
  • [Cites] Gene. 2016 Jun 10;584(1):97-109 [26968890.001]
  • [Cites] Sci Pharm. 2010;78(1):33-45 [21179373.001]
  • [Cites] Int J Mol Sci. 2013 Dec 02;14(12):23533-44 [24317429.001]
  • [Cites] Pharm Biol. 2010 Mar;48(3):269-74 [20645812.001]
  • [Cites] Complement Ther Med. 2015 Apr;23(2):165-74 [25847554.001]
  • [Cites] Toxicol Mech Methods. 2014 Oct;24(7):495-503 [25045923.001]
  • [Cites] BMC Complement Altern Med. 2012 Oct 30;12:202 [23110539.001]
  • [Cites] Chem Biol Interact. 2009 Sep 14;181(1):85-94 [19446539.001]
  • [Cites] Phytother Res. 2011 Sep;25(9):1294-300 [21312304.001]
  • [Cites] J Ethnopharmacol. 2015 Nov 4;174:644-58 [26165828.001]
  • [Cites] PLoS One. 2012;7(10):e46641 [23077516.001]
  • [Cites] J Ethnopharmacol. 2000 Apr;70(1):65-8 [10720790.001]
  • [Cites] Cancer Chemother Pharmacol. 2005 Jan;55(1):79-90 [15372201.001]
  • [Cites] Trends Mol Med. 2012 Jan;18(1):13-26 [22177734.001]
  • [Cites] Autophagy. 2015;11(6):867-80 [25836756.001]
  • [Cites] Oncogene. 2014 Feb 27;33(9):1158-66 [23455323.001]
  • [Cites] Anal Biochem. 2013 May 15;436(2):187-9 [23416182.001]
  • [Cites] J Ethnopharmacol. 2000 Apr;70(1):1-7 [10720783.001]
  • [Cites] Phytother Res. 2015 Aug;29(8):1123-30 [25914334.001]
  • [Cites] BMC Complement Altern Med. 2014 Mar 29;14:114 [24679057.001]
  • [Cites] Int J Oncol. 2004 Sep;25(3):555-62 [15289856.001]
  • (PMID = 28694778.001).
  • [ISSN] 1663-9812
  • [Journal-full-title] Frontiers in pharmacology
  • [ISO-abbreviation] Front Pharmacol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; North Africa / anticancer / cancer / ethnobotanical / medicinal plants
  •  go-up   go-down


27. Prokop I, Yearwood K, Da Breo H, Rooney P, Walker RH, Sobering AK: Presentation and care of a family with Huntington disease in a resource-limited community. J Clin Mov Disord; 2017;4:4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: In high-income countries patients with Huntington disease (HD) typically present to healthcare providers after developing involuntary movements, or for pre-symptomatic genetic testing if at familial risk.
  • The experience of healthcare for such progressive neurodegenerative diseases in low- and middle-income nations is in stark contrast with the standard of care in high-income countries.
  • RESULTS: Through family recollection and by direct observation we identified four generations of individuals affected with HD.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Geriatr Psychiatry Neurol. 2010 Dec;23 (4):243-59 [20923757.001]
  • [Cites] J Neural Transm (Vienna). 2012 Nov;119(11):1361-5 [22398875.001]
  • [Cites] Genet Test Mol Biomarkers. 2010 Oct;14(5):629-36 [20722493.001]
  • [Cites] Brain. 1998 Mar;121 ( Pt 3):459-67 [9549522.001]
  • [Cites] Asian Pac J Cancer Prev. 2011;12 (6):1619-26 [22126509.001]
  • [Cites] Lancet Neurol. 2011 Jan;10 (1):31-42 [21130037.001]
  • [Cites] West Indian Med J. 1963 Mar;12:39-46 [13969988.001]
  • [Cites] Cytogenet Genome Res. 2003;100(1-4):25-55 [14526163.001]
  • [Cites] Am J Hum Genet. 1997 May;60(5):1202-10 [9150168.001]
  • [Cites] Curr Neurol Neurosci Rep. 2015;15(2):514 [25620691.001]
  • [Cites] Am J Nurs. 2008 Sep;108(9 Suppl):23-7; quiz 27 [18797217.001]
  • [Cites] Intern Med J. 2013 Dec;43(12):1272-9 [23654213.001]
  • [Cites] Nat Rev Neurol. 2014 Apr;10 (4):204-16 [24614516.001]
  • [Cites] Qual Life Res. 2012 Oct;21(8):1425-35 [22081218.001]
  • [Cites] J Clin Exp Neuropsychol. 2007 May;29(4):365-76 [17497560.001]
  • [Cites] Soc Sci Med. 2004 Jan;58(1):137-49 [14572927.001]
  • [Cites] Int J Palliat Nurs. 2005 Nov;11(11):562, 564-71 [16471043.001]
  • [Cites] Patient Educ Couns. 2007 Mar;65(3):279-87 [17000074.001]
  • [Cites] Psychosom Med. 2006 May-Jun;68(3):414-20 [16738073.001]
  • [Cites] Front Biosci (Schol Ed). 2013 Jan 01;5:1-18 [23277034.001]
  • [Cites] Support Care Cancer. 2016 Jan;24(1):409-18 [26093976.001]
  • [Cites] J Neurol Sci. 2013 Dec 15;335(1-2):101-4 [24054538.001]
  • [Cites] Brain. 2003 Jul;126(Pt 7):1599-603 [12805114.001]
  • [Cites] Patient Educ Couns. 2005 Feb;56(2):139-46 [15653242.001]
  • [Cites] Cell. 1993 Mar 26;72(6):971-83 [8458085.001]
  • [Cites] J Am Board Fam Med. 2011 Jan-Feb;24(1):115-6 [21209352.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8834-8 [12857955.001]
  • [Cites] Mov Disord. 2013 Jul;28(8):1142-5 [23495076.001]
  • [Cites] Dialogues Clin Neurosci. 2007;9(2):191-7 [17726917.001]
  • [Cites] Lancet. 2000 Dec 9;356(9246):1944-5 [11130517.001]
  • [Cites] Ann Oncol. 2012 Apr;23 Suppl 3:66-9 [22628419.001]
  • [Cites] Lancet. 2007 Jan 20;369(9557):218-28 [17240289.001]
  • [Cites] Brain Res Bull. 2007 Apr 30;72(2-3):165-71 [17352941.001]
  • [Cites] Clin Genet. 2011 Sep;80(3):281-6 [20880124.001]
  • [Cites] Dialogues Clin Neurosci. 2016 Mar;18(1):91-8 [27069383.001]
  • [Cites] Trends Mol Med. 2003 Nov;9(11):490-5 [14604827.001]
  • [Cites] J Int Neuropsychol Soc. 2011 Sep;17(5):788-95 [21729402.001]
  • (PMID = 28413688.001).
  • [ISSN] 2054-7072
  • [Journal-full-title] Journal of clinical movement disorders
  • [ISO-abbreviation] J Clin Mov Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Anticipation / Cultural competency / Huntington disease / Resource-limited community / Trinucleotide repeat disorder
  •  go-up   go-down


28. Tarp J, Bugge A, Andersen LB, Sardinha LB, Ekelund U, Brage S, Møller NC: Does adiposity mediate the relationship between physical activity and biological risk factors in youth?: a cross-sectional study from the International Children's Accelerometry Database (ICAD). Int J Obes (Lond); 2017 Oct 03;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND/OBJECTIVES: To model the association between accumulating 60 daily minutes of moderate-to-vigorous physical activity and a composite score of biological risk factors into a direct and an indirect effect, using abdominal obesity as the mediator.
  • SUBJECTS/METHODS: Cross-sectional data from the International Children's Accelerometry Database (ICAD) including 6-18-year-old children and adolescents (N=3412) from 4 countries providing at least 3 days of accelerometry-assessed physical activity.
  • Modelling the associations suggested that 0.24 standard deviations (95% CI: -0.32, -0.16) was attributed to the direct effect and -0.07 (95% CI: -0.11, -0.02) to the indirect effect indicating that 22% of the total effect was mediated by central adiposity.
  • Modelling 30 and 90 min of moderate-to-vigorous physical activity per day resulted in changes in the direct but not the indirect effect.
  • The majority of the difference was explained by the direct effect of physical activity.International Journal of Obesity advance online publication, 31 October 2017; doi:10.1038/ijo.2017.241.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29087387.001).
  • [ISSN] 1476-5497
  • [Journal-full-title] International journal of obesity (2005)
  • [ISO-abbreviation] Int J Obes (Lond)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


29. Ilboudo PG, Huang XX, Ngwira B, Mwanyungwe A, Mogasale V, Mengel MA, Cavailler P, Gessner BD, Le Gargasson JB: Cost-of-illness of cholera to households and health facilities in rural Malawi. PLoS One; 2017;12(9):e0185041
MedlinePlus Health Information. consumer health - Rural Health Concerns.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cholera remains an important public health problem in many low- and middle-income countries.
  • Data collected for the assessment in households included direct and indirect costs borne by cholera patients and their families while only direct costs were considered for the assessment conducted in health facilities.
  • Moreover, 52% of households used coping strategies to compensate for direct and indirect costs imposed by the disease.
  • These findings have direct policy implications regarding priority investments for the prevention and control of cholera.

  • Genetic Alliance. consumer health - Cholera.
  • MedlinePlus Health Information. consumer health - Cholera.
  • MedlinePlus Health Information. consumer health - Health Facilities.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Vaccine. 2006 May 29;24(22):4890-5 [16298025.001]
  • [Cites] Value Health. 2009 Sep;12(6):899-908 [19824189.001]
  • [Cites] BMC Infect Dis. 2013 Nov 04;13:518 [24188717.001]
  • [Cites] J Health Popul Nutr. 2003 Dec;21(4):304-8 [15043004.001]
  • [Cites] Health Econ. 2008 Dec;17(12):1393-412 [18246595.001]
  • [Cites] BMC Int Health Hum Rights. 2009 Apr 30;9:8 [19405948.001]
  • [Cites] J Health Popul Nutr. 2006 Mar;24(1):1-5 [16796143.001]
  • [Cites] J Infect Dis. 2013 Nov 1;208 Suppl 1:S8-14 [24101650.001]
  • [Cites] Bull World Health Organ. 2012 Mar 1;90(3):209-218A [22461716.001]
  • [Cites] PLoS Med. 2007 Nov 27;4(11):e336 [18044983.001]
  • [Cites] Curr Top Microbiol Immunol. 2014;379:231-58 [24402712.001]
  • [Cites] PLoS Negl Trop Dis. 2016 Dec 8;10 (12 ):e0005124 [27930668.001]
  • [Cites] Emerg Infect Dis. 2016 Mar;22(3):410-6 [26886511.001]
  • [Cites] Malawi Med J. 2012 Jun;24(2):29-33 [23638267.001]
  • [Cites] PLoS Negl Trop Dis. 2008 Feb 20;2(2):e173 [18299707.001]
  • [Cites] J Infect Dis. 2013 Nov 1;208 Suppl 1:S107-14 [24101638.001]
  • [Cites] PLoS One. 2013 Dec 03;8(12):e81231 [24312540.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Sep 09;9(9):e0004072 [26352143.001]
  • [Cites] PLoS Med. 2013;10(9):e1001512 [24058301.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jun 04;9(6):e0003832 [26043000.001]
  • [Cites] PLoS Negl Trop Dis. 2012;6(10):e1844 [23056660.001]
  • [Cites] Clin Mol Hepatol. 2014 Dec;20(4):327-37 [25548737.001]
  • [Cites] Epidemiol Infect. 2012 Mar;140(3):500-9 [21554781.001]
  • [Cites] Bull World Health Organ. 2016 Sep 1;94(9):667-674 [27708472.001]
  • [Cites] Health Policy Plan. 2004 Mar;19(2):127-35 [14982891.001]
  • [Cites] N Engl J Med. 2013 Feb 14;368(7):599-609 [23301694.001]
  • (PMID = 28934285.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


30. Piano L, Maselli F, Viceconti A, Gianola S, Ciuro A: Direct access to physical therapy for the patient with musculoskeletal disorders, a literature review. J Phys Ther Sci; 2017 Aug;29(8):1463-1471

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Direct access to physical therapy for the patient with musculoskeletal disorders, a literature review.
  • [Purpose] To present legislation comparing direct and referred access-or other measures-to physical therapy.
  • [Results] legislation on Direct Access highlights inconsistencies among the countries belonging to World Confederation for Physical Therapy.
  • Direct Access could be an effective, safe and efficient organization model for the management of patients with musculoskeletal diseases and seems to be more effective safer and cost effective.
  • [Conclusion] Direct Access is a virtuous model which can help improve the global quality of physical therapy services.
  • Further studies are required to confirm this approach and determine whether the findings of the present overview can be replicated in different countries and healthcare systems.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Man Ther. 2010 Aug;15(4):355-63 [20097115.001]
  • [Cites] Br J Gen Pract. 1993 Feb;43(367):61-4 [8466777.001]
  • [Cites] BMC Musculoskelet Disord. 2005 Jun 17;6:32 [15963232.001]
  • [Cites] Ann Rheum Dis. 2014 Jul;73(7):1323-30 [24553908.001]
  • [Cites] Phys Ther. 1997 Jan;77(1):10-8 [8996459.001]
  • [Cites] Phys Ther. 2014 Jan;94(1):14-30 [24029295.001]
  • [Cites] Physiotherapy. 2013 Dec;99(4):285-91 [23537881.001]
  • [Cites] Phys Ther. 2014 Mar;94(3):363-70 [24092899.001]
  • [Cites] Physiotherapy. 2011 Jun;97(2):107-14 [21497244.001]
  • [Cites] Ann Rheum Dis. 2014 Jun;73(6):982-9 [24550172.001]
  • [Cites] J Occup Environ Med. 2000 Jan;42(1):35-9 [10652686.001]
  • [Cites] Clin J Pain. 2006 Jul-Aug;22(6):505-11 [16788335.001]
  • [Cites] J Physiother. 2010;56(4):217-8 [21091408.001]
  • [Cites] Phys Ther. 2008 Aug;88(8):936-46 [18566108.001]
  • [Cites] Phys Ther. 2012 Feb;92(2):236-50 [22033072.001]
  • [Cites] J Allied Health. 2015 Fall;44(3):164-8 [26342614.001]
  • [Cites] BMC Musculoskelet Disord. 2014 Mar 12;15:77 [24618345.001]
  • [Cites] Arthritis Res Ther. 2012 Feb 29;14(1):205 [22404958.001]
  • [Cites] Physiotherapy. 1977 Aug;63(8):246-8 [896988.001]
  • [Cites] Ann Rheum Dis. 2014 Jul;73(7):1309-15 [24482302.001]
  • [Cites] Phys Ther. 1991 May;71(5):382-9 [2027894.001]
  • [Cites] J Orthop Sports Phys Ther. 2005 Oct;35(10):674-8 [16294989.001]
  • [Cites] Man Ther. 2015 Apr;20(2):335-41 [25454683.001]
  • [Cites] Health Serv Res. 2012 Apr;47(2):633-54 [22092033.001]
  • [Cites] Phys Ther. 2013 Apr;93(4):449-59 [23197847.001]
  • [Cites] BMJ. 2016 Jan 05;352:h6844 [26732983.001]
  • [Cites] Ann Rheum Dis. 2014 Jun;73(6):968-74 [24665116.001]
  • [Cites] Lancet. 2015 Aug 22;386(9995):743-800 [26063472.001]
  • [Cites] Phys Ther. 1989 Oct;69(10):850-7 [2780811.001]
  • [Cites] J Epidemiol Community Health. 1999 Oct;53(10 ):643-50 [10616677.001]
  • (PMID = 28878484.001).
  • [ISSN] 0915-5287
  • [Journal-full-title] Journal of physical therapy science
  • [ISO-abbreviation] J Phys Ther Sci
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Japan
  • [Keywords] NOTNLM ; Musculoskeletal diseases / Physical therapy specialty / Referral and consultation
  •  go-up   go-down


31. Roure S, Valerio L, Pérez-Quílez O, Fernández-Rivas G, Martínez-Cuevas O, Alcántara-Román A, Viasus D, Pedro-Botet ML, Sabrià M, Clotet B: Epidemiological, clinical, diagnostic and economic features of an immigrant population of chronic schistosomiasis sufferers with long-term residence in a non-endemic country (North Metropolitan area of Barcelona, 2002-2016). PLoS One; 2017;12(9):e0185245
Genetic Alliance. consumer health - Schistosomiasis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiological, clinical, diagnostic and economic features of an immigrant population of chronic schistosomiasis sufferers with long-term residence in a non-endemic country (North Metropolitan area of Barcelona, 2002-2016).
  • Direct microbiological diagnosis was more useful in patients with less than 5 years of residence in the EU (p = 0.05).
  • CONCLUSION: Morbidity associated with chronic long-term schistosomiasis is frequent among African immigrants in non-endemic countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS Negl Trop Dis. 2015 Jul 31;9(7):e0003963 [26230990.001]
  • [Cites] J Urol. 1997 Apr;157(4):1232-5; discussion 1235-6 [9120909.001]
  • [Cites] J Trop Med. 2016;2016:5405207 [27635146.001]
  • [Cites] Eur J Public Health. 2014 Aug;24 Suppl 1:47-56 [25107998.001]
  • [Cites] PLoS Negl Trop Dis. 2013 Jul 25;7(7):e2268 [23936559.001]
  • [Cites] Sante. 2010 Oct-Dec;20(4):201-8 [21320812.001]
  • [Cites] Bull Soc Pathol Exot. 2006 May;99(2):110-2 [16821442.001]
  • [Cites] BMJ. 2011 May 17;342:d2651 [21586478.001]
  • [Cites] PLoS Negl Trop Dis. 2015 May 14;9(5):e0003752 [25973845.001]
  • [Cites] Int J Mol Sci. 2015 Jul 16;16(7):16085-103 [26193254.001]
  • [Cites] BJU Int. 2001 Dec;88(9):915-20 [11851613.001]
  • [Cites] Euro Surveill. 2015 Jun 11;20(23):null [26084315.001]
  • [Cites] Lancet. 2006 Sep 23;368(9541):1106-18 [16997665.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2015 Mar;109(3):214-20 [25575554.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2014 Mar;108(3):159-64 [24535152.001]
  • [Cites] Lancet Infect Dis. 2016 Aug;16(8):971-9 [27197551.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2002 Mar;21(3):219-23 [11957026.001]
  • [Cites] Clin Med (Lond). 2015 Feb;15(1):67-9 [25650202.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2000 Sep-Oct;94(5):531-4 [11132383.001]
  • [Cites] Lancet. 2014 Jun 28;383(9936):2253-64 [24698483.001]
  • [Cites] Infect Agent Cancer. 2013 May 24;8(1):19 [23705833.001]
  • [Cites] Res Rep Trop Med. 2014 Oct 17;2014(5):65-75 [25400499.001]
  • [Cites] Clin Vaccine Immunol. 2012 Jun;19(6):948-53 [22441394.001]
  • [Cites] Ghana Med J. 2011 Mar;45(1):16-21 [21572820.001]
  • [Cites] J Pediatr Urol. 2014 Feb;10(1):88-93 [23891456.001]
  • [Cites] Rev Med Interne. 2006 Aug;27(8):595-9 [16822596.001]
  • [Cites] Enferm Infecc Microbiol Clin. 2013 Apr;31(4):205-9 [22683176.001]
  • [Cites] Clin Microbiol Infect. 2015 Jun;21(6):529-42 [25843503.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jul 28;9(7):e0003959 [26217948.001]
  • [Cites] Trop Med Int Health. 2008 Dec;13(12):1509-17 [19055625.001]
  • [Cites] Transplantation. 1987 Dec;44(6):795-8 [2962342.001]
  • (PMID = 28953954.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Karbalaie Niya MH, Rezaee-Zavareh MS, Ranaei A, Alavian SM: Hepatitis E virus seroprevalence rate among Eastern Mediterranean and middle eastern countries; A systematic review and pooled analysis. Microb Pathog; 2017 Sep;110:252-256

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatitis E virus seroprevalence rate among Eastern Mediterranean and middle eastern countries; A systematic review and pooled analysis.
  • HEV occurrence is more common in developing countries and recently increased in developed countries too.
  • In this regard, we aimed to design a systematic review and pooled analysis to determine seroprevalence of anti-HEV antibody in ME and EMR countries.
  • EVIDENCE ACQUISITION: By using PRISMA guideline, data were collected from papers identified through PubMed, Web of Science, Science Direct, Scopus and also from some national and regional databases from January 1990 to June 2016.
  • HEV prevalence in the ME, WHO EMR countries, and in total, calculated by each country population size based on 2015 UN report.
  • Considering anti-HEV antibody (IgG), prevalence of HEV infection in the countries of ME, WHO EMR and in total were 12.17% (95% CI: 11.79-12.57), 11.81% (95% CI: 11.43-12.21), and 11.87% (95% CI: 11.52-12.23) respectively.
  • CONCLUSIONS: HEV seroprevalence in WHO EMR and ME countries has high rate and more considerations are needed for the prevention and control of this infection especially in high-risk groups such as pregnant women.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017. Published by Elsevier Ltd.
  • (PMID = 28688980.001).
  • [ISSN] 1096-1208
  • [Journal-full-title] Microbial pathogenesis
  • [ISO-abbreviation] Microb. Pathog.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Eastern Mediterranean region / Epidemiology / Hepatitis E virus / Middle East / Prevalence / Systematic review
  •  go-up   go-down


33. Masoud S, Rajabi G, Delavari F, Rezaei N: Evaluating Awareness of Pediatricians and General Practitioners on Transformation of the Health System in Iran. Acta Med Iran; 2017 Jan;55(1):49-52

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study was to measure the level of awareness of practitioners in Iran, after initiating the new transformation of the health system in the country, starting from May 2014.
  • 57.7% of physicians were completely aware of the time of the new system settlement in the country, while the rest had either no idea or did not know the exact date.
  • The participants suggested a few items promote the health system in the country; among them, decreasing the direct payment between patients and physicians was suggested most frequently.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28188943.001).
  • [ISSN] 1735-9694
  • [Journal-full-title] Acta medica Iranica
  • [ISO-abbreviation] Acta Med Iran
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Iran
  • [Keywords] NOTNLM ; Awareness / Healthcare / Hospital / Physicians
  •  go-up   go-down


34. O'Hara J, Hughes D, Camp C, Burke T, Carroll L, Diego DG: The cost of severe haemophilia in Europe: the CHESS study. Orphanet J Rare Dis; 2017 May 31;12(1):106

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This burden has been quantified and documented for a number of European countries in recent years.
  • However, few studies have taken a standardised methodology across multiple countries simultaneously, and sought to amalgamate all three levels of burden for severe disease.
  • The overall aim of the 'Cost of Haemophilia in Europe: a Socioeconomic Survey' (CHESS) study was to capture the annualised economic and psychosocial burden of severe haemophilia in five European countries.
  • In turn, patients provided corresponding direct and indirect non-medical cost information, including work loss and out-of-pocket expenses, as well as information on quality of life and adherence.
  • The direct and indirect costs for the patient sample were calculated and extrapolated to population level.
  • The total annual cost of severe haemophilia across the five countries for 2014 was estimated at EUR 1.4 billion, or just under EUR 200,000 per patient.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Manag Care Pharm. 2007 Nov-Dec;13(9):790-8 [18062730.001]
  • [Cites] Haemophilia. 2004 May;10(3):199-217 [15086318.001]
  • [Cites] Haemophilia. 2004 Oct;10 Suppl 4:152-6 [15479389.001]
  • [Cites] Haemophilia. 2012 Mar;18(2):276-83 [22188641.001]
  • [Cites] Haemophilia. 2005 Nov;11 Suppl 1:11-7 [16219044.001]
  • [Cites] Haemophilia. 2012 Nov;18(6):868-74 [22642565.001]
  • [Cites] Clin Interv Aging. 2007;2(3):361-8 [18044186.001]
  • [Cites] Blood. 2003 Oct 1;102(7):2358-63 [12816859.001]
  • [Cites] Haemophilia. 2016 Jan;22(1):96-102 [26278414.001]
  • [Cites] Eur J Health Econ. 2016 Apr;17 Suppl 1:53-65 [27048374.001]
  • [Cites] Blood Transfus. 2014 Apr;12 Suppl 3:s567-75 [24922297.001]
  • [Cites] J Thromb Haemost. 2004 Jul;2(7):1047-54 [15219185.001]
  • [Cites] BMC Health Serv Res. 2015 Oct 26;15:484 [26502954.001]
  • [Cites] Value Health. 2012 May;15(3):429-36 [22583452.001]
  • [Cites] Haemophilia. 2009 Jul;15(4):853-63 [19228203.001]
  • [Cites] Med Care. 1997 Nov;35(11):1095-108 [9366889.001]
  • [Cites] Hematology Am Soc Hematol Educ Program. 2011;2011:413-8 [22160067.001]
  • [Cites] Semin Thromb Hemost. 2005 Nov;31(5):561-8 [16276465.001]
  • [Cites] JAMA. 2002 Jul 17;288(3):358-62 [12117401.001]
  • [Cites] Blood. 2011 Jun 9;117(23 ):6367-70 [21471523.001]
  • [Cites] J Med Econ. 2015 Jun;18(6):457-65 [25660324.001]
  • [Cites] Blood. 2007 Aug 1;110(3):815-25 [17446349.001]
  • [Cites] Indian J Med Res. 2014 Jul;140(1):19-31 [25222774.001]
  • [Cites] Haemophilia. 2006 Mar;12(2):154-62 [16476090.001]
  • [Cites] Haemophilia. 1998 Jul;4(4):558-63 [9873794.001]
  • [Cites] Haemophilia. 2009 May;15(3):665-75 [19432921.001]
  • [Cites] Diabetologia. 2002 Jul;45(7):S5-12 [12136405.001]
  • [Cites] Orphanet J Rare Dis. 2012 May 02;7:24 [22551339.001]
  • [Cites] J Thromb Haemost. 2006 Mar;4(3):507-9 [16460431.001]
  • [Cites] Value Health. 2013 Jul-Aug;16(5):814-22 [23947975.001]
  • [Cites] Orphanet J Rare Dis. 2014 Mar 21;9:39 [24655371.001]
  • [Cites] Haemophilia. 2017 Jan;23 (1):105-114 [27761962.001]
  • [Cites] J Intern Med. 2016 Jun;279(6):498-501 [27199237.001]
  • [Cites] Haemophilia. 2013 Jul;19(4):499-502 [23517072.001]
  • [Cites] Haemophilia. 2011 Jan;17(1):21-7 [20579110.001]
  • (PMID = 28569181.001).
  • [ISSN] 1750-1172
  • [Journal-full-title] Orphanet journal of rare diseases
  • [ISO-abbreviation] Orphanet J Rare Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Burden / Cost / Haemophilia / Health economics / Health-related quality of life
  •  go-up   go-down


35. Vangen S, Bødker B, Ellingsen L, Saltvedt S, Gissler M, Geirsson RT, Nyfløt LT: Maternal deaths in the Nordic countries. Acta Obstet Gynecol Scand; 2017 Sep;96(9):1112-1119
MedlinePlus Health Information. consumer health - Health Problems in Pregnancy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Maternal deaths in the Nordic countries.
  • The aim of the study was to identify maternal deaths in the five Nordic countries, to classify causes of death based on internationally acknowledged criteria, and to identify areas that would benefit from further teaching, training or research to possibly reduce the number of maternal deaths.
  • National audit groups collected data by linkage of registers and direct reporting from hospitals.
  • RESULTS: We registered 168 maternal deaths, 90 direct and 78 indirect cases.
  • The maternal mortality ratio was 7.2/100 000 live births ranging from 6.8 to 8.1 between the countries.
  • CONCLUSION: Direct deaths exceeded indirect maternal deaths in the Nordic countries.
  • [MeSH-minor] Adult. Cause of Death. Female. Humans. Maternal Age. Maternal Health Services. Pregnancy. Registries. Scandinavian and Nordic Countries / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Nordic Federation of Societies of Obstetrics and Gynecology.
  • (PMID = 28542709.001).
  • [ISSN] 1600-0412
  • [Journal-full-title] Acta obstetricia et gynecologica Scandinavica
  • [ISO-abbreviation] Acta Obstet Gynecol Scand
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Maternal death / cause of death / heart diseases / preeclampsia / pregnancy / suicide / thromboembolism
  •  go-up   go-down


36. de Vries ST, van der Sar MJM, Cupelli A, Baldelli I, Coleman AM, Montero D, Šipić I, Andrić A, Wennberg A, Ahlqvist-Rastad J, Denig P, Mol PGM, SCOPE Work Package 6: Communication on Safety of Medicines in Europe: Current Practices and General Practitioners' Awareness and Preferences. Drug Saf; 2017 Aug;40(8):729-742

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The survey among regulators was emailed to a representative of each of the 27 European countries participating in the Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action.
  • HCPs from nine European countries (Denmark, Spain, Croatia, Ireland, Italy, The Netherlands, Norway, Sweden, and the UK) were asked about their preferences through a link to the survey on websites, in newsletters, and/or in a direct email.
  • RESULTS: Current NCA practices were reported for 26 countries.
  • In 23 countries (88%), NCAs published direct healthcare professional communications (DHPCs, i.e. urgent communication letters for serious safety issues) on their website in addition to distribution to individual HCPs.
  • Educational materials were available on the NCA's website in 10 countries (40%), and 21 NCAs (81%) indicated they had their own bulletin/newsletter, which is often presented on the NCA's website (15 countries; 60%).
  • Preference for an electronic copy rather than a hardcopy varied per country (36% in Sweden to 72% in Spain).
  • Most GPs were aware of urgent communications and preferred similar senders of safety communications; however, their preferences towards the format differed per country.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Drug Saf. 2010 Jun 1;33(6):463-74 [20486729.001]
  • [Cites] Prev Med. 1984 May;13(3):299-319 [6387698.001]
  • [Cites] Int Clin Psychopharmacol. 2016 Jan;31(1):34-41 [26451964.001]
  • [Cites] Implement Sci. 2015 Dec 01;10:164 [26626547.001]
  • [Cites] Drug Saf. 2012 Nov 1;35(11):1061-72 [23061782.001]
  • [Cites] Implement Sci. 2015 Nov 04;10:156 [26537589.001]
  • [Cites] Cochrane Database Syst Rev. 2012 Oct 17;10:CD004398 [23076904.001]
  • [Cites] Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91 [11124735.001]
  • [Cites] Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):896-9 [22730332.001]
  • [Cites] BMJ. 2005 Oct 15;331(7521):903 [16223828.001]
  • (PMID = 28540672.001).
  • [ISSN] 1179-1942
  • [Journal-full-title] Drug safety
  • [ISO-abbreviation] Drug Saf
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] New Zealand
  • [Investigator] Bouder F; Escudero Y; García J; Knudsen Y; Loughlin L; Maciá MA; Michan L; Rodriguez A; Samdal H
  •  go-up   go-down


37. Garland NY, Kheng S, De Leon M, Eap H, Forrester JA, Hay J, Oum P, Sam Ath S, Stock S, Yem S, Lucas G, Weiser TG: Using the WHO Surgical Safety Checklist to Direct Perioperative Quality Improvement at a Surgical Hospital in Cambodia: The Importance of Objective Confirmation of Process Completion. World J Surg; 2017 Dec;41(12):3012-3024

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Using the WHO Surgical Safety Checklist to Direct Perioperative Quality Improvement at a Surgical Hospital in Cambodia: The Importance of Objective Confirmation of Process Completion.
  • In addition to cultural and organizational barriers faced by high-income countries, resource-constrained settings face scarcity of durable and consumable goods.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29038828.001).
  • [ISSN] 1432-2323
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Balasubramanian M, Spencer AJ, Short SD, Watkins K, Chrisopoulos S, Brennan DS: The Life Story Experience of "Migrant Dentists" in Australia: Potential Implications for Health Workforce Governance and International Cooperation. Int J Health Policy Manag; 2016 Oct 10;6(6):317-326

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The migration of dentists is a major policy challenge facing both developing and developed countries.
  • Dentists from over 120 countries migrate to Australia, and a large proportion are from developing countries.
  • LSE1 (health system and general lifestyle concerns in home country), LSE2 (appreciation towards Australian way of life) and LSE3 (settlement concerns in Australia) scales varied by migrant dentist groups, sex, and years since arrival to Australia (chi-square, P < .05).
  • In a logistic regression model, migrants mainly from developing countries (ie, the examination pathway group) faced greater health system and general lifestyle concerns in their home countries (9.32; 3.51-24.72) and greater settlement challenges in Australia (5.39; 3.51-8.28), compared to migrants from well-developed countries, who obtained direct recognition of qualifications.
  • CONCLUSION: Migrant dentists, mainly from developing countries, face challenges both in their home countries and in Australia.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int Dent J. 2014 Jun;64(3):117-26 [24863646.001]
  • [Cites] Int Dent J. 2015 Feb;65(1):39-44 [25371293.001]
  • [Cites] Soc Sci Med. 2007 Sep;65(5):915-23 [17570573.001]
  • [Cites] Health Aff (Millwood). 2006 Mar-Apr;25(2):380-93 [16610096.001]
  • [Cites] Aust Dent J. 2005 Sep;50(3):179-85 [16238216.001]
  • [Cites] Int Dent J. 2012 Dec;62(6):278-91 [23252585.001]
  • [Cites] Health Policy. 2013 Apr;110(1):6-13 [23200603.001]
  • [Cites] Aust Health Rev. 2014 Sep;38(4):412-9 [25001317.001]
  • [Cites] J Dent Educ. 2006 Aug;70(8):884-91 [16896091.001]
  • [Cites] N Z Dent J. 2008 Sep;104(3):97-103 [18980050.001]
  • [Cites] Aust Dent J. 1982 Feb;27(1):11-5 [6956270.001]
  • [Cites] Community Dent Oral Epidemiol. 2016 Aug;44(4):301-12 [26992031.001]
  • [Cites] Health Policy. 2015 Dec;119(12 ):1636-44 [26321192.001]
  • [Cites] Aust Health Rev. 2016 Apr;40(2):168-73 [26235492.001]
  • [Cites] Soc Sci Med. 2009 Jul;69(2):172-7 [19501443.001]
  • [Cites] Bull World Health Organ. 2005 Sep;83(9):661-9 [16211157.001]
  • [Cites] Int Dent J. 2011 Oct;61(5):281-6 [21995377.001]
  • [Cites] Aust Dent J. 2011 Mar;56(1):23-32 [21332737.001]
  • [Cites] Periodontol 2000. 2012 Oct;60(1):98-109 [22909109.001]
  • [Cites] Soc Sci Med. 2014 Aug;115:64-71 [24953498.001]
  • [Cites] Health Policy Plan. 2015 May;30(4):442-50 [24816569.001]
  • [Cites] Br Dent J. 2015 Mar;218(6):329-31 [25812880.001]
  • [Cites] Lancet. 2004 Nov 27-Dec 3;364(9449):1984-90 [15567015.001]
  • [Cites] Bull World Health Organ. 2013 Nov 1;91(11):816-23 [24347705.001]
  • [Cites] Annu Rev Anthropol. 1980;9:135-234 [12264425.001]
  • [Cites] Health Policy. 2012 Dec;108(2-3):122-32 [23153568.001]
  • [Cites] Bull World Health Organ. 2004 Aug;82(8):587-94 [15375448.001]
  • [Cites] Health Policy. 2015 Dec;119(12 ):1565-75 [26584576.001]
  • [Cites] Aust Dent J. 2008 Sep;53(3):217-25 [18782365.001]
  • [Cites] Eval Health Prof. 2004 Jun;27(2):152-64 [15140292.001]
  • [Cites] Community Dent Health. 2016 Sep;33(3):225-231 [28509519.001]
  • [Cites] Int Dent J. 2015 Jun;65(3):146-55 [25676718.001]
  • (PMID = 28812824.001).
  • [ISSN] 2322-5939
  • [Journal-full-title] International journal of health policy and management
  • [ISO-abbreviation] Int J Health Policy Manag
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Iran
  • [Keywords] NOTNLM ; Dentists / Health Policy / International Cooperation / Migration / Workforce Governance
  •  go-up   go-down


39. Ravuvu A, Friel S, Thow AM, Snowdon W, Wate J: Protocol to monitor trade agreement food-related aspects: the Fiji case study. Health Promot Int; 2017 Apr 26;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Specific trade agreements appear to have played an influential role in the volume and types of foods entering different countries, yet there is currently no systematic and objective monitoring of trade agreements for their impacts on food environments.
  • Recently, INFORMAS was set up to monitor and benchmark food environments, government policies and private sector actions within countries and globally.
  • This paper describes the INFORMAS trade protocol, an approach to collecting food-related information about four domains of trade: trade in goods; trade in services and foreign direct investment; domestic supports, and policy space.
  • The application of the monitoring protocol also highlights challenges for data collection associated with each trade domain that should be considered for future data collection and analysis in other low and middle income countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
  • (PMID = 28453626.001).
  • [ISSN] 1460-2245
  • [Journal-full-title] Health promotion international
  • [ISO-abbreviation] Health Promot Int
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; food environments / monitoring / non-communicable diseases / trade agreements
  •  go-up   go-down


40. Zaprutko T, Kopciuch D, Kus K, Merks P, Nowicka M, Augustyniak I, Nowakowska E: Affordability of medicines in the European Union. PLoS One; 2017;12(2):e0172753
MedlinePlus Health Information. consumer health - Schizophrenia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The analysis concerned 2012 and was conducted between 2013 and 2015 in all the European Union (EU) countries divided into 3 groups depending on the date of their accession to the EU.
  • Due to unavailability in some countries, the exact number of analyzed medicines varies.
  • The cheapest drugs were found in various countries but never in the poorest ones like Bulgaria or Romania.
  • Unaffordability of medications may lead to the patients' non-compliance and therefore to increased direct and indirect costs of treatment.

  • MedlinePlus Health Information. consumer health - Drug Safety.
  • MedlinePlus Health Information. consumer health - Multiple Sclerosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Health Policy Plan. 2013 Oct;28(7):692-704 [23174879.001]
  • [Cites] PLoS One. 2014 Feb 12;9(2):e87576 [24533058.001]
  • [Cites] Indian J Palliat Care. 2016 Apr-Jun;22(2):163-7 [27162427.001]
  • [Cites] Health Policy. 2007 May;81(2-3):376-84 [16945449.001]
  • [Cites] Schizophr Bull. 2004;30(2):279-93 [15279046.001]
  • [Cites] Health Econ Rev. 2011 Nov 21;1(1):18 [22828053.001]
  • [Cites] Lancet. 2009 Jan 17;373(9659):240-9 [19042012.001]
  • [Cites] Psychiatr Q. 2015 Dec;86(4):569-79 [25736799.001]
  • [Cites] PLoS Med. 2016 May 31;13(5):e1002032 [27243629.001]
  • [Cites] BMC Health Serv Res. 2015 Aug 27;15:345 [26310243.001]
  • [Cites] Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79 [21924589.001]
  • [Cites] Health Aff (Millwood). 2008 Jan-Feb;27(1):221-33 [18180499.001]
  • [Cites] Health Policy. 2012 Jan;104(1):50-60 [22014843.001]
  • [Cites] PLoS One. 2016 Jul 13;11(7):e0159129 [27411042.001]
  • [Cites] Croat Med J. 2011 Apr 15;52(2):183-97 [21495202.001]
  • [Cites] Afr J Prim Health Care Fam Med. 2014 Jun 24;6(1):E1-6 [26245401.001]
  • [Cites] Int J Technol Assess Health Care. 2012 Oct;28(4):358-66 [22980497.001]
  • [Cites] Annu Rev Public Health. 2004;25:475-95 [15015931.001]
  • [Cites] Int J Clin Pharmacol Ther. 2005 Oct;43(10):472-9 [16240704.001]
  • [Cites] BMC Health Serv Res. 2011 Jan 26;11:17 [21269426.001]
  • [Cites] Rev Saude Publica. 2011 Feb;45(1):14-23 [21085885.001]
  • [Cites] Rev Panam Salud Publica. 2011 Jan;29(1):46-51 [21390419.001]
  • [Cites] Int J Pharm Pract. 2009 Apr;17(2):79-88 [20214255.001]
  • [Cites] South Med Rev. 2012 Dec;5(2):34-41 [23532710.001]
  • [Cites] BMJ. 2005 Oct 22;331(7522):958-60 [16239695.001]
  • [Cites] Value Health. 2015 Jun;18(4):484-92 [26091603.001]
  • (PMID = 28241019.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Drugs, Essential
  •  go-up   go-down


41. Bursztein Lipsicas C, Levav I, Levine SZ: Holocaust exposure and subsequent suicide risk: a population-based study. Soc Psychiatry Psychiatr Epidemiol; 2017 Mar;52(3):311-317
MedlinePlus Health Information. consumer health - Suicide.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Persons born in Holocaust-exposed European countries during the years 1922-1945 that immigrated to Israel by 1965 were identified in the Population Registry (N = 209,429), and followed up for suicide (1950-2014).
  • They were divided into three groups based on likely exposure to Nazi persecution: those who immigrated before (indirect; n = 20,229; 10%), during (partial direct; n = 17,189; 8%), and after (full direct; n = 172,061; 82%) World War II.
  • Groups were contrasted for suicide risk, accounting for the extent of genocide in their respective countries of origin, high (>70%) or lower levels (<50%).
  • RESULTS: Survival analysis showed that compared to the indirect exposure group, the partial direct exposure group from countries with high genocide level had a statistically significant (P < .05) increased suicide risk for the main outcome (calendar year: HR 1.78, 95% CI 1.09, 2.90).
  • This effect significantly (P < .05) replicated in two sensitivity analyses for countries with higher relative levels of genocide (age: HR 1.77, 95% CI 1.09, 2.89; years since immigration: HR 1.85, 95% CI 1.14, 3.02).
  • The full direct exposure group was not at significant suicide risk compared to the indirect exposure group.
  • Suicide associations for groups from countries with relative lower level of genocide were not statistically significant.
  • DISCUSSION: This study partly converges with findings identifying Holocaust survivors (full direct exposure) as a resilient group.
  • A tentative mechanism for higher vulnerability to suicide risk of the partial direct exposure group from countries with higher genocide exposure includes protracted guilt feelings, having directly witnessed atrocities and escaped death.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMC Public Health. 2015 Oct 15;15:1055 [26472204.001]
  • [Cites] Br J Med Psychol. 1994 Dec;67 ( Pt 4):353-62 [7888398.001]
  • [Cites] Soc Sci Med. 2011 Feb;72(4):608-16 [21211874.001]
  • [Cites] J Epidemiol Community Health. 2012 Oct;66(10):927-33 [22045850.001]
  • [Cites] Psychol Med. 2016 Mar;46(4):855-63 [26619765.001]
  • [Cites] Am J Psychiatry. 1992 Dec;149(12):1707-10 [1443248.001]
  • [Cites] Annu Rev Psychol. 2007;58:425-52 [16968209.001]
  • [Cites] Prev Med. 2004 Aug;39(2):419-23 [15226055.001]
  • [Cites] Suicide Life Threat Behav. 2013 Jun;43(3):290-5 [23379368.001]
  • [Cites] Am J Psychiatry. 2003 Jun;160(6):1086-92 [12777266.001]
  • [Cites] Psychol Bull. 2011 May;137(3):391-420 [21443319.001]
  • [Cites] Schizophr Bull. 2010 Jan;36(1):26-32 [19759092.001]
  • [Cites] Psychol Med. 2006 Feb;36(2):145-57 [16420711.001]
  • [Cites] Am J Psychiatry. 1979 May;136(5):637-41 [434238.001]
  • [Cites] Am J Orthopsychiatry. 2002 Apr;72(2):194-203 [15792059.001]
  • [Cites] PLoS One. 2013 Jul 24;8(7):e69179 [23894427.001]
  • [Cites] Psychol Bull. 2010 Sep;136(5):677-98 [20804233.001]
  • [Cites] J Trauma Stress. 2004 Oct;17(5):403-11 [15633919.001]
  • [Cites] Soc Psychiatry Psychiatr Epidemiol. 2007 May;42(5):396-402 [17384892.001]
  • [Cites] J Epidemiol Community Health. 2015 Feb;69(2):117-22 [25488977.001]
  • [Cites] Soc Psychiatry Psychiatr Epidemiol. 2016 Jan;51(1):115-23 [26364837.001]
  • [Cites] J Conflict Resolut. 2009 Jun;53(2):363-389 [22140275.001]
  • [Cites] J Trauma Dissociation. 2009;10(1):38-56 [19197711.001]
  • [Cites] PLoS One. 2016 Feb 22;11(2):e0149524 [26901411.001]
  • [Cites] Lancet. 2016 Mar 19;387(10024):1227-39 [26385066.001]
  • [Cites] Eur J Public Health. 2015 Feb;25(1):63-71 [25096258.001]
  • (PMID = 28032138.001).
  • [ISSN] 1433-9285
  • [Journal-full-title] Social psychiatry and psychiatric epidemiology
  • [ISO-abbreviation] Soc Psychiatry Psychiatr Epidemiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Epidemiology / Genocide / Holocaust / Suicide
  •  go-up   go-down


42. Cabibbe AM, Cirillo DM: Best approaches to drug-resistance surveillance at the country level. Int J Mycobacteriol; 2016 Dec;5 Suppl 1:S40-S41

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Best approaches to drug-resistance surveillance at the country level.
  • : In 2014, the World Health Organization (WHO) recommendation to include the endorsed rapid molecular technologies (Xpert MTB/RIF, line probe assays) into surveillance systems and surveys allowed the testing of more tuberculosis (TB) patients for drug resistance at country level than ever before.
  • These features make WGS, moreso than the conventional molecular tools, an ideal tool to monitor transmission and drug resistance trends in countries, providing deep and wide information in a standardized way.
  • Classical sequencing and NGS approaches have been successfully used in a recent study conducted in five countries with high burden of TB and multidrug resistant tuberculosis (MDR-TB) and aimed at investigating levels of resistance to pyrazinamide among patients with TB by pncA sequencing [doi: 10.1016/S1473-3099(16)30190-6].
  • This work innovatively demonstrated that the establishment of strong links between national (peripheral and reference laboratories) and supranational laboratories, with the former possibly processing indirect or direct samples and generating sequencing data, and the latter supporting them for bioinformatics analysis and data interpretation, will soon make WGS and targeted NGS the preferred tools to conduct public health surveillances in TB field, thus helping the strategies adopted by TB control programs at local and national levels.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016.
  • (PMID = 28043601.001).
  • [ISSN] 2212-554X
  • [Journal-full-title] International journal of mycobacteriology
  • [ISO-abbreviation] Int J Mycobacteriol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Drug-resistance tuberculosis / Molecular tests / Mycobacterium tuberculosis / Surveillance / Whole genome sequencing
  •  go-up   go-down


43. Pichon-Riviere A, Bardach A, Augustovski F, Alcaraz A, Reynales-Shigematsu LM, Pinto MT, Castillo-Riquelme M, Torres EP, Osorio DI, Huayanay L, Munarriz CL, de Miera-Juárez BS, Gallegos-Rivero V, Puente C, Navia-Bueno MD, Caporale J: [Financial impact of smoking on health systems in Latin America: A study of seven countries and extrapolation to the regional level]. Rev Panam Salud Publica; 2016 Oct;40(4):213-221

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Financial impact of smoking on health systems in Latin America: A study of seven countries and extrapolation to the regional level].
  • Objective: Estimate smoking-attributable direct medical costs in Latin American health systems.
  • The model was calibrated and validated for Argentina, Bolivia, Brazil, Chile, Colombia, Mexico, and Peru, countries that account for 78% of Latin America's population; the results were then extrapolated to the regional level.
  • Results: Every year, smoking is responsible for 33 576 billion dollars in direct costs to health systems.
  • The region's countries should seriously consider stronger measures, such as an increase in tobacco taxes.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28001196.001).
  • [ISSN] 1680-5348
  • [Journal-full-title] Revista panamericana de salud publica = Pan American journal of public health
  • [ISO-abbreviation] Rev. Panam. Salud Publica
  • [Language] spa
  • [Publication-type] Journal Article; English Abstract
  • [Publication-country] United States
  •  go-up   go-down


44. Balog A, Hartel T, Loxdale HD, Wilson K: Differences in the progress of the biopesticide revolution between the EU and other major crop-growing regions. Pest Manag Sci; 2017 Nov;73(11):2203-2208

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The relatively low level of biopesticide research in the EU (6880 ISI papers) versus the United States (18 839), India (9501) and China (7875) relates to the greater complexity of EU-based biopesticide regulations compared with these other countries.
  • Compared with the other aforementioned countries, far fewer biopesticide products are available in the EU market, mainly as a direct result of the severe regulatory factors present there.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Society of Chemical Industry.
  • (PMID = 28470963.001).
  • [ISSN] 1526-4998
  • [Journal-full-title] Pest management science
  • [ISO-abbreviation] Pest Manag. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; biopesticide research / environmental laws / environmentally friendly agriculture / pesticide laws / political decisions
  •  go-up   go-down


45. Gräfe L, Böger D, Büntzel J, Eßer D, Hoffmann K, Jecker P, Müller A, Radtke G, Volk GF, Koscielny S, Guntinas-Lichius O: [Direct Microlaryngoscopy: A Population-Based Analysis on Outcome, Complications and Surgery Rates]. Laryngorhinootologie; 2017 Jul;96(7):467-472

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Direct Microlaryngoscopy: A Population-Based Analysis on Outcome, Complications and Surgery Rates].
  • Although microlaryngoscopy is an integral part of surgical routine of otorhinolaryngologists, there is no population-based data published on surgery rates and efficiency of microlaryngoscopy country-wide or nation-wide.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Georg Thieme Verlag KG Stuttgart · New York.
  • (PMID = 28470661.001).
  • [ISSN] 1438-8685
  • [Journal-full-title] Laryngo- rhino- otologie
  • [ISO-abbreviation] Laryngorhinootologie
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


46. Morgan JR, Servidone M, Easterbrook P, Linas BP: Economic evaluation of HCV testing approaches in low and middle income countries. BMC Infect Dis; 2017 Nov 01;17(Suppl 1):697

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Economic evaluation of HCV testing approaches in low and middle income countries.
  • The advent of highly effective direct acting antiviral (DAA) therapy, which is becoming available at increasingly lower costs in low and middle income countries (LMICs), represents a major opportunity to expand access to testing and treatment.
  • Overall, the guidelines recommended focused testing in high risk-groups, particularly PWID, prisoners, and men who have sex with men; with consideration of two other approaches:- birth cohort testing in those countries with epidemiological evidence of a significant birth cohort effect; and routine access to testing across the general population in those countries with a high HCV seroprevalence above 2% - 5% in the general population.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29143681.001).
  • [ISSN] 1471-2334
  • [Journal-full-title] BMC infectious diseases
  • [ISO-abbreviation] BMC Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Cost effectiveness / Economic evaluation / Hepatitis C / Screening / Testing / WHO
  •  go-up   go-down


47. Mastorci F, Vassalle C, Chatzianagnostou K, Marabotti C, Siddiqui K, Eba AO, Mhamed SAS, Bandopadhyay A, Nazzaro MS, Passera M, Pingitore A: Undernutrition and Overnutrition Burden for Diseases in Developing Countries: The Role of Oxidative Stress Biomarkers to Assess Disease Risk and Interventional Strategies. Antioxidants (Basel); 2017 Jun 08;6(2)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Undernutrition and Overnutrition Burden for Diseases in Developing Countries: The Role of Oxidative Stress Biomarkers to Assess Disease Risk and Interventional Strategies.
  • In particular, developing countries are facing a double burden caused by coexisting under- and over-nutrition, which causes a change in the disease profile from infectious diseases to a chronic degenerative pattern.
  • This review discusses the under- and over-nutrition context in Mauritania and India, two countries that are experiencing a nutritional transition, and where we began a collaboration with local medical staff to integrate interventional and diagnostic guidelines.
  • Moreover, the possibility of improving the outcome by the direct employment of antioxidant remains plausible.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Diabetes Metab Syndr. 2016 Apr-Jun;10 (2 Suppl 1):S123-6 [27016886.001]
  • [Cites] BMJ. 2008 Jul 25;337:a605 [18658189.001]
  • [Cites] Curr Diabetes Rev. 2017;13(1):65-80 [27515855.001]
  • [Cites] Antioxidants (Basel). 2015 Nov 12;4(4):719-36 [26783955.001]
  • [Cites] Clin Biochem. 2008 Oct;41(14-15):1162-7 [18692492.001]
  • [Cites] Int J Biomed Sci. 2014 Jun;10(2):118-23 [25018680.001]
  • [Cites] Proc Nutr Soc. 2008 Feb;67(1):82-90 [18234135.001]
  • [Cites] Proc Nutr Soc. 2014 Aug;73(3):385-8 [24824339.001]
  • [Cites] Int J Cardiol. 2015;187:519-24 [25846664.001]
  • [Cites] Ann N Y Acad Sci. 2014 Apr;1311:88-101 [24725148.001]
  • [Cites] Clin Chem Lab Med. 2011 Sep;49(9):1509-13 [21679134.001]
  • [Cites] Toxicol Appl Pharmacol. 2012 Jun 15;261(3):255-62 [22521606.001]
  • [Cites] Indian J Pediatr. 2009 Jul;76(7):705-9 [19381504.001]
  • [Cites] Mol Cell Biochem. 2016 Aug;419(1-2):193-203 [27421852.001]
  • [Cites] Epidemiol Health. 2016 Dec 14;38:e2016057 [28092932.001]
  • [Cites] Diabetes Technol Ther. 2015 Feb;17(2):134-41 [25478993.001]
  • [Cites] J Diabetes. 2011 Dec;3(4):278-92 [21649865.001]
  • [Cites] Coron Artery Dis. 2003 May;14(3):213-8 [12702924.001]
  • [Cites] J Diabetes Metab Disord. 2015 Apr 14;14:24 [25897417.001]
  • [Cites] Dis Markers. 2009;26(5-6):273-85 [19773616.001]
  • [Cites] Br J Nutr. 2012 Oct;108(7):1325-35 [22863082.001]
  • [Cites] J Clin Diagn Res. 2013 Oct;7(10):2146-8 [24298460.001]
  • [Cites] Lancet. 2015 Apr 4;385(9975):1333-42 [25499546.001]
  • [Cites] Heart. 2013 Nov;99(21):1554-61 [23680886.001]
  • [Cites] Indian Heart J. 2014 May-Jun;66(3):263-71 [24973830.001]
  • [Cites] Coron Artery Dis. 2015 Mar;26(2):176-83 [25369999.001]
  • [Cites] Clin Chem Lab Med. 2002 Aug;40(8):802-9 [12392309.001]
  • [Cites] Br J Nutr. 2016 Oct;116(8):1416-1424 [27725001.001]
  • [Cites] Matern Child Nutr. 2011 Apr;7 Suppl 1:113-32 [21410892.001]
  • [Cites] Arch Physiol Biochem. 2013 Feb;119(1):15-21 [23373727.001]
  • [Cites] Glob Health Action. 2014 May 15;7:23248 [24848651.001]
  • [Cites] J Nat Sci Biol Med. 2016 Jul-Dec;7(2):155-60 [27433066.001]
  • [Cites] Nutrition. 2015 Jul-Aug;31(7-8):916-22 [26059364.001]
  • [Cites] Circulation. 2001 Nov 27;104(22):2746-53 [11723030.001]
  • [Cites] Clin Biochem. 2009 May;42(7-8):739-41 [19101532.001]
  • [Cites] Food Sci Nutr. 2014 Nov;2(6):700-5 [25493188.001]
  • [Cites] Food Sci Nutr. 2015 May;3(3):257-71 [25988001.001]
  • [Cites] Nutr Health. 2001;15(2):97-111 [11694072.001]
  • [Cites] Fertil Steril. 2012 Feb;97(2):414-9 [22196713.001]
  • [Cites] J Atheroscler Thromb. 2012;19(8):712-7 [22785135.001]
  • [Cites] Int J Equity Health. 2016 Jul 08;15(1):104 [27391031.001]
  • (PMID = 28594364.001).
  • [ISSN] 2076-3921
  • [Journal-full-title] Antioxidants (Basel, Switzerland)
  • [ISO-abbreviation] Antioxidants (Basel)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; antioxidants / cardiovascular disease / epidemiological transition / inflammatory biomarkers / non-communicable diseases / nutrition / oxidative stress biomarkers
  •  go-up   go-down


48. Voysey M, Fanshawe TR, Kelly DF, O'Brien KL, Kandasamy R, Shrestha S, Thorson S, Hinds J, Pollard AJ: Serotype-specific correlates of protection for pneumococcal carriage: an analysis of immunity in 19 countries. Clin Infect Dis; 2017 Oct 21;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serotype-specific correlates of protection for pneumococcal carriage: an analysis of immunity in 19 countries.
  • Background: Pneumococcal conjugate vaccines (PCVs) provide direct protection against disease in those vaccinated, and interrupt transmission through the prevention of nasopharyngeal carriage.
  • Protective correlates were on average 2.15 times higher in low/lower middle income countries than in high/upper middle income countries (GMR 2.15, 95%CI 1.46-3.17, p=0.0024).
  • Higher antibody concentrations are required for protection in low-income countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29069415.001).
  • [ISSN] 1537-6591
  • [Journal-full-title] Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • [ISO-abbreviation] Clin. Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


49. Diallo AF, Cong X, Henderson WA, McGrath J: Management of childhood diarrhea by healthcare professionals in low income countries: An integrative review. Int J Nurs Stud; 2017 Jan;66:82-92
MedlinePlus Health Information. consumer health - Diarrhea.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of childhood diarrhea by healthcare professionals in low income countries: An integrative review.
  • Nevertheless uptake of these interventions have been slow in developing countries and many children suffering from diarrhea are not receiving adequate care according to the World Health Organization recommended guidelines for the clinical management of childhood diarrhea.
  • OBJECTIVES: The aim of this integrative review is to appraise healthcare professionals' management of childhood diarrhea in low-income countries.
  • METHOD: A comprehensive search performed from December 2014 to April 2015 used five databases and focused on observational studies of healthcare professional's management of childhood diarrhea in low-income countries.
  • Only one study used direct observation of the healthcare professionals during practice and the remaining eight used a combination of research designs.
  • [MeSH-major] Developing Countries. Diarrhea / therapy

  • Genetic Alliance. consumer health - Diarrhea.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 Elsevier Ltd. All rights reserved.
  • (PMID = 28043020.001).
  • [ISSN] 1873-491X
  • [Journal-full-title] International journal of nursing studies
  • [ISO-abbreviation] Int J Nurs Stud
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Antibiotics use / Childhood diarrhea / Clinical management of childhood diarrhea / Healthcare providers / Low income countries / Oral rehydration therapy / Prescribing behaviors / World Health Organization
  •  go-up   go-down


50. Fitzpatrick C, Haines A, Bangert M, Farlow A, Hemingway J, Velayudhan R: An economic evaluation of vector control in the age of a dengue vaccine. PLoS Negl Trop Dis; 2017 Aug;11(8):e0005785
MedlinePlus Health Information. consumer health - Dengue.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We employ a dynamic Markov model of the effects of vector control on dengue in both vectors and humans over a 15-year period, in six countries: Brazil, Columbia, Malaysia, Mexico, the Philippines, and Thailand.
  • We evaluate the cost (direct medical costs and control programme costs) and cost-effectiveness of sustained vector control, outbreak response and/or medical case management, in the presence of a (hypothetical) highly targeted and low cost immunization strategy using a (non-hypothetical) medium-efficacy vaccine.
  • High-burden endemic countries should proceed to map populations to be covered by sustained vector control.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Trop Med Hyg. 1988 Jan;38(1):172-80 [3341519.001]
  • [Cites] Cad Saude Publica. 2009;25 Suppl 1:S115-24 [19287856.001]
  • [Cites] Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14688-93 [26553981.001]
  • [Cites] N Engl J Med. 2015 Sep 24;373(13):1195-206 [26214039.001]
  • [Cites] Infect Dis Poverty. 2016 May 03;5:44 [27142081.001]
  • [Cites] Am J Trop Med Hyg. 2014 Dec;91(6):1235-42 [25294616.001]
  • [Cites] Am J Trop Med Hyg. 2011 May;84(5):764-72 [21540387.001]
  • [Cites] Vaccine. 2013 Aug 20;31(37):3957-61 [23791696.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2395-400 [8146129.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jun 01;9(6):e0003810 [26030922.001]
  • [Cites] Lancet. 2011 May 14;377(9778):1673-80 [21546076.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jun 26;9(6):e0003894 [26115104.001]
  • [Cites] Am J Trop Med Hyg. 2011 Feb;84(2):200-7 [21292885.001]
  • [Cites] Am J Trop Med Hyg. 2000 Mar;62(3):378-83 [11037781.001]
  • [Cites] BMC Bioinformatics. 2016 Apr 16;17 :166 [27083696.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2007 Jun;101(6):578-86 [17368696.001]
  • [Cites] Am J Trop Med Hyg. 2008 Jun;78(6):862-7 [18541760.001]
  • [Cites] Am J Trop Med Hyg. 2015 Nov;93(5):1020-7 [26416116.001]
  • [Cites] Emerg Infect Dis. 2013 Apr;19(4):542-50 [23628282.001]
  • [Cites] BMC Public Health. 2013 Nov 06;13:1048 [24195519.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jul 21;9(7):e0003937 [26196686.001]
  • [Cites] Int J Infect Dis. 2007 May;11(3):263-7 [16899384.001]
  • [Cites] N Engl J Med. 2015 Jan 8;372(2):113-23 [25365753.001]
  • [Cites] Sci Total Environ. 2012 Aug 1;431:385-91 [22705874.001]
  • [Cites] PLoS Negl Trop Dis. 2016 Mar 17;10(3):e0004551 [26986468.001]
  • [Cites] Pathog Glob Health. 2015 Feb;109(1):10-8 [25546339.001]
  • [Cites] Vaccine. 2004 Mar 12;22(9-10):1275-80 [15003657.001]
  • [Cites] PLoS Med. 2016 Nov 29;13(11):e1002181 [27898668.001]
  • [Cites] Am J Trop Med Hyg. 2008 Sep;79(3):364-71 [18784227.001]
  • [Cites] Nature. 2013 Apr 25;496(7446):504-7 [23563266.001]
  • [Cites] PLoS Negl Trop Dis. 2013;7(2):e2055 [23437406.001]
  • [Cites] PLoS Negl Trop Dis. 2014 May 08;8(5):e2848 [24810901.001]
  • [Cites] Med Vet Entomol. 2008 Sep;22(3):203-21 [18816269.001]
  • [Cites] Trop Med Int Health. 2012 Jun;17(6):767-74 [22943302.001]
  • [Cites] Arch Virol. 2013 Jul;158(7):1445-59 [23471635.001]
  • [Cites] J Coll Physicians Surg Pak. 2013 Jul;23(7):463-7 [23823947.001]
  • [Cites] BMJ. 2015 Jul 08;351:h3267 [26156323.001]
  • [Cites] J R Soc Interface. 2013 Jul 03;10(86):20130414 [23825116.001]
  • [Cites] PLoS Negl Trop Dis. 2010 Oct 26;4(10):e858 [21049010.001]
  • [Cites] PLoS Negl Trop Dis. 2016 Dec 21;10 (12 ):e0005179 [28002420.001]
  • [Cites] Lancet Infect Dis. 2016 Aug;16(8):880-2 [27477966.001]
  • [Cites] Trop Med Int Health. 2012 Jan;17(1):123-32 [21906216.001]
  • [Cites] PLoS Negl Trop Dis. 2011 Mar 01;5(3):e975 [21390158.001]
  • [Cites] PLoS Negl Trop Dis. 2015 May 07;9(5):e0003655 [25951103.001]
  • [Cites] PLoS Negl Trop Dis. 2014 Nov 06;8(11):e3260 [25375830.001]
  • [Cites] Malays J Pathol. 2002 Jun;24(1):23-7 [16329552.001]
  • [Cites] Pharmacoeconomics. 2015 Nov;33(11):1107-35 [26048354.001]
  • [Cites] Rev Panam Salud Publica. 2006 Jul;20(1):39-43 [17018223.001]
  • [Cites] PLoS Negl Trop Dis. 2012;6(8):e1760 [22880140.001]
  • [Cites] Epidemics. 2015 Jun;11:92-102 [25979287.001]
  • [Cites] Epidemiol Infect. 2014 Mar;142(3):545-61 [23800514.001]
  • [Cites] PLoS Negl Trop Dis. 2012;6(8):e1799 [22953017.001]
  • [Cites] Am J Trop Med Hyg. 2009 May;80(5):846-55 [19407136.001]
  • [Cites] Math Biosci. 2007 Aug;208(2):571-89 [17303188.001]
  • [Cites] Lancet. 2014 Oct 11;384(9951):1358-65 [25018116.001]
  • [Cites] BMC Public Health. 2009 May 27;9:155 [19473500.001]
  • [Cites] Am J Trop Med Hyg. 1997 Feb;56(2):159-67 [9080874.001]
  • [Cites] Am J Trop Med Hyg. 1998 Aug;59(2):265-71 [9715944.001]
  • [Cites] Int J Health Geogr. 2014 Dec 09;13:50 [25487167.001]
  • [Cites] BMC Infect Dis. 2014 Aug 20;14:447 [25139524.001]
  • [Cites] PLoS One. 2012;7(11):e49085 [23139836.001]
  • [Cites] Nihon Koshu Eisei Zasshi. 2015;62(5):238-50 [26118707.001]
  • [Cites] Expert Rev Vaccines. 2016;15(4):519-28 [26642099.001]
  • [Cites] Am J Trop Med Hyg. 2012 Sep;87(3):554-8 [22826478.001]
  • [Cites] Trop Med Int Health. 2007 Sep;12(9):1026-36 [17875014.001]
  • [Cites] PLoS Negl Trop Dis. 2011 Dec;5(12):e1426 [22206028.001]
  • [Cites] Rev Panam Salud Publica. 2003 Jul;14(1):9-16 [12952602.001]
  • [Cites] J Infect Dis. 2010 Jan 1;201(1):5-14 [19929380.001]
  • [Cites] Am J Trop Med Hyg. 2016 Nov 2;95(5):1137-1147 [27601519.001]
  • [Cites] Lancet. 2016 Aug 6;388(10044):556-7 [27529102.001]
  • [Cites] PLoS Negl Trop Dis. 2016 May 26;10 (5):e0004588 [27227829.001]
  • (PMID = 28806786.001).
  • [ISSN] 1935-2735
  • [Journal-full-title] PLoS neglected tropical diseases
  • [ISO-abbreviation] PLoS Negl Trop Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dengue Vaccines
  •  go-up   go-down


51. Paradies P, Iarussi F, Sasanelli M, Capogna A, Lia RP, Zucca D, Greco B, Cantacessi C, Otranto D: Occurrence of strongyloidiasis in privately owned and sheltered dogs: clinical presentation and treatment outcome. Parasit Vectors; 2017 Jul 20;10(1):345

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The increasing number of reports of human infections by Strongyloides stercoralis from a range of European countries over the last 20 years has spurred the interest of the scientific community towards this parasite and, in particular, towards the role that infections of canine hosts may play in the epidemiology of human disease.
  • Strongyloides stercoralis infection was diagnosed by coproscopy on direct faecal smear and via the Baermann method.
  • Data indicate that S. stercoralis infection may pose a concern for sheltered animals and raise questions on potential risks of infection for staff of municipal shelters in southern European countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Vet Scand. 2007 Dec 12;49:37 [18076758.001]
  • [Cites] Rev Bras Parasitol Vet. 2012 Apr-Jun;21(2):101-6 [22832748.001]
  • [Cites] Cochrane Database Syst Rev. 2016 Jan 18;(1):CD007745 [26778150.001]
  • [Cites] AIDS. 2007 Mar 12;21(5):649-50 [17314529.001]
  • [Cites] Exp Parasitol. 1984 Jun;57(3):287-96 [6723900.001]
  • [Cites] WormBook. 2015 Jul 16;:1-17 [26183912.001]
  • [Cites] J Parasitol. 2002 Jun;88(3):536-9 [12099422.001]
  • [Cites] PLoS Negl Trop Dis. 2013 May 09;7(5):e2214 [23675546.001]
  • [Cites] Vet Parasitol. 2006 Mar 15;136(2):137-45 [16321470.001]
  • [Cites] Vet Rec. 2009 May 2;164(18):559-60 [19411688.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Nov 05;9(11):e0004150 [26540412.001]
  • [Cites] Ann Trop Med Parasitol. 2011 Sep;105(6):413-24 [22117850.001]
  • [Cites] Parasitol Int. 2014 Aug;63(4):597-603 [24704609.001]
  • [Cites] PLoS Negl Trop Dis. 2014 Jan 09;8(1):e2640 [24427320.001]
  • [Cites] Vet Parasitol. 2007 Jun 20;147(1-2):132-9 [17448603.001]
  • [Cites] J Am Vet Med Assoc. 1992 Sep 1;201(5):726-30 [1399774.001]
  • [Cites] Dtsch Tierarztl Wochenschr. 1993 Nov;100(11):426-8 [8261912.001]
  • [Cites] Emerg Infect Dis. 2009 Sep;15(9):1531-3 [19788836.001]
  • [Cites] Singapore Med J. 2014 Jul;55(7):367-71 [25091885.001]
  • [Cites] Med Microbiol Immunol. 2006 Jun;195(2):49-54 [16538445.001]
  • [Cites] Clin Microbiol Infect. 2015 Jun;21(6):543-52 [25887711.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Feb 10;9(2):e0003491 [25668740.001]
  • [Cites] Vet Parasitol. 2013 Mar 31;193(1-3):78-84 [23265188.001]
  • [Cites] Vet Parasitol. 2007 Sep 1;148(2):170-3 [17573197.001]
  • [Cites] Biomed Res Int. 2014;2014:696508 [24883320.001]
  • (PMID = 28728589.001).
  • [ISSN] 1756-3305
  • [Journal-full-title] Parasites & vectors
  • [ISO-abbreviation] Parasit Vectors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Clinical presentation / Dog / Faecal monitoring / Strongyloides stercoralis / Treatment / Zoonosis
  •  go-up   go-down


52. Burns DK, Jones AP, Goryakin Y, Suhrcke M: Is foreign direct investment good for health in low and middle income countries? An instrumental variable approach. Soc Sci Med; 2017 05;181:74-82

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is foreign direct investment good for health in low and middle income countries? An instrumental variable approach.
  • There is a scarcity of quantitative research into the effect of FDI on population health in low and middle income countries (LMICs).
  • When controlling for time trends, country fixed effects, correlation between repeated observations, relevant covariates, and endogeneity via a novel instrumental variable approach, we find FDI to have a beneficial effect on overall health, proxied by life expectancy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28371630.001).
  • [ISSN] 1873-5347
  • [Journal-full-title] Social science & medicine (1982)
  • [ISO-abbreviation] Soc Sci Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Development (major topic) / Foreign direct investment (major topic) / Instrumental variables (major topic) / Low and middle income countries (major topic) / Panel data regression (major topic) / Population health (major topic)
  •  go-up   go-down


53. Nevitt SJ, Sudell M, Weston J, Tudur Smith C, Marson AG: Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev; 2017 06 29;6:CD011412
Hazardous Substances Data Bank. VALPROIC ACID .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We performed pairwise meta-analysis of head-to-head comparisons between drugs within trials to obtain 'direct' treatment effect estimates and we performed frequentist network meta-analysis to combine direct evidence with indirect evidence across the treatment network of 10 drugs.
  • We investigated inconsistency between direct estimates and network meta-analysis via node splitting.
  • We could not include IPD from the remaining 41 trials in analysis for a variety of reasons, such as being unable to contact an author or sponsor to request data, data being lost or no longer available, cost and resources required to prepare data being prohibitive, or local authority or country-specific restrictions.We were able to calculate direct treatment effect estimates for between half and two thirds of comparisons across the outcomes of the review, however for many of the comparisons, data were contributed by only a single trial or by a small number of participants, so confidence intervals of estimates were wide.Network meta-analysis showed that for the primary outcome 'Time to withdrawal of allocated treatment,' for individuals with partial seizures; levetiracetam performed (statistically) significantly better than both current first-line treatments carbamazepine and lamotrigine; lamotrigine performed better than all other treatments (aside from levetiracetam), and carbamazepine performed significantly better than gabapentin and phenobarbitone (high-quality evidence).
  • In general, the earliest licenced treatments (phenytoin and phenobarbitone) performed better than the other treatments for both seizure types (moderate- to high-quality evidence).Generally, direct evidence and network meta-analysis estimates (direct plus indirect evidence) were numerically similar and consistent with confidence intervals of effect sizes overlapping.The most commonly reported adverse events across all drugs were drowsiness/fatigue, headache or migraine, gastrointestinal disturbances, dizziness/faintness and rash or skin disorders.

  • Genetic Alliance. consumer health - Epilepsy.
  • MedlinePlus Health Information. consumer health - Epilepsy.
  • Hazardous Substances Data Bank. OXCARBAZEPINE .
  • Hazardous Substances Data Bank. CARBAMAZEPINE .
  • Hazardous Substances Data Bank. Phenobarbital .
  • Hazardous Substances Data Bank. PHENYTOIN .
  • Hazardous Substances Data Bank. GABAPENTIN .
  • Hazardous Substances Data Bank. ZONISAMIDE .
  • Hazardous Substances Data Bank. PIRACETAM .
  • Hazardous Substances Data Bank. LAMOTRIGINE .
  • Hazardous Substances Data Bank. TOPIRAMATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28661008.001).
  • [ISSN] 1469-493X
  • [Journal-full-title] The Cochrane database of systematic reviews
  • [ISO-abbreviation] Cochrane Database Syst Rev
  • [Language] eng
  • [Publication-type] Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Amines; 0 / Anticonvulsants; 0 / Cyclohexanecarboxylic Acids; 0 / Isoxazoles; 0 / Triazines; 0H73WJJ391 / topiramate; 230447L0GL / etiracetam; 30237-26-4 / Fructose; 33CM23913M / Carbamazepine; 459384H98V / zonisamide; 56-12-2 / gamma-Aminobutyric Acid; 614OI1Z5WI / Valproic Acid; 6158TKW0C5 / Phenytoin; 6CW7F3G59X / gabapentin; U3H27498KS / lamotrigine; VZI5B1W380 / oxcarbazepine; YQE403BP4D / Phenobarbital; ZH516LNZ10 / Piracetam
  •  go-up   go-down


54. Bawack RE, Kala Kamdjoug JR: Adequacy of UTAUT in clinician adoption of health information systems in developing countries: The case of Cameroon. Int J Med Inform; 2018 Jan;109:15-22

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adequacy of UTAUT in clinician adoption of health information systems in developing countries: The case of Cameroon.
  • PURPOSE: Despite the great potential Health Information Systems (HIS) have in improving the quality of healthcare delivery services, very few studies have been carried out on the adoption of such systems in developing countries.
  • This article is concerned with investigating the adequacy of UTAUT<sup>1</sup> in determining factors that influence the adoption of HIS by clinicians in developing countries, based on the case of Cameroon.
  • Self-efficacy and cost effectiveness has no direct significant effect on HIS adoption in the context of this study.
  • CONCLUSIONS: The original UTAUT is not adequate in identifying factors that influence the adoption of HIS by clinicians in developing countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier B.V. All rights reserved.
  • (PMID = 29195701.001).
  • [ISSN] 1872-8243
  • [Journal-full-title] International journal of medical informatics
  • [ISO-abbreviation] Int J Med Inform
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Keywords] NOTNLM ; Cameroon / Clinician / Developing countries / Health information system / UTAUT
  •  go-up   go-down


55. Kulhánová I, Bray F, Fadhil I, Al-Zahrani AS, El-Basmy A, Anwar WA, Al-Omari A, Shamseddine A, Znaor A, Soerjomataram I: Profile of cancer in the Eastern Mediterranean region: The need for action. Cancer Epidemiol; 2017 04;47:125-132

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Many countries in the Eastern Mediterranean region (EMR) are undergoing marked demographic and socioeconomic transitions that are increasing the cancer burden in region.
  • METHODS: GLOBOCAN 2012 data were used to estimate cancer incidence and mortality by country, cancer type, sex and age in 22 EMR countries.
  • We calculated age-standardized incidence and mortality rates (per 100,000) using direct method of standardization.
  • RESULTS: The cancer incidence and mortality rates vary considerably between countries in the EMR.
  • For females, breast cancer is the most common cancer in all 22 countries, followed by cervical cancer, which ranks high only in the lower-income countries in the region.
  • For males, lung, prostate, and colorectal cancer in combination represent almost 30% of the cancer burden in countries that have attained very high levels of human development.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017. Published by Elsevier Ltd.
  • (PMID = 28268206.001).
  • [ISSN] 1877-783X
  • [Journal-full-title] Cancer epidemiology
  • [ISO-abbreviation] Cancer Epidemiol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Cancer (major topic) / Eastern Mediterranean region (major topic) / Incidence (major topic) / Mortality (major topic) / Risk factors (major topic)
  •  go-up   go-down


56. Meisel C, Sadowski CE, Kohlstedt D, Keller K, Stäritz F, Grübling N, Becker K, Mackenroth L, Rump A, Schröck E, Arnold N, Wimberger P, Kast K: Spectrum of genetic variants of BRCA1 and BRCA2 in a German single center study. Arch Gynecol Obstet; 2017 May;295(5):1227-1238
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • More similarities seem to be shared with our direct neighbor countries compared to other European countries.

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28324225.001).
  • [ISSN] 1432-0711
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / BRCA1 Protein; 0 / BRCA1 protein, human; 0 / BRCA2 Protein; 0 / BRCA2 protein, human
  • [Keywords] NOTNLM ; BRCA1 / BRCA2 / Germany / Hereditary breast cancer / Mutational spectrum
  •  go-up   go-down


57. Gassasse Z, Smith D, Finer S, Gallo V: Association between urbanisation and type 2 diabetes: an ecological study. BMJ Glob Health; 2017;2(4):e000473

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study is to investigate the association between urbanisation and T2D at country level, worldwide, and to explore the role of intermediate variables (physical inactivity, sugar consumption and obesity).
  • Methods: Data for 207 countries were collected from accessible datasets.
  • Direct acyclic graphs were used to describe the association between urbanisation, T2D and their intermediate variables (physical inactivity, sugar consumption and obesity).
  • In middle-income countries (MIC) UP, AI and GDP were significantly associated with T2D prevalence, while in high-income countries (HIC), physical inactivity and obesity were the main determinant of T2D prevalence.
  • Conclusions: The type of urban growth, not urbanisation per se, predicted T2D prevalence at country level.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 2016 Dec 10;388(10062):2912-2924 [27671668.001]
  • [Cites] J Urban Health. 2007 May;84(3 Suppl):i16-26 [17356903.001]
  • [Cites] Popul Health Metr. 2006 Apr 24;4:5 [16635266.001]
  • [Cites] Soc Work Public Health. 2014;29(4):335-41 [24871771.001]
  • [Cites] Public Health Nutr. 2016 May;19(7):1270-8 [26365215.001]
  • [Cites] Diabet Med. 2012 Jun;29(6):755-60 [22132939.001]
  • [Cites] Int J Health Serv. 2009;39(4):749-70 [19927413.001]
  • [Cites] Environ Res. 2012 May;115:37-50 [22480534.001]
  • [Cites] Public Health. 2014 Oct;128(10):886-95 [25369353.001]
  • [Cites] Am J Public Health. 2004 Sep;94(9):1574-9 [15333317.001]
  • [Cites] Int J Occup Med Environ Health. 2014 Dec 18;:null [25519942.001]
  • [Cites] J Epidemiol Community Health. 2015 Jul;69(7):715-8 [25987723.001]
  • [Cites] Nutr Metab Cardiovasc Dis. 2014 Oct;24(10 ):1105-11 [24954422.001]
  • [Cites] J Glob Health. 2014 Jun;4(1):010404 [24976963.001]
  • [Cites] Global Health. 2005 Aug 03;1:14 [16078989.001]
  • [Cites] PLoS Med. 2010 Apr 27;7(4):e1000268 [20436961.001]
  • [Cites] Urban Stud. 2015 Jul;52(9):1594-1614 [26321770.001]
  • [Cites] Lancet. 2016 May 28;387(10034):2207-17 [27045735.001]
  • [Cites] Int J Equity Health. 2012 Jun 12;11:31 [22691443.001]
  • [Cites] Global Health. 2006 Mar 28;2:4 [16569239.001]
  • [Cites] Int J Hyg Environ Health. 2003 Aug;206(4-5):269-78 [12971682.001]
  • [Cites] Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596 [28601585.001]
  • [Cites] Int J Diabetes Dev Ctries. 2010 Apr;30(2):63-8 [20535308.001]
  • [Cites] Diabetologia. 2012 Dec;55(12):3182-92 [22923063.001]
  • [Cites] Lancet. 2012 Mar 3;379(9818):843-52 [22386037.001]
  • [Cites] World J Diabetes. 2012 Jun 15;3(6):110-7 [22737281.001]
  • [Cites] Public Health Nutr. 2016 Sep;19(13):2336-46 [27265445.001]
  • [Cites] Diabetologia. 2016 Apr;59(4):709-18 [26831300.001]
  • [Cites] Am J Clin Nutr. 2014 Jun;99(6):1479-86 [24740206.001]
  • [Cites] Ann N Y Acad Sci. 2013 Apr;1281:64-91 [23551121.001]
  • [Cites] J Urban Health. 2008 Nov;85(6):938-51 [18931915.001]
  • (PMID = 29104770.001).
  • [ISSN] 2059-7908
  • [Journal-full-title] BMJ global health
  • [ISO-abbreviation] BMJ Glob Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; descriptive study / environmental health / epidemiology / nutrition / public health
  •  go-up   go-down


58. Cher BP, Chen C, Yoong J: Prevalence-based, disease-specific estimate of the social cost of smoking in Singapore. BMJ Open; 2017 Apr 07;7(4):e014377

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These include direct and indirect costs of inpatient treatment, premature mortality, loss of productivity due to medical leaves and smoking breaks.
  • Direct healthcare costs amounted to US$14.9 million where ischaemic heart disease and lung cancer had the highest cost burden.
  • CONCLUSIONS: The social cost of smoking is smaller in Singapore than in other Asian countries.
  • This is partly because of the nature of such costs (indirect or intangible costs such as productivity losses are often not salient) or data limitations (a potentially significant fraction of direct healthcare expenditure may be in private primary care where costs are not systematically captured and reported).
  • The case of Singapore thus illustrates that even in countries perceived as success stories, strong multisectoral anti-tobacco strategies and a supporting research agenda continue to be needed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
  • [Cites] BMJ Open. 2014 Jul 09;4(7):e005199 [25009135.001]
  • [Cites] BMC Pulm Med. 2011 Jun 14;11:36 [21672193.001]
  • [Cites] Int J Cancer. 2008 Jan 1;122(1):155-64 [17893872.001]
  • [Cites] Milbank Q. 1986;64(4):489-547 [3102916.001]
  • [Cites] N Engl J Med. 1978 Mar 9;298(10):569-71 [625314.001]
  • [Cites] Int J Cardiol. 2014 Jun 1;174(1):64-72 [24742812.001]
  • [Cites] Br J Psychiatry. 2012 Jun;200(6):454-61 [22539779.001]
  • [Cites] Tob Control. 2011 Jul;20(4):266-72 [21339491.001]
  • [Cites] BMC Cancer. 2012 Sep 03;12:385 [22943444.001]
  • [Cites] Int J Chron Obstruct Pulmon Dis. 2015 Jul 21;10:1409-16 [26229460.001]
  • [Cites] PLoS One. 2013 Jul 26;8(7):e69915 [23922856.001]
  • [Cites] Singapore Med J. 2002 Jul;43(7):340-4 [12437040.001]
  • [Cites] Am J Epidemiol. 2013 Aug 1;178(3):325-38 [23785114.001]
  • [Cites] Tob Control. 2003 Mar;12(1):37-44 [12612360.001]
  • [Cites] Tob Control. 2014 Sep;23(5):428-33 [23733918.001]
  • [Cites] PLoS One. 2014 Jan 23;9(1):e86397 [24466073.001]
  • [Cites] Tob Control. 2016 Jan;25(1):96-100 [25512430.001]
  • [Cites] Diabetes Care. 1999 Nov;22(11):1887-98 [10546025.001]
  • (PMID = 28389491.001).
  • [ISSN] 2044-6055
  • [Journal-full-title] BMJ open
  • [ISO-abbreviation] BMJ Open
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; PUBLIC HEALTH / Tobacco and smoking
  •  go-up   go-down


59. Murimi MW, Moyeda-Carabaza AF: Effective nutrition education and communication for sustainable maternal and child health. Proc Nutr Soc; 2017 Nov;76(4):504-515

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The purpose of the present paper is to review the factors that contributed to the attainment of the MDG 4 and MDG 5 by analysing the interventions conducted by the countries that achieved at least 5·0 and 5·5 %, respectively, and determine the level of their intervention based on the MCH conceptual framework.
  • Out of the eighteen selected countries discussed, fifteen countries achieved their target for either MDG 4 or MDG 5 or both, while three countries did not achieve their target.
  • The countries that were more likely to achieve their targets addressed the societal, underlying and direct causes, and implemented country wide policies.
  • In contrast, the countries that did not succeed were more likely to address the direct causes with poor policy implementation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28662730.001).
  • [ISSN] 1475-2719
  • [Journal-full-title] The Proceedings of the Nutrition Society
  • [ISO-abbreviation] Proc Nutr Soc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; ANV antenatal care / MCH maternal and child health / MDG Millennium Development Goals / Effective interventions / Maternal and child health / Nutrition education
  •  go-up   go-down


60. Wilson A, Vento M, Shah PS, Saugstad O, Finer N, Rich W, Morton RL, Rabi Y, Tarnow-Mordi W, Suzuki K, Wright IM, Oei JL: A review of international clinical practice guidelines for the use of oxygen in the delivery room resuscitation of preterm infants. Acta Paediatr; 2018 Jan;107(1):20-27

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A search of public databases using the terms 'clinical practice guidelines', 'preterm', 'oxygen' and 'resuscitation' was made and complemented by direct query to consensus groups, resuscitation expert committees and clinicians.
  • Data were extracted to include the three criteria for assessment: country of origin, gestation and initial FiO<sub>2</sub> and target SpO<sub>2</sub> for the first 10 minutes of life.
  • Most countries suggested altering FiO<sub>2</sub> to meet SpO<sub>2</sub> targets recommended by expert committees, However, specific five-minute SpO<sub>2</sub> targets differed by up to 20% (70-90%) between guidelines.
  • Five countries did not specify SpO<sub>2</sub> targets.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] ©2017 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
  • (PMID = 28792628.001).
  • [ISSN] 1651-2227
  • [Journal-full-title] Acta paediatrica (Oslo, Norway : 1992)
  • [ISO-abbreviation] Acta Paediatr.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Norway
  • [Keywords] NOTNLM ; Clinical practice guidelines / Oxygen / Preterm and resuscitation
  •  go-up   go-down


61. Blackman I, Papastavrou E, Palese A, Vryonides S, Henderson J, Willis E: Predicting variations to missed nursing care: A three-nation comparison. J Nurs Manag; 2017 Jul 27;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: This study expands on previous MISSCARE research but now applies and predicts missed care within three countries.
  • RESULTS: Five latent variables have direct predictor effects on missed care frequencies.
  • CONCLUSION: Cross country comparisons of missed nursing care allow for a more refined identification of strategies for remediation for both managers and clinicians.
  • IMPLICATIONS FOR NURSING MANAGEMENT: Reliable consensus estimates about the types and frequencies of missed care can be scaled with variables identified to predict missed care across three different countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 John Wiley & Sons Ltd.
  • (PMID = 28752529.001).
  • [ISSN] 1365-2834
  • [Journal-full-title] Journal of nursing management
  • [ISO-abbreviation] J Nurs Manag
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Australia / Cyprus / Italy / missed nursing / multi-variate analysis
  •  go-up   go-down


62. Morgan C, Bowling M, Bartram J, Lyn Kayser G: Water, sanitation, and hygiene in schools: Status and implications of low coverage in Ethiopia, Kenya, Mozambique, Rwanda, Uganda, and Zambia. Int J Hyg Environ Health; 2017 Aug;220(6):950-959
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Little multi-country research has been published on WaSH in rural schools in Sub-Saharan Africa.
  • In this multi-national cross-sectional WaSH study, we document WaSH access, continuity, quality, quantity, and reliability in 2270 schools that were randomly sampled in rural regions of six Sub-Saharan African countries: Ethiopia, Kenya, Mozambique, Rwanda, Uganda, and Zambia.
  • Data collection included: school WaSH surveys containing internationally established WaSH indicators, direct observation, and field- and laboratory-based microbiological water quality testing.
  • Fewer than 23% of rural schools in the six countries studied met the World Health Organization's recommended student-to-latrine ratios for boys and for girls.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier GmbH. All rights reserved.
  • (PMID = 28539190.001).
  • [ISSN] 1618-131X
  • [Journal-full-title] International journal of hygiene and environmental health
  • [ISO-abbreviation] Int J Hyg Environ Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Disparities / Education / Handwashing / Health / Menstruation / WaSH
  •  go-up   go-down


63. Westbrook C: Opening the debate on MRI practitioner education - Is there a need for change? Radiography (Lond); 2017 Sep;23 Suppl 1:S70-S74

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It was conducted as part of a study exploring the value of direct-entry into MRI via a specialized undergraduate degree without first qualifying as a radiographer.
  • Direct entry via a specialized undergraduate degree is permitted in some countries, and research suggests that this is a beneficial way of learning MRI.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Crown Copyright © 2017. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 28780957.001).
  • [ISSN] 1532-2831
  • [Journal-full-title] Radiography (London, England : 1995)
  • [ISO-abbreviation] Radiography (Lond)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Education / Magnetic Resonance Imaging (MRI) / Radiography / Specialism / Specialist education
  •  go-up   go-down


64. Montibeler EE, de Oliveira DR: DENGUE ENDEMIC AND ITS IMPACT ON THE GROSS NATIONAL PRODUCT OF BRAZILIAN'S ECONOMY. Acta Trop; 2017 Nov 29;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Using Leontief's method, it became possible to estimate the direct and indirect impact on the workforce and output by one country.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier B.V. All rights reserved.
  • (PMID = 29197500.001).
  • [ISSN] 1873-6254
  • [Journal-full-title] Acta tropica
  • [ISO-abbreviation] Acta Trop.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Brazil / Dengue / Leontief / economic loss / input-output table / workforce
  •  go-up   go-down


65. Boglione L, Cardellino CS, Cusato J, De Nicolò A, Cariti G, Di Perri G, D'Avolio A: Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. Infect Genet Evol; 2017 Jul;51:167-172
University of Turin Instituional Repository AperTO. Full Text from .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The new direct-acting antivirals agents (DAAs) rapidly changed the treatment approach in chronic hepatitis C (CHC); however, the interferon (IFN)-free therapies availability is currently different in some countries, due to higher costs of these drugs.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017. Published by Elsevier B.V.
  • (PMID = 28315743.001).
  • [ISSN] 1567-7257
  • [Journal-full-title] Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
  • [ISO-abbreviation] Infect. Genet. Evol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Fibrosis / Genotype 1 / Genotype 4 / HCV / IL28B / PEG-IFN
  •  go-up   go-down


66. Ayhan N, Alten B, Ivovic V, Dvořák V, Martinkovic F, Omeragic J, Stefanovska J, Petric D, Vaselek S, Baymak D, Kasap OE, Volf P, Charrel RN: Direct evidence for an expanded circulation area of the recently identified Balkan virus (Sandfly fever Naples virus species) in several countries of the Balkan archipelago. Parasit Vectors; 2017 Aug 29;10(1):402
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Direct evidence for an expanded circulation area of the recently identified Balkan virus (Sandfly fever Naples virus species) in several countries of the Balkan archipelago.
  • CONCLUSIONS: We report here (i) the first direct evidence that the Balkan virus initially described in coastal Albania has a much wider dissemination area than originally believed, (ii) two real-time RT-PCR assays that may be useful for further screening of patients presenting with fever of unknown origin that may be caused by Balkan virus infection, (iii) entomological results suggesting that Balkan virus is likely transmitted by Phlebotomus neglectus, and possibly other sand fly species of the subgenus Larroussius.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Med Virol. 2003 Sep;71(1):140-9 [12858420.001]
  • [Cites] Vector Borne Zoonotic Dis. 2009 Oct;9(5):519-30 [19055373.001]
  • [Cites] Emerg Infect Dis. 2007 Mar;13(3):465-8 [17552102.001]
  • [Cites] PLoS Negl Trop Dis. 2016 Mar 23;10(3):e0004519 [27007326.001]
  • [Cites] Clin Microbiol Infect. 2011 Apr;17(4):585-7 [21414085.001]
  • [Cites] Med Glas (Zenica). 2010 Aug;7(2):96-105 [21258303.001]
  • [Cites] J Clin Virol. 2012 Sep;55(1):4-7 [22795597.001]
  • [Cites] Am J Trop Med Hyg. 1978 Mar;27(2 Pt 2 Suppl):372-440 [646031.001]
  • [Cites] Bull World Health Organ. 1976;54(6):663-74 [829416.001]
  • [Cites] J Virol. 2015 Apr;89(8):4080-91 [25653443.001]
  • [Cites] Acta Med Iugosl. 1987;41(2):89-97 [3039802.001]
  • [Cites] J Clin Microbiol. 2009 Aug;47(8):2398-404 [19535518.001]
  • [Cites] Emerg Infect Dis. 2011 May;17(5):940-1 [21529422.001]
  • [Cites] Virus Res. 2016 Mar 2;214:19-25 [26795868.001]
  • [Cites] J Hyg Epidemiol Microbiol Immunol. 1991;35(2):129-40 [1658128.001]
  • [Cites] Bosn J Basic Med Sci. 2009 Feb;9(1):39-43 [19284393.001]
  • [Cites] Clin Microbiol Infect. 2012 Jun;18(6):E200-3 [22512547.001]
  • [Cites] Acta Med Iugosl. 1990;44(1):15-20 [2159683.001]
  • [Cites] J Gen Virol. 2010 May;91(Pt 5):1275-83 [20089800.001]
  • [Cites] Euro Surveill. 2010 Mar 11;15(10):19507 [20403307.001]
  • [Cites] Vector Borne Zoonotic Dis. 2016 Dec;16(12 ):802-806 [27788062.001]
  • [Cites] Am J Trop Med Hyg. 2014 Apr;90(4):760-3 [24534812.001]
  • [Cites] Antiviral Res. 2013 Oct;100(1):54-74 [23872312.001]
  • (PMID = 28851425.001).
  • [ISSN] 1756-3305
  • [Journal-full-title] Parasites & vectors
  • [ISO-abbreviation] Parasit Vectors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Arbovirus / Bunyaviridae / Emergence / Fever / Meningitis / Phlebotomus / Phlebovirus / Phylogeny / Sand fly / Toscana virus
  •  go-up   go-down


67. Sah AK, Joshi B, Khadka DK, Gupta BP, Adhikari A, Singh SK, Rai G, Vaidya GS, Rajbhandari R, Pant B, Rai SK: Comparative Study of GeneXpert MTB/RIF Assay and Multiplex PCR Assay for Direct Detection of Mycobacterium tuberculosis in Suspected Pulmonary Tuberculosis Patients. Curr Microbiol; 2017 Sep;74(9):1026-1032

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative Study of GeneXpert MTB/RIF Assay and Multiplex PCR Assay for Direct Detection of Mycobacterium tuberculosis in Suspected Pulmonary Tuberculosis Patients.
  • Pulmonary tuberculosis (PTB) is one of the major infectious diseases in developing countries.
  • The objective of this study was to compare rapid diagnostics technique, GeneXpert MTB/RIF (GeneXpert) and Multiplex PCR assay (MPCR) targeting IS6110 segment and mpb64 gene for direct detection of Mycobacterium tuberculosis (MTB) in suspected PTB patients.
  • Thus, we recommend MPCR alongside GeneXpert for the better diagnostic accuracy of PTB in a resource-limited country where tuberculosis is endemic.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Ophthalmic Inflamm Infect. 2013 Jan 28;3(1):25 [23514226.001]
  • [Cites] Pathology. 1978 Jul;10(3):257-61 [364389.001]
  • [Cites] J Clin Microbiol. 1990 Mar;28(3):495-503 [1691208.001]
  • [Cites] J Clin Microbiol. 1997 Jun;35(6):1492-8 [9163468.001]
  • [Cites] J Bacteriol. 2008 May;190(9):3408-10 [18326566.001]
  • [Cites] Indian J Med Microbiol. 2013 Oct-Dec;31(4):370-3 [24064644.001]
  • [Cites] Indian J Med Microbiol. 2013 Jan-Mar;31(1):24-8 [23508425.001]
  • [Cites] Lancet Infect Dis. 2013 Apr;13(4):349-61 [23531388.001]
  • [Cites] J Glob Infect Dis. 2013 Apr;5(2):49-53 [23853431.001]
  • [Cites] J Clin Microbiol. 2011 Dec;49(12):4138-41 [21956978.001]
  • [Cites] Indian J Med Res. 2013 Mar;137(3):442-4 [23640550.001]
  • [Cites] J Clin Microbiol. 2013 Nov;51(11):3631-7 [23985924.001]
  • [Cites] Pak J Med Sci. 2015 Jan-Feb;31(1):105-10 [25878624.001]
  • [Cites] J Clin Microbiol. 1996 May;34(5):1209-15 [8727904.001]
  • [Cites] BMC Genomics. 2013 Jun 25;14:422 [23800083.001]
  • [Cites] J Clin Microbiol. 2012 Feb;50(2):326-36 [22162548.001]
  • [Cites] Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009593 [23440842.001]
  • [Cites] Tuberk Toraks. 2011;59(3):213-20 [22087516.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2009 Jan 16;58(1):7-10 [19145221.001]
  • [Cites] Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Dec;82(6):780-4 [4617483.001]
  • [Cites] Indian J Med Microbiol. 2012 Apr-Jun;30(2):182-6 [22664434.001]
  • [Cites] PLoS One. 2011;6(6):e20458 [21738575.001]
  • [Cites] Tuberculosis (Edinb). 2007 Sep;87(5):393-404 [17627889.001]
  • [Cites] Lancet. 2010 May 29;375(9729):1920-37 [20488517.001]
  • [Cites] J Clin Microbiol. 1991 Nov;29(11):2578-86 [1685494.001]
  • [Cites] Int Orthop. 2012 Feb;36(2):255-9 [21442201.001]
  • [Cites] PLoS One. 2013 Oct 29;8(10):e77456 [24204834.001]
  • [Cites] Int J Mycobacteriol. 2013 Sep;2(3):179-82 [26785988.001]
  • [Cites] J Clin Microbiol. 2011 Aug;49(8):3068-70 [21677069.001]
  • [Cites] BMC Infect Dis. 2014 Nov 14;14:589 [25395048.001]
  • [Cites] J Biol Chem. 2010 Dec 3;285(49):38270-82 [20889498.001]
  • [Cites] Indian J Med Microbiol. 2013 Oct-Dec;31(4):366-9 [24064643.001]
  • [Cites] J Clin Diagn Res. 2016 May;10(5):DC09-12 [27437212.001]
  • (PMID = 28612135.001).
  • [ISSN] 1432-0991
  • [Journal-full-title] Current microbiology
  • [ISO-abbreviation] Curr. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


68. Briolant S, Pradines B, Basco LK: [Role of primaquine in malaria control and elimination in French-speaking Africa]. Bull Soc Pathol Exot; 2017 Aug;110(3):198-206
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primaquine, an 8-aminoquinoline, is a relatively unknown and underutilized drug in French-speaking African countries.
  • There is an ethical concern in administering primaquine as a gametocytocide as it does not confer any direct benefit to the treated patient.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28417346.001).
  • [ISSN] 0037-9085
  • [Journal-full-title] Bulletin de la Societe de pathologie exotique (1990)
  • [ISO-abbreviation] Bull Soc Pathol Exot
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  • [Keywords] NOTNLM ; Drug resistance / Duffy antigen / French-speaking Africa / G6PD deficiency / Malaria / Plasmodium falciparum / Plasmodium ovale / Plasmodium vivax / Primaquine
  •  go-up   go-down


69. Lackenbauer W, Janssen J, Roddam H, Selfe J: Is keep/refer decision making an integral part of national guidelines for the physiotherapy profession within Europe? A review. Physiotherapy; 2016 Nov 28;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, it is currently unknown how individual European countries have implemented this in their national guidelines.
  • OBJECTIVES: To determine if keep/refer decision making abilities are an integral part of national guidelines for the physiotherapy profession of member countries of the European Network of Physiotherapy in Higher Education (ENPHE).
  • Despite the fact that in the WCPT guidelines keep/refer decision making abilities are clearly described as a core element, there exists huge inconsistency as to how various European (with direct and non direct access systems) countries have included them in their national guidelines.
  • CONCLUSION: Despite the fact that most ENPHE member countries deem a close collaboration between health care professionals important and that physiotherapists should know the limitation of their expertise, keep/refer decision making abilities as explicitly stated in the WCPT guidelines were not included in the majority of guidelines that were reviewed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Chartered Society of Physiotherapy. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 28823566.001).
  • [ISSN] 1873-1465
  • [Journal-full-title] Physiotherapy
  • [ISO-abbreviation] Physiotherapy
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Keep/refer decision making ability / National competency guidelines / Physiotherapy
  •  go-up   go-down


70. Russell GM, Miller WL, Gunn JM, Levesque JF, Harris MF, Hogg WE, Scott CM, Advocat JR, Halma L, Chase SM, Crabtree BF: Contextual levers for team-based primary care: lessons from reform interventions in five jurisdictions in three countries. Fam Pract; 2017 Oct 23;
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Contextual levers for team-based primary care: lessons from reform interventions in five jurisdictions in three countries.
  • Objective: To synthesize findings across five jurisdictions in three countries to identify common contextual factors influencing the successful implementation of teamwork within PC practices.
  • Team-based PC was promoted when funding extended beyond fee-for-service, where care delivery did not require direct physician involvement and where governance was inclusive of non-physician disciplines.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29069376.001).
  • [ISSN] 1460-2229
  • [Journal-full-title] Family practice
  • [ISO-abbreviation] Fam Pract
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Evaluation studies / health care reform / policy / primary health care / qualitative research
  •  go-up   go-down


71. Ibrahim A, Umar UI, Usman UM, Owolabi LF: Economic evaluation of childhood epilepsy in a resource-challenged setting: A preliminary survey. Epilepsy Behav; 2017 Nov;76:84-88

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Considerable disease variability exists between patients with epilepsy, and the societal costs for epilepsy care are overall high, because of high frequency in the general population especially in children from developing countries.
  • Prevalence-based costs were stratified by patients' sociodemographic characteristics and socioeconomic scores (SES).
  • The 'bottom-up' and 'human capital' approaches were used to generate estimates on the direct and indirect (productivity losses) costs of epilepsy, respectively.
  • Majority (61.3%) belong to the low socioeconomic class (Ogunlesi SES class IV and V) and reside (80.6%) in an urban setting.
  • The total direct and indirect costs per month were ₦2,149,965.00 ($8497.88) and ₦363,187.80 ($1435.52), respectively.
  • Investigative procedures are the principal cost drivers (₦15,861.17 or $18.15) comprising approximately 58.7% of the total direct costs per patient.
  • CONCLUSIONS: Cost of investigations contributed immensely to the total direct cost of care in our study.
  • With the present economic situation in the country, out-of-pocket payments may contribute significantly to catastrophic expenditures and worsening of secondary treatment gap in children with epilepsy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Inc. All rights reserved.
  • (PMID = 28917500.001).
  • [ISSN] 1525-5069
  • [Journal-full-title] Epilepsy & behavior : E&B
  • [ISO-abbreviation] Epilepsy Behav
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Direct cost / Economic recession / Epilepsy / Indirect cost
  •  go-up   go-down


72. Samms-Vaughan M, Lambert M: The impact of polyvictimisation on children in LMICs: the case of Jamaica. Psychol Health Med; 2017 Jan 29;:1-14

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Children who experience polyvictimization in high-income countries (HICs) are at higher risk for mental health-related trauma symptoms.
  • There is limited information on the impact of polyvictimisation on children with high levels of exposure, as occurs in some low- and middle-income countries (LMICs).
  • Findings from Structural Equational Modelling indicated that for both genders, exposure to polyvictimisation had a direct negative effect on intellectual functioning, and an indirect negative effect on achievement mediated through intellectual functioning.
  • For boys, polyvictimisation had a direct negative effect on behavioural risk.
  •   In Jamaica, a LMIC country with high levels of polyvictimisation, there is a significant negative effect of polyvictimisation on children.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28133980.001).
  • [ISSN] 1465-3966
  • [Journal-full-title] Psychology, health & medicine
  • [ISO-abbreviation] Psychol Health Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Jamaica / LMIC / Polyvictimisation / Violence / childhood
  •  go-up   go-down


73. Shah R, Shah S: Delayed presentation or delayed diagnosis? A retrospective study of prospectively collected data of 482 foot and ankle injuries. Injury; 2017 Aug;48 Suppl 2:S27-S32
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Delayed presentation of injury cases is common in developing countries like India.
  • Of these twenty six cases were never treated by qualified orthopaedic surgeons and were labelled as direct delayed presentations, and the remaining 72 cases who were treated by qualified orthopaedic surgeons, but could not be diagnosed and presented late, were labelled as indirect delayed presentations.
  • CONCLUSIONS: In developing countries like India, patients did neglect their foot and ankle injuries and presented late.
  • This is contrary to the common belief that in developing countries like India, only patients would be solely responsible for delayed presentations after injury.
  • Because delayed diagnosis by clinicians seemed more alarming than delayed presentation by patients, focus of prevention of foot and ankle injuries in developing countries should shift more towards educating clinicians than patients.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28802418.001).
  • [ISSN] 1879-0267
  • [Journal-full-title] Injury
  • [ISO-abbreviation] Injury
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Delayed diagnosis / Delayed presentation / Failure to diagnose / Failure to suspect / Foot and ankle injuries / Indirect delayed presentations
  •  go-up   go-down


74. Hayashida K, Kajino K, Simukoko H, Simuunza M, Ndebe J, Chota A, Namangala B, Sugimoto C: Direct detection of falciparum and non-falciparum malaria DNA from a drop of blood with high sensitivity by the dried-LAMP system. Parasit Vectors; 2017 Jan 13;10(1):26

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Direct detection of falciparum and non-falciparum malaria DNA from a drop of blood with high sensitivity by the dried-LAMP system.
  • BACKGROUND: Because of the low sensitivity of conventional rapid diagnostic tests (RDTs) for malaria infections, the actual prevalence of the diseases, especially those caused by non-Plasmodium falciparum (non-Pf) species, in asymptomatic populations remain less defined in countries lacking in well-equipped facilities for accurate diagnoses.
  • Our direct blood dry LAMP system (CZC-LAMP) was applied to the diagnosis of malaria as simple, rapid and highly sensitive method as an alternative for conventional RDTs in malaria endemic areas where laboratory resources are limited.
  • The direct blood LAMP diagnostic methods, in which 1 μl of anticoagulated blood were used as the template, showed the sensitivities of 98.1% for Pf, 92.1% for non-Pf, and the specificities of 98.1% for Pf, 100% for non-Pf.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28086864.001).
  • [ISSN] 1756-3305
  • [Journal-full-title] Parasites & vectors
  • [ISO-abbreviation] Parasit Vectors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


75. Franzo G, Massi P, Tucciarone CM, Barbieri I, Tosi G, Fiorentini L, Ciccozzi M, Lavazza A, Cecchinato M, Moreno A: Think globally, act locally: Phylodynamic reconstruction of infectious bronchitis virus (IBV) QX genotype (GI-19 lineage) reveals different population dynamics and spreading patterns when evaluated on different epidemiological scales. PLoS One; 2017;12(9):e0184401
MedlinePlus Health Information. consumer health - Coronavirus Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Infectious bronchitis virus (IBV) represents one of the poultry industry major threats, particularly in high density producing countries.
  • Our analysis, based on 807 partial S1 sequences of strains collected from 18 countries between 1993 and 2015, demonstrates that this genotype originated in China well before its first identification.
  • After a prolonged local circulation, it started spreading to other European, Asian and Middle East countries in successive waves, which were mirrored by concomitant fluctuations in viral population size.
  • Interestingly, the within-Europe spread was characterized by a higher estimated migration rate compared with the inter-continental one, potentially reflecting the closer geographic and economic relationships among these countries.
  • Globally, the spreading dynamics and evolution of the QX genotype were reconstructed from its very origin to nowadays, demonstrating the need of more effective direct control measures, particularly within each country.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Infect Genet Evol. 2016 Apr;39:349-364 [26883378.001]
  • [Cites] Mol Biol Evol. 2013 Mar;30(3):713-24 [23180580.001]
  • [Cites] Mol Phylogenet Evol. 2016 Jul;100:269-80 [27114187.001]
  • [Cites] Avian Dis. 2001 Apr-Jun;45(2):416-24 [11417821.001]
  • [Cites] PLoS One. 2010 Oct 29;5(10):e13640 [21060827.001]
  • [Cites] Avian Pathol. 2017 Feb;46(1):28-35 [27329854.001]
  • [Cites] Mol Biol Evol. 2012 Sep;29(9):2157-67 [22403239.001]
  • [Cites] Avian Pathol. 2014;43(5):406-13 [25133705.001]
  • [Cites] Mol Biol Evol. 2013 Apr;30(4):772-80 [23329690.001]
  • [Cites] Avian Dis. 1971 Jan-Mar;15(1):42-8 [5547755.001]
  • [Cites] Mol Biol Evol. 2016 Aug;33(8):2167-9 [27189542.001]
  • [Cites] Infect Genet Evol. 2012 Aug;12(6):1305-11 [22609285.001]
  • [Cites] Avian Dis. 2012 Dec;56(4):634-41 [23397833.001]
  • [Cites] Vet Rec. 2005 May 28;156(22):720 [15923564.001]
  • [Cites] Virus Res. 2011 Jun;158(1-2):225-34 [21539870.001]
  • [Cites] Vet Rec. 2010 Nov 27;167(22):877-9 [21262658.001]
  • [Cites] Arch Virol. 2001;146(5):963-73 [11448033.001]
  • [Cites] Virus Evol. 2015 May 26;1(1):vev003 [27774277.001]
  • [Cites] Vet Rec. 1987 Jun 27;120(26):617-8 [2820108.001]
  • [Cites] Vaccine. 2016 Nov 4;34(46):5670-5676 [27670071.001]
  • [Cites] Virus Evol. 2016 Mar 02;2(1):vew003 [27774296.001]
  • [Cites] Avian Pathol. 2009 Dec;38(6):449-56 [19937534.001]
  • [Cites] Avian Pathol. 2008 Jun;37(3):247-57 [18568650.001]
  • [Cites] Avian Pathol. 2011 Oct;40(5):463-71 [21834621.001]
  • [Cites] Science. 2006 Apr 21;312(5772):384-8 [16627734.001]
  • [Cites] Vaccine. 2014 Nov 28;32(50):6765-7 [25446828.001]
  • [Cites] Mol Ecol Resour. 2011 May;11(3):423-34 [21481200.001]
  • [Cites] Mol Biol Evol. 2012 Aug;29(8):1969-73 [22367748.001]
  • [Cites] Acta Vet Hung. 2015 Sep;63(3):382-8 [26551428.001]
  • [Cites] Mol Biol Evol. 2006 Oct;23(10):1891-901 [16818476.001]
  • [Cites] Bioinformatics. 2005 Mar 1;21(5):676-9 [15509596.001]
  • [Cites] Avian Pathol. 2012;41(3):239-50 [22702451.001]
  • [Cites] PLoS One. 2013 Jun 20;8(6):e67366 [23840680.001]
  • [Cites] Arch Virol. 2016 May;161(5):1229-37 [26887967.001]
  • [Cites] Vet Rec. 2008 Jan 19;162(3):99-100 [18204039.001]
  • [Cites] Vaccine. 2007 Jul 26;25(30):5637-44 [17126960.001]
  • [Cites] Avian Pathol. 2011 Feb;40(1):93-102 [21331953.001]
  • [Cites] Vet Microbiol. 2012 Mar 23;155(2-4):237-46 [22005179.001]
  • [Cites] Avian Pathol. 2011 Oct;40(5):507-14 [21854179.001]
  • [Cites] Avian Pathol. 1999 Oct;28(5):477-85 [26911602.001]
  • [Cites] Arch Virol. 2017 May;162(5):1237-1250 [28116527.001]
  • [Cites] Virus Genes. 2010 Dec;41(3):414-6 [20844944.001]
  • [Cites] J Virol. 2011 Dec;85(23):12815-20 [21957308.001]
  • [Cites] PLoS Comput Biol. 2009 Sep;5(9):e1000520 [19779555.001]
  • [Cites] Nucleic Acids Res. 2012 Jan;40(Database issue):D593-8 [22006842.001]
  • [Cites] Avian Dis. 2003 Jul-Sep;47(3):594-601 [14562886.001]
  • [Cites] Avian Pathol. 2006 Oct;35(5):379-93 [16990148.001]
  • [Cites] Avian Pathol. 2008 Oct;37(5):487-93 [18798022.001]
  • [Cites] J Virol. 2005 Sep;79(18):11555-8 [16140732.001]
  • [Cites] Virus Evol. 2016 Apr 09;2(1):vew007 [27774300.001]
  • [Cites] Viruses. 2011 Sep;3(9):1777-99 [21994806.001]
  • [Cites] Virol J. 2006 Sep 20;3:78 [16987422.001]
  • [Cites] Avian Pathol. 2011 Jun;40(3):223-35 [21711181.001]
  • [Cites] Syst Biol. 2010 May;59(3):307-21 [20525638.001]
  • [Cites] Nat Methods. 2012 Jul 30;9(8):772 [22847109.001]
  • [Cites] Vet Ital. 2007 Jul-Sep;43(3):723-30 [20422551.001]
  • (PMID = 28880958.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


76. Mobaraki H, Azami-Aghdash S, Sarabi Asiabar A, Rezapour A, Kafaei Mehr MH, Emamgolizadeh S: Cost-effectiveness of Eplerenone in treatment of cardiovascular diseases: a systematic review. Med J Islam Repub Iran; 2017;31:4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The required information were collected using key Mesh words from the following databases: Google scholar, PubMed, Science Direct, MagIran, SID, Scopus, and handsearching journals and the references of the selected articles.
  • The selected studies have been conducted in 8 countries (The United States, Britain, Australia, Switzerland, France, Spain, the Netherlands, and Canada).
  • Incremental cost-effectiveness ratio was high in the United States compared to European countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Medicine (Baltimore). 2016 May;95(18):e3531 [27149456.001]
  • [Cites] Asian Pac J Cancer Prev. 2014;15(8):3715-20 [24870782.001]
  • [Cites] Arch Cardiovasc Dis. 2008 Sep;101(9):515-21 [19041835.001]
  • [Cites] Clin Ther. 2003 Sep;25(9):2388-404 [14604739.001]
  • [Cites] Med J Islam Repub Iran. 2015 Aug 10;29:246 [26793637.001]
  • [Cites] Cardiovasc Drugs Ther. 2006 Jun;20(3):193-204 [16775667.001]
  • [Cites] N Engl J Med. 2003 Apr 3;348(14):1309-21 [12668699.001]
  • [Cites] Med J Islam Repub Iran. 2016 Feb 14;30:327 [27390697.001]
  • [Cites] Circulation. 2005 Mar 8;111(9):1106-13 [15723981.001]
  • [Cites] Am J Cardiovasc Drugs. 2014 Jun;14(3):209-16 [24610254.001]
  • [Cites] Curr Hypertens Rep. 2014 Feb;16(2):414 [24407447.001]
  • [Cites] Am J Cardiol. 2004 Apr 15;93(8):990-6 [15081441.001]
  • [Cites] Heart. 2014 Nov;100(21):1681-7 [24993605.001]
  • [Cites] Pharmacoeconomics. 2005;23(10):1057-72 [16235978.001]
  • [Cites] Int J Cardiol. 2014 Nov 15;177(1):219-28 [25499383.001]
  • [Cites] Value Health. 2012 May;15(3):420-8 [22583451.001]
  • [Cites] Int J Cardiol. 2015 Dec 1;200:8-11 [25466561.001]
  • [Cites] J Am Coll Cardiol. 2011 Nov 1;58(19):1958-66 [22032706.001]
  • [Cites] Am J Cardiovasc Drugs. 2016 Oct;16(5):365-76 [27300508.001]
  • [Cites] Ann Pharmacother. 2005 Jan;39(1):68-76 [15590870.001]
  • [Cites] Circulation. 2012 Jan 17;125(2):271-9 [22128223.001]
  • [Cites] Proc (Bayl Univ Med Cent). 2004 Apr;17(2):217-20 [16200104.001]
  • [Cites] Circulation. 2009 Jan 27;119(3):398-407 [19139382.001]
  • [Cites] J Evid Based Med. 2014 Feb;7(1):26-31 [25155563.001]
  • [Cites] J Med Ethics. 2013 Feb;39(2):110-4 [23015747.001]
  • [Cites] Eur J Health Econ. 2008 Feb;9(1):69-78 [17447095.001]
  • [Cites] J Renin Angiotensin Aldosterone Syst. 2011 Sep;12(3):340-7 [21393354.001]
  • [Cites] Neth Heart J. 2005 Nov;13(11):393-400 [25696430.001]
  • [Cites] Am J Cardiovasc Drugs. 2010;10(1):55-63 [20104935.001]
  • (PMID = 28638811.001).
  • [ISSN] 1016-1430
  • [Journal-full-title] Medical journal of the Islamic Republic of Iran
  • [ISO-abbreviation] Med J Islam Repub Iran
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Iran
  • [Keywords] NOTNLM ; Cardiovascular Disease / Cost-effectiveness / Eplerenone / Systematic Review
  •  go-up   go-down


77. Falade BA, Bauer MW: 'I have faith in science and in God': Common sense, cognitive polyphasia and attitudes to science in Nigeria. Public Underst Sci; 2017 Feb 01;:963662517690293

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Nigeria is a large country with a complex diversity of religious, ethnic and cultural practices that condition the reception and elaboration of science in everyday life.
  • Scientific knowledge and religiosity have a direct bearing on expectations of progress and feeling of fear and worry about science; mythical image is independent of this.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28194998.001).
  • [ISSN] 1361-6609
  • [Journal-full-title] Public understanding of science (Bristol, England)
  • [ISO-abbreviation] Public Underst Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; attitudes / cognitive polyphasia / faith / interaction / religion / science / trust
  •  go-up   go-down


78. Torres-Mejía G, Navarro-Lechuga E, Tuesca-Molina RJ, Ángeles-Llerenas A: The Epidemiological Challenges of Breast Cancer among Premenopausal Women in Limited Resource Settings. Rev Invest Clin; 2017 Mar-Apr;69(2):59-65

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this context, the aim of the present review is to identify factors that make breast cancer in premenopausal women an epidemiological challenge in developing countries.
  • Breast cancer in premenopausal women should be included in the political and strategic agendas in developing countries to direct the necessary resources for prevention, detection, and control.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28453504.001).
  • [ISSN] 0034-8376
  • [Journal-full-title] Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
  • [ISO-abbreviation] Rev. Invest. Clin.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


79. Knudsen MT, Hermansen JE, Cederberg C, Herzog F, Vale J, Jeanneret P, Sarthou JP, Friedel JK, Balázs K, Fjellstad W, Kainz M, Wolfrum S, Dennis P: Characterization factors for land use impacts on biodiversity in life cycle assessment based on direct measures of plant species richness in European farmland in the 'Temperate Broadleaf and Mixed Forest' biome. Sci Total Environ; 2017 Feb 15;580:358-366

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization factors for land use impacts on biodiversity in life cycle assessment based on direct measures of plant species richness in European farmland in the 'Temperate Broadleaf and Mixed Forest' biome.
  • Based on a unique dataset derived from field recording of plant species diversity in farmland across six European countries, the present study provides new midpoint occupation Characterization Factors (CF) expressing the Potentially Disappeared Fraction (PDF) to estimate land use impacts on biodiversity in the 'Temperate Broadleaf and Mixed Forest' biome in Europe.
  • While species richness differs between countries, the calculated CFs are able to distinguish between different land use types (pastures (monocotyledons or mixed), arable land and hedges) and management practices (organic or conventional production systems) across countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 Elsevier B.V. All rights reserved.
  • (PMID = 27979626.001).
  • [ISSN] 1879-1026
  • [Journal-full-title] The Science of the total environment
  • [ISO-abbreviation] Sci. Total Environ.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Biodiversity damage potential / Conventional farming / General habitat categories / LCA / Organic agriculture / Potentially disappeared fraction of species
  •  go-up   go-down


80. Higgs ES, Dubey SA, Coller BAG, Simon JK, Bollinger L, Sorenson RA, Wilson B, Nason MC, Hensley LE: Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak. Curr Top Microbiol Immunol; 2017 Sep 17;
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Past experience with limited localized outbreaks, lack of licensed medical countermeasures, reluctance by first responders to direct scarce resources to clinical research, community resistance to outside interventions, and lack of local infrastructure were among the factors delaying clinical research during the outbreak.
  • Each of the three Ebola virus disease-affected countries, Sierra Leone, Guinea, and Liberia, conducted a phase II/III Ebola virus vaccine trial.
  • Thoughtful and intensive community engagement in each country enabled the critical community partnership and acceptance of the phase II/III in each country.
  • Due to the delayed clinical trial initiation, relative to the epidemiologic peak of the outbreak in the three countries, vaccine interventions may or may not have played a major role in bringing the epidemic under control.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28918539.001).
  • [ISSN] 0070-217X
  • [Journal-full-title] Current topics in microbiology and immunology
  • [ISO-abbreviation] Curr. Top. Microbiol. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


81. Andrade A, Dominski FH, Coimbra DR: Scientific production on indoor air quality of environments used for physical exercise and sports practice: Bibliometric analysis. J Environ Manage; 2017 Jul 01;196:188-200

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The databases Scielo, Science Direct, Scopus, Lilacs, Medline via Pubmed, and SportDiscus were searched from their inception to March 2016.
  • Bibliometric analysis was performed for authors, institutions, countries, and collaborative networks, in relation to publication year, theme, citation network, funding agency, and analysis of titles and keywords of publications.
  • Country, area, and impact factor of the journals were analyzed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28284941.001).
  • [ISSN] 1095-8630
  • [Journal-full-title] Journal of environmental management
  • [ISO-abbreviation] J. Environ. Manage.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Air pollutants / Air pollution / Bibliometric / Health / Indoor / Motor activity / Sports
  •  go-up   go-down


82. Hiby E, Hiby L: Direct Observation of Dog Density and Composition during Street Counts as a Resource Efficient Method of Measuring Variation in Roaming Dog Populations over Time and between Locations. Animals (Basel); 2017 Aug 03;7(8)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Direct Observation of Dog Density and Composition during Street Counts as a Resource Efficient Method of Measuring Variation in Roaming Dog Populations over Time and between Locations.
  • Dog population management is conducted in many countries to address the public health risks from roaming dogs and threats to their welfare.
  • The implementation of this method in seven locations reveals significant difference in roaming dog density between locations and reduction in density within one location subject to intervention.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMC Vet Res. 2008 Jan 31;4:6 [18237372.001]
  • [Cites] BMC Vet Res. 2012 Dec 05;8:236 [23217194.001]
  • [Cites] Prev Vet Med. 2013 Feb 1;108(2-3):209-17 [22906504.001]
  • [Cites] Vet Rec. 2013 May 4;172(18):473 [23492927.001]
  • [Cites] BMC Vet Res. 2011 Aug 11;7:46 [21834979.001]
  • [Cites] Vet Rec. 2006 Sep 16;159(12):379-83 [16980523.001]
  • [Cites] Prev Vet Med. 2010 Oct 1;97(1):51-7 [20696487.001]
  • [Cites] Prev Vet Med. 2010 May 1;94(3-4):272-81 [20096943.001]
  • [Cites] BMC Vet Res. 2017 May 30;13(1):143 [28558736.001]
  • (PMID = 28771177.001).
  • [ISSN] 2076-2615
  • [Journal-full-title] Animals : an open access journal from MDPI
  • [ISO-abbreviation] Animals (Basel)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; animal welfare / dog / dog population management / evaluation / monitoring / population density / stray dog / strip transect / survey
  •  go-up   go-down


83. Saha NC, Anwar KS, Mollah AH, Akhter S, Amin MR, Mollah AA: Age and Gender-dependent Correlates as Risk Factors of Recurrent Headache among Bangladeshi Secondary School Children. Mymensingh Med J; 2017 Oct;26(4):831-839

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Magnitude of recurrent headache (RHA) is not well explored among school-children (schoolers) particularly in developing countries like Bangladesh, though recent literature reveals that RHA connotes serious public health implication(s) particularly in schoolers in resource constraint countries.
  • Cross-sectional population based respondent-dependent study employing direct interviews using pre-tested open and closed-ended questionnaire following ICHD-II (2004) diagnostic criteria.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29208872.001).
  • [ISSN] 2408-8757
  • [Journal-full-title] Mymensingh medical journal : MMJ
  • [ISO-abbreviation] Mymensingh Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Bangladesh
  •  go-up   go-down


84. Huybrechts KF, Desai RJ, Park M, Gagne JJ, Najafzadeh M, Avorn J: The Potential Return on Public Investment in Detecting Adverse Drug Effects. Med Care; 2017 Jun;55(6):545-551
MedlinePlus Health Information. consumer health - Drug Reactions.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Many countries lack fully functional pharmacovigilance programs, and public budgets allocated to pharmacovigilance in industrialized countries remain low due to resource constraints and competing priorities.
  • RESULTS: We found that earlier drug withdrawal made possible by active safety surveillance would most likely have resulted in savings in direct medical costs of $773-$884 million for rofecoxib, $3-$10 million for cerivastatin, and $38-$63 million for troglitazone in the United States through the prevention of adverse events.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] JAMA. 2004 Dec 1;292(21):2585-90 [15572716.001]
  • [Cites] Epidemiology. 2012 Mar;23(2):238-46 [22266893.001]
  • [Cites] Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):417-26 [15269925.001]
  • [Cites] Am J Med. 2003 Mar;114(4):299-306 [12681458.001]
  • [Cites] N Engl J Med. 2011 Dec 8;365(23):2151-3 [22150034.001]
  • [Cites] Am J Health Syst Pharm. 2003 Mar 15;60(6):578-81 [12659062.001]
  • [Cites] N Engl J Med. 2005 Mar 17;352(11):1092-102 [15713943.001]
  • [Cites] Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):1023-32 [27146123.001]
  • [Cites] J Manag Care Pharm. 2011 Sep;17(7):531-46 [21870894.001]
  • [Cites] Med Care. 2013 Aug;51(8 Suppl 3):S4-10 [23752258.001]
  • [Cites] JAMA. 2004 Dec 1;292(21):2622-31 [15572720.001]
  • [Cites] Lancet. 2004 Dec 4-10;364(9450):2021-9 [15582059.001]
  • [Cites] Lancet. 2001 Jun 9;357(9271):1870-5 [11410214.001]
  • [Cites] Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):619-27 [24788694.001]
  • [Cites] JAMA. 1999 Apr 21;281(15):1381-6 [10217053.001]
  • [Cites] Drug Saf. 2010 Aug 1;33(8):689-703 [20635827.001]
  • [Cites] Curr Med Res Opin. 2008 Feb;24(2):461-8 [18194592.001]
  • [Cites] N Engl J Med. 2007 Nov 29;357(22):2219-21 [18046025.001]
  • [Cites] JAMA. 2017 Feb 14;317(6):581-582 [28056124.001]
  • [Cites] Am Heart J. 2012 Aug;164(2):186-93 [22877803.001]
  • [Cites] Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003685 [15674912.001]
  • [Cites] Arch Intern Med. 2005 Jan 24;165(2):158-60 [15668360.001]
  • [Cites] Am J Gastroenterol. 2003 Jan;98 (1):175-9 [12526954.001]
  • [Cites] N Engl J Med. 2012 Jul 19;367(3):193-7 [22808954.001]
  • [Cites] Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):762-72 [17457957.001]
  • [Cites] N Engl J Med. 2014 Jun 5;370(23):2165-7 [24897081.001]
  • (PMID = 28505041.001).
  • [ISSN] 1537-1948
  • [Journal-full-title] Medical care
  • [ISO-abbreviation] Med Care
  • [Language] eng
  • [Grant] United States / NIMH NIH HHS / MH / K01 MH099141
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


85. Xiao F, Pu J, Wen Q, Huang Q, Zhang Q, Huang B, Huang S, Lan A, Zhang Y, Li J, Zhao D, Shen J, Wu H, He Y, Li H, Yang X: Association between the ERCC2 Asp312Asn polymorphism and risk of cancer. Oncotarget; 2017 Jul 18;8(29):48488-48506

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cancer is the leading cause of death in economically developed countries and the second leading cause of death in developing countries.
  • We searched the PubMed, EMBASE, Science Direct, Web of Science, and CNKI databases for studies published from January 1, 2005 to January 1, 2016.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Neurobiol. 2016 May;53(4):2705-14 [26264164.001]
  • [Cites] Hum Genet. 2006 Jul;119(6):659-68 [16738949.001]
  • [Cites] Cancer Epidemiol. 2009 Oct;33(3-4):257-60 [19736055.001]
  • [Cites] Carcinogenesis. 2006 Sep;27(9):1835-41 [16571649.001]
  • [Cites] Anticancer Res. 2007 Jul-Aug;27(4C):2893-6 [17695467.001]
  • [Cites] Hum Mutat. 2005 Apr;25(4):353-9 [15776433.001]
  • [Cites] Gene. 2015 Oct 15;571(1):9-16 [26232607.001]
  • [Cites] Carcinogenesis. 2005 Jul;26(7):1263-71 [15746160.001]
  • [Cites] J Toxicol Environ Health A. 2008;71(13-14):887-97 [18569591.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1336-40 [16835333.001]
  • [Cites] Mol Biol Rep. 2012 Jan;39(1):709-14 [21553048.001]
  • [Cites] Tumour Biol. 2015 Sep;36(10):7569-79 [25916209.001]
  • [Cites] Urol Oncol. 2011 Nov-Dec;29(6):641-6 [19914098.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1614-9 [16985021.001]
  • [Cites] Cancer Causes Control. 2010 Feb;21(2):289-300 [19902366.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):258-65 [16492913.001]
  • [Cites] Tumour Biol. 2014 Apr;35(4):3905-15 [24347488.001]
  • [Cites] Gene. 2014 Aug 10;546(2):156-61 [24933002.001]
  • [Cites] Tumour Biol. 2014 Jun;35(6):5245-57 [24504678.001]
  • [Cites] World J Gastroenterol. 2014 Nov 28;20(44):16765-73 [25469049.001]
  • [Cites] Carcinogenesis. 2009 May;30(5):785-92 [19270000.001]
  • [Cites] Mutat Res. 2007 Jun 1;619(1-2):68-80 [17363013.001]
  • [Cites] Breast Cancer Res Treat. 2010 Aug;123(1):203-12 [20111903.001]
  • [Cites] BMC Cancer. 2007 Aug 16;7:162 [17705814.001]
  • [Cites] Biol Res. 2013;46(2):161-7 [23959014.001]
  • [Cites] Int J Mol Epidemiol Genet. 2012;3(1):1-17 [22493747.001]
  • [Cites] Breast Cancer Res Treat. 2006 Jul;98(2):209-15 [16685590.001]
  • [Cites] Cancer Epidemiol. 2011 Apr;35(2):170-4 [20863780.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10 ):2033-41 [17932351.001]
  • [Cites] Cancer Genet Cytogenet. 2007 May;175(1):47-51 [17498557.001]
  • [Cites] Curr Med Chem. 2013;20(10):1225-31 [23432583.001]
  • [Cites] Tumour Biol. 2014 Nov;35(11):11243-59 [25113251.001]
  • [Cites] Carcinogenesis. 2009 Mar;30(3):472-9 [19029193.001]
  • [Cites] Clin Cancer Res. 2007 Jun 15;13(12):3753-8 [17575242.001]
  • [Cites] Carcinogenesis. 2007 Jun;28(6):1254-8 [17264068.001]
  • [Cites] Carcinogenesis. 2006 May;27(5):997-1007 [16308313.001]
  • [Cites] Prostate. 2010 Feb 1;70(2):113-9 [19760636.001]
  • [Cites] Lung Cancer. 2011 Aug;73(2):138-46 [21195504.001]
  • [Cites] World J Gastroenterol. 2015 Jul 14;21(26):7988-8003 [26185370.001]
  • [Cites] Int J Hematol. 2013 Dec;98(6):681-6 [24258710.001]
  • [Cites] Oncotarget. 2016 Nov 8;7(45):73935-73944 [27738340.001]
  • [Cites] Mutat Res. 2007 Jul 28;631(2):101-10 [17531525.001]
  • [Cites] Asian Pac J Cancer Prev. 2014;15(18):7713-8 [25292051.001]
  • [Cites] Anticancer Res. 2009 Oct;29(10):3903-7 [19846926.001]
  • [Cites] Genet Mol Res. 2014 May 16;13(2):3812-8 [24938468.001]
  • [Cites] Medicine (Baltimore). 2016 Mar;95(10 ):e2927 [26962789.001]
  • [Cites] Cell. 2011 Mar 4;144(5):646-74 [21376230.001]
  • [Cites] Am J Epidemiol. 2005 Jan 1;161(1):1-14 [15615908.001]
  • [Cites] PLoS Med. 2016 Apr 12;13(4):e1001992 [27071029.001]
  • [Cites] Pediatr Hematol Oncol. 2009 Sep;26(6):467-72 [19657998.001]
  • [Cites] Tumour Biol. 2014 Mar;35(3):1907-15 [24101192.001]
  • [Cites] Clin Chim Acta. 2005 Sep;359(1-2):150-5 [16002061.001]
  • [Cites] Clin Chem Lab Med. 2007;45(7):822-8 [17617021.001]
  • [Cites] Gene. 2013 Nov 10;530(2):309-14 [23973729.001]
  • [Cites] Reprod Biomed Online. 2016 Jul;33(1):39-49 [27157932.001]
  • [Cites] Int J Cancer. 2008 Nov 1;123(9):2095-104 [18709642.001]
  • [Cites] Oncol Lett. 2015 Apr;9(4):1657-1661 [25789018.001]
  • [Cites] Int J Clin Exp Med. 2015 Nov 15;8(11):20236-44 [26884936.001]
  • [Cites] DNA Cell Biol. 2010 Apr;29(4):183-90 [20070155.001]
  • [Cites] BMJ. 2003 Sep 6;327(7414):557-60 [12958120.001]
  • [Cites] Int J Cancer. 2005 Sep 20;116(5):768-73 [15849729.001]
  • [Cites] Lung Cancer. 2008 Feb;59(2):171-9 [17913280.001]
  • [Cites] Carcinogenesis. 2006 May;27(5):1030-7 [16311243.001]
  • [Cites] Chin J Cancer. 2015 Mar 05;34(3):108-14 [25962431.001]
  • [Cites] Mol Biol Rep. 2010 Jan;37(1):301-9 [19669592.001]
  • [Cites] Breast Cancer Res Treat. 2007 Jan;101(1):65-71 [16823510.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2569-78 [16284380.001]
  • [Cites] Carcinogenesis. 2006 Mar;27(3):610-8 [16258177.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2526-32 [17164380.001]
  • [Cites] JAMA. 2006 Feb 8;295(6):676-80 [16467236.001]
  • [Cites] Breast Cancer Res Treat. 2010 Jan;119(1):201-11 [19360465.001]
  • [Cites] Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb;16(1):97-100 [18315909.001]
  • [Cites] Clin Exp Otorhinolaryngol. 2010 Mar;3(1):42-7 [20379402.001]
  • [Cites] Indian J Hum Genet. 2012 Jan;18(1):47-55 [22754221.001]
  • [Cites] Oncotarget. 2016 Nov 15;7(46):76021-76035 [27738347.001]
  • [Cites] Anticancer Res. 2008 May-Jun;28(3B):1853-6 [18630471.001]
  • [Cites] Oral Oncol. 2010 Oct;46(10):761-6 [20850372.001]
  • [Cites] Oncotarget. 2017 Feb 7;8(6):9806-9822 [28039461.001]
  • [Cites] Carcinogenesis. 2006 Jul;27(7):1377-85 [16399771.001]
  • [Cites] Carcinogenesis. 2006 Mar;27(3):560-7 [16195237.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1828-31 [16030124.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):878-84 [15824159.001]
  • [Cites] Urology. 2009 Mar;73(3):675-80 [19041121.001]
  • [Cites] CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29 [25559415.001]
  • [Cites] Tumour Biol. 2014 Apr;35(4):2959-65 [24234258.001]
  • [Cites] Ai Zheng. 2009 Nov;28(11):1163-7 [19895736.001]
  • [Cites] Mol Vis. 2011 Jan 12;17:127-33 [21245954.001]
  • [Cites] Exp Mol Med. 2005 Apr 30;37(2):86-90 [15886521.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1539-44 [15941969.001]
  • [Cites] Asian Pac J Cancer Prev. 2013;14(1):231-6 [23534729.001]
  • [Cites] Oncol Lett. 2012 Aug;4(2):247-251 [22844363.001]
  • [Cites] Am J Hum Genet. 2006 Mar;78(3):464-79 [16465622.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):536-42 [16537713.001]
  • [Cites] Tumour Biol. 2015 Nov;36(11):8953-72 [26081619.001]
  • [Cites] Int J Cancer. 2007 May 15;120(10):2148-56 [17290401.001]
  • [Cites] Chin J Physiol. 2010 Apr 30;53(2):130-5 [21793320.001]
  • [Cites] Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2101-8 [16609022.001]
  • [Cites] Exp Mol Pathol. 2011 Aug;91(1):331-4 [21419115.001]
  • [Cites] DNA Repair (Amst). 2005 Sep 28;4(10):1068-74 [16054878.001]
  • [Cites] Breast Cancer Res Treat. 2010 Aug;123(1):227-31 [20127278.001]
  • [Cites] Carcinogenesis. 2007 Aug;28(8):1697-702 [17470448.001]
  • [Cites] Asian Pac J Cancer Prev. 2014;15(16):6619-25 [25169498.001]
  • [Cites] PLoS One. 2012;7(4):e35220 [22536360.001]
  • [Cites] Carcinogenesis. 2008 Nov;29(11):2132-8 [18701435.001]
  • [Cites] Reprod Biomed Online. 2008 Jul;17(1):36-41 [18616887.001]
  • [Cites] Mol Biol Rep. 2012 Feb;39(2):1895-901 [21643959.001]
  • [Cites] Oncotarget. 2016 Nov 29;7(48):79901-79913 [27821804.001]
  • [Cites] Mol Cancer. 2008 May 02;7:36 [18454848.001]
  • [Cites] Mol Biol Rep. 2012 Jan;39(1):57-69 [21614524.001]
  • [Cites] Sci Rep. 2014 Feb 17;4:4112 [24531312.001]
  • [Cites] J Cancer. 2016 Jan 01;7(2):144-52 [26819637.001]
  • [Cites] Biomarkers. 2014 Sep;19(6):509-16 [25089939.001]
  • [Cites] Tumour Biol. 2013 Oct;34(5):2843-8 [23700156.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):306-11 [16492920.001]
  • [Cites] J Exp Clin Cancer Res. 2009 Dec 14;28:153 [20003391.001]
  • [Cites] Carcinogenesis. 2000 Apr;21(4):551-5 [10753184.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1633-8 [17684138.001]
  • [Cites] Sci Rep. 2014 Sep 11;4:6281 [25209371.001]
  • [Cites] Cancer Causes Control. 2008 Dec;19(10):1077-83 [18478337.001]
  • [Cites] J Appl Genet. 2010;51(3):343-52 [20720310.001]
  • [Cites] Medicine (Baltimore). 2015 Sep;94(39):e1593 [26426637.001]
  • [Cites] Int J Cancer. 2009 Sep 15;125(6):1431-9 [19444904.001]
  • [Cites] Mol Biol Rep. 2011 Mar;38(3):1507-13 [20842450.001]
  • (PMID = 28489582.001).
  • [ISSN] 1949-2553
  • [Journal-full-title] Oncotarget
  • [ISO-abbreviation] Oncotarget
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Keywords] NOTNLM ; ERCC2 Asp312Asn / cancer / meta-analysis / polymorphism / trial sequence analysis
  •  go-up   go-down


86. Kim H, Ryu DR: A prime determinant in selecting dialysis modality: peritoneal dialysis patient survival. Kidney Res Clin Pract; 2017 Mar;36(1):22-28

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Peritoneal dialysis (PD) is an established treatment for ESRD patients worldwide; it has a variety of advantages, including autonomy and flexibility, as well as economic benefits in many countries compared to hemodialysis (HD).
  • Although direct comparison of survival rate between the dialysis modalities by randomized controlled trials is difficult due to the ethical issues, it has always been a crucial point when deciding which dialysis modality should be recommended to patients.
  • Recently, in many countries, including the United States, Brazil, Spain, Australia, and New Zealand, the survival rate in PD patients has significantly improved.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nefrologia. 2014;34(1):18-33 [24463879.001]
  • [Cites] Nephrol Dial Transplant. 2012 Sep;27(9):3568-75 [22391139.001]
  • [Cites] Kidney Int. 2003 Sep;64(3):1071-9 [12911559.001]
  • [Cites] Am J Kidney Dis. 1999 Apr;33(4):617-32 [10196002.001]
  • [Cites] Semin Dial. 2006 Jan-Feb;19(1):32-40 [16423180.001]
  • [Cites] Arch Intern Med. 2011 Jan 24;171(2):110-8 [20876398.001]
  • [Cites] Medicine (Baltimore). 2012 May;91(3):144-51 [22525667.001]
  • [Cites] Adv Perit Dial. 1989;5:91-6 [2577437.001]
  • [Cites] Kidney Res Clin Pract. 2014 Mar;33(1):9-18 [26877945.001]
  • [Cites] Kidney Int. 2014 Nov;86(5):877-80 [25360491.001]
  • [Cites] Kidney Int. 2014 Nov;86(5):991-1000 [24805104.001]
  • [Cites] Perit Dial Int. 2007 Jul-Aug;27(4):432-40 [17602152.001]
  • [Cites] PLoS One. 2013 Dec 30;8(12):e84257 [24386357.001]
  • [Cites] Kidney Int Suppl. 2006 Nov;(103):S3-11 [17080109.001]
  • [Cites] Int J Cardiol. 2015 Nov 1;198:95-101 [26159246.001]
  • [Cites] Nephrol Dial Transplant. 2010 Aug;25(8):2737-44 [20189930.001]
  • [Cites] Curr Opin Nephrol Hypertens. 2015 May;24(3):276-83 [25774747.001]
  • [Cites] J Am Soc Nephrol. 2009 Jan;20(1):155-63 [19092128.001]
  • [Cites] Am J Kidney Dis. 2016 Mar;67(3 Suppl 1):Svii, S1-305 [26925525.001]
  • [Cites] Perit Dial Int. 2001;21 Suppl 3:S307-13 [11887842.001]
  • [Cites] J Am Soc Nephrol. 2003 Feb;14(2):415-24 [12538742.001]
  • [Cites] Perit Dial Int. 2014 Nov-Dec;34(7):714-23 [25185014.001]
  • [Cites] Am J Kidney Dis. 2015 Sep;66(3):489-98 [25958081.001]
  • [Cites] Nephrol Dial Transplant. 2011 Sep;26(9):2940-7 [21325351.001]
  • [Cites] JAMA. 1970 Sep 28;213(13):2268-9 [5468937.001]
  • [Cites] Perit Dial Int. 2005 Feb;25 Suppl 3:S84-7 [16048265.001]
  • [Cites] J Am Soc Nephrol. 2002 May;13(5):1279-87 [11961016.001]
  • [Cites] Nephrol Dial Transplant. 2002 Sep;17(9):1661-6 [12198220.001]
  • [Cites] BMC Nephrol. 2015 Apr 14;16:53 [25885318.001]
  • [Cites] Nephrol Dial Transplant. 2008 May;23(5):1475-8 [18303111.001]
  • [Cites] Nephron Clin Pract. 2005;99(3):c86-91 [15665551.001]
  • [Cites] Yonsei Med J. 2015 May;56(3):666-75 [25837171.001]
  • [Cites] Nephrol Dial Transplant. 2008 Dec;23(12):3972-6 [18577531.001]
  • [Cites] Nephrol Dial Transplant. 2016 Jan;31(1):120-8 [26311215.001]
  • [Cites] Contrib Nephrol. 2012;178:30-4 [22652712.001]
  • (PMID = 28428932.001).
  • [ISSN] 2211-9132
  • [Journal-full-title] Kidney research and clinical practice
  • [ISO-abbreviation] Kidney Res Clin Pract
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Korea (South)
  • [Keywords] NOTNLM ; Cardiovascular diseases / Hemodialysis / Mortality / Peritoneal dialysis
  •  go-up   go-down


87. Huic A, Jelic M, Kamenov Z: Essentialist Beliefs About Homosexuality Predict Positive and Negative Behavioral Intentions Toward Lesbian Women and Gay Men. J Homosex; 2017 Sep 21;:1-25

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A sample of 997 exclusively heterosexual adults participated in an online study set in Croatia, a country with high homophobia undergoing social change that threatens the higher status of the heterosexual majority.
  • Importantly, essentialist beliefs had both indirect (with attitudes as mediators) and direct effects on behavioral intentions speaking in favor of their robust role in explaining LG-related phenomena.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28934073.001).
  • [ISSN] 1540-3602
  • [Journal-full-title] Journal of homosexuality
  • [ISO-abbreviation] J Homosex
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Essentialist beliefs / attitudes toward LGs / homosexuality / negative behavior / positive behavior
  •  go-up   go-down


88. Worsley A, Wang W, Sarmugam R, Pham Q, Februhartanty J, Ridley S: Family Food Providers' Perceptions of the Causes of Obesity and Effectiveness of Weight Control Strategies in Five Countries in the Asia Pacific Region: A Cross-Sectional Survey. Nutrients; 2017 Jan 18;9(1)
MedlinePlus Health Information. consumer health - Obesity.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Family Food Providers' Perceptions of the Causes of Obesity and Effectiveness of Weight Control Strategies in Five Countries in the Asia Pacific Region: A Cross-Sectional Survey.
  • The rise of the middle classes in developing countries and the associated epidemiological transition raises the importance of assessing this population group's awareness of the causes of obesity and effective weight control strategies in order to develop effective health promotion strategies.
  • The CFA and SEM showed that demographics, region of residence, personal values and perceptions of the causes of obesity (<i>Unhealthy food behaviours</i>, influences <i>Beyond personal control</i> and <i>Environmental influences</i>) had direct and indirect associations with three weight control methods factors, named: <i>Healthy habits, Eat less, sit less</i>, and <i>Dieting.
  • Further research is required among lower socio economic status (SES) populations.

  • Genetic Alliance. consumer health - Obesity.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Obes Rev. 2013 Nov;14 Suppl 2:1-8 [24102826.001]
  • [Cites] Int J Obes Relat Metab Disord. 2003 Dec;27(12):1465-71 [14634676.001]
  • [Cites] J Econ Perspect. 2008;22(2):3-28 [19212452.001]
  • [Cites] Am J Prev Med. 2013 Apr;44(4):358-64 [23498101.001]
  • [Cites] Lancet. 2013 Feb 23;381(9867):670-9 [23410611.001]
  • [Cites] Health Educ Res. 2006 Dec;21(6):848-61 [17095572.001]
  • [Cites] Med J Aust. 2007 May 7;186(9):458-60 [17484707.001]
  • [Cites] J Am Diet Assoc. 2000 Aug;100(8):947-9 [10955055.001]
  • [Cites] Am J Clin Nutr. 2004 Jan;79(1):6-16 [14684391.001]
  • [Cites] PLoS Med. 2012;9(7):e1001254 [22802734.001]
  • [Cites] Asia Pac J Clin Nutr. 2000 Mar;9(1):24-32 [24394312.001]
  • [Cites] J Epidemiol Community Health. 1995 Feb;49(1):28-32 [7707001.001]
  • (PMID = 28106781.001).
  • [ISSN] 2072-6643
  • [Journal-full-title] Nutrients
  • [ISO-abbreviation] Nutrients
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; Asia Pacific / food providers / obesity / perceptions / survey / weight concerns
  •  go-up   go-down


89. Tetteh S, Bibb RJ, Martin SJ: Maxillofacial prostheses challenges in resource constrained regions. Disabil Rehabil; 2017 Oct 24;:1-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In addition, interviews were conducted with researchers, clinicians and prosthetists that had direct experience of volunteering or working in resource-limited countries.
  • RESULTS: Results from the review and interviews suggest rehabilitating patients in resource-limited countries remains challenging and efforts to improve the situation requires a multifactorial approach.
  • CONCLUSIONS: In conclusion, public health awareness programmes to reduce the causation of injuries and bespoke maxillofacial prosthetics training programmes to suit these countries, as opposed to attempting to replicate Western training programmes.
  • The possibility of developing training programs to suit these resource limited countries and not necessarily follow conventional fabrication methods must be looked into further by educational entities.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29065718.001).
  • [ISSN] 1464-5165
  • [Journal-full-title] Disability and rehabilitation
  • [ISO-abbreviation] Disabil Rehabil
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Facial prosthetic / facial disfigurement / maxillofacial / rehabilitation / resource-limited areas
  •  go-up   go-down


90. Rodrigues CMC, Groves H: Community-acquired pneumonia in children; the challenges of microbiological diagnosis. J Clin Microbiol; 2017 Dec 13;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To improve the management of CAP, we must distinguish CAP from other common paediatric conditions and develop better diagnostic methods to detect the causative organism, so to best direct appropriate resources in both industrialised and developing countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Rodrigues and Groves.
  • (PMID = 29237789.001).
  • [ISSN] 1098-660X
  • [Journal-full-title] Journal of clinical microbiology
  • [ISO-abbreviation] J. Clin. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


91. Cock MJW, Beseh PK, Buddie AG, Cafá G, Crozier J: Molecular methods to detect Spodoptera frugiperda in Ghana, and implications for monitoring the spread of invasive species in developing countries. Sci Rep; 2017 Jun 22;7(1):4103

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular methods to detect Spodoptera frugiperda in Ghana, and implications for monitoring the spread of invasive species in developing countries.
  • We discuss possible routes of entry to Africa, of which the likeliest is adults and/or egg masses transported on direct commercial flights between the Americas and West Africa, followed by dispersal by adult flight within Africa.
  • As authenticated barcodes for vouchered specimens of more pests become available, this approach has the potential to become a valuable in-country tool to support national capability in rapid and reliable pest diagnosis and identification.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Mar Biol Biotechnol. 1994 Oct;3(5):294-9 [7881515.001]
  • [Cites] PLoS One. 2017 Feb 6;12 (2):e0171743 [28166292.001]
  • [Cites] Genetica. 2015 Jun;143(3):305-16 [25694156.001]
  • [Cites] Proc Biol Sci. 2003 Feb 7;270(1512):313-21 [12614582.001]
  • [Cites] BMC Bioinformatics. 2004 Aug 19;5:113 [15318951.001]
  • [Cites] Genome. 2016 Sep;59(9):641-60 [27584861.001]
  • [Cites] Mol Biol Evol. 1993 May;10(3):512-26 [8336541.001]
  • [Cites] PLoS One. 2013 Jul 08;8(7):e66213 [23861743.001]
  • [Cites] Mol Biol Evol. 2013 Dec;30(12):2725-9 [24132122.001]
  • [Cites] Mol Phylogenet Evol. 2012 Dec;65(3):855-70 [22939903.001]
  • [Cites] Nucleic Acids Res. 2004 Mar 19;32(5):1792-7 [15034147.001]
  • [Cites] Mol Ecol Notes. 2007 May 1;7(3):355-364 [18784790.001]
  • [Cites] PLoS One. 2015 Apr 08;10(4):e0122407 [25853412.001]
  • [Cites] PLoS One. 2016 Oct 27;11(10 ):e0165632 [27788251.001]
  • [Cites] J Econ Entomol. 2012 Apr;105(2):573-82 [22606829.001]
  • [Cites] Bull World Health Organ. 1987;65(5):659-62 [3501345.001]
  • [Cites] Clin Microbiol Infect. 2003 Mar;9(3):172-85 [12667249.001]
  • [Cites] Nucleic Acids Res. 1994 Nov 11;22(22):4673-80 [7984417.001]
  • (PMID = 28642581.001).
  • [ISSN] 2045-2322
  • [Journal-full-title] Scientific reports
  • [ISO-abbreviation] Sci Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


92. Capistrant BD, Friedemann-Sánchez G, Novak LK, Zuijdwijk C, Ogle GD, Pendsey S: Mental health and well-being among type 1 diabetes caregivers in India: Evidence from the IDREAM study. Diabetes Res Clin Pract; 2017 Dec;134:168-177

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIMS: Although more than half of the world's children with T1D live in developing countries, still little is known about how caregiving for children with T1D affects the parent/caregivers' health in low- and middle-income country settings.
  • Caregivers with high subjective caregiving burden and high objective direct caregiving burden had an adjusted 30% probability of elevated depressive symptoms (PHQ≥10).
  • CONCLUSIONS: Among Indian T1D caregivers, high subjective caregiving burden and objective direct caregiving burden were associated with a high risk for caregiver depression and poorer well-being.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier B.V. All rights reserved.
  • (PMID = 29054484.001).
  • [ISSN] 1872-8227
  • [Journal-full-title] Diabetes research and clinical practice
  • [ISO-abbreviation] Diabetes Res. Clin. Pract.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Keywords] NOTNLM ; Caregiver / Depression / Type 1 diabetes / Well-being
  •  go-up   go-down


93. Koçak E, Şarkgüneşi A: The impact of foreign direct investment on CO&lt;sub&gt;2&lt;/sub&gt; emissions in Turkey: new evidence from cointegration and bootstrap causality analysis. Environ Sci Pollut Res Int; 2017 Oct 23;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The impact of foreign direct investment on CO<sub>2</sub> emissions in Turkey: new evidence from cointegration and bootstrap causality analysis.
  • Pollution haven hypothesis (PHH), which is defined as foreign direct investment inducing a raising impact on the pollution level in the hosting country, is lately a subject of discussion in the field of economics.
  • This study, within the scope of related discussion, aims to look into the potential impact of foreign direct investments on CO<sub>2</sub> emission in Turkey in 1974-2013 period using environmental Kuznets curve (EKC) model.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29063405.001).
  • [ISSN] 1614-7499
  • [Journal-full-title] Environmental science and pollution research international
  • [ISO-abbreviation] Environ Sci Pollut Res Int
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Bootstrap causality / CO2 emissions / Cointegration / Environmental Kuznets curve hypothesis / Pollution haven hypothesis / Turkey
  •  go-up   go-down


94. Ahmed Bhuiyan M, Rashid Khan HU, Zaman K, Hishan SS: Measuring the impact of global tropospheric ozone, carbon dioxide and sulfur dioxide concentrations on biodiversity loss. Environ Res; 2018 Jan;160:398-411

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study is to examine the impact of air pollutants, including mono-nitrogen oxides (NOx), nitrous oxide (N<sub>2</sub>O), sulfur dioxide (SO<sub>2</sub>), carbon dioxide emissions (CO<sub>2</sub>), and greenhouse gas (GHG) emissions on ecological footprint, habitat area, food supply, and biodiversity in a panel of thirty-four developed and developing countries, over the period of 1995-2014.
  • The results reveal that NOx and SO<sub>2</sub> emissions both have a negative relationship with ecological footprints, while N<sub>2</sub>O emission and real GDP per capita have a direct relationship with ecological footprints.
  • SO<sub>2</sub> emission has a direct relationship with per capita food production, while GDP per capita significantly affected per capita food production and food supply variability across countries.
  • Trade liberalization policies considerably affected the potential habitat area and biological diversity in a panel of countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Inc. All rights reserved.
  • (PMID = 29065379.001).
  • [ISSN] 1096-0953
  • [Journal-full-title] Environmental research
  • [ISO-abbreviation] Environ. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Air Pollutants; 0 / Greenhouse Gases; 0 / Nitrogen Oxides; 0UZA3422Q4 / Sulfur Dioxide; 142M471B3J / Carbon Dioxide; 66H7ZZK23N / Ozone; K50XQU1029 / Nitrous Oxide
  • [Keywords] NOTNLM ; Air pollutants / Biological diversity / Ecological footprint / Panel cointegrating regressions
  •  go-up   go-down


95. Guest GD, McLeod E, Perry WRG, Tangi V, Pedro J, Ponifasio P, Hedson J, Tudravu J, Pikacha D, Vreede E, Leodoro B, Tapaua N, Kong J, Oten B, Teapa D, Korin S, Wilson L, Mesol S, Tuneti K, Meara JG, Watters DA: Collecting data for global surgical indicators: a collaborative approach in the Pacific Region. BMJ Glob Health; 2017;2(4):e000376

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In 2015, the Lancet Commission on Global Surgery (LCoGS) recommended six surgical metrics to enable countries to measure their surgical and anaesthesia care delivery.
  • With support from the Royal Australasian College of Surgeons and the Pacific Islands Surgical Association, 14 South Pacific countries collaborated to collect the first four of six LCoGS indicators.
  • Thirteen countries collected all four indicators over a 6-month period from October 2015 to April 2016.
  • Only 5 of 13 countries (38%) achieved 2-hour access for at least 80% of their population, with a range of 20% (Papua New Guinea and Solomon Islands) to over 65% (Fiji and Samoa).
  • Five of 13 (38%) countries met the target surgical volume of 5000 procedures per 100 000 population, with six performing less than 1600.
  • Four of 14 (29%) countries had at least 20 surgical, anaesthesia and obstetric providers in their workforce per 100 000 population, with a range of 0.9 (Timor Leste) to 18.5 (Tuvalu).
  • Perioperative mortality rate was reported by 13 of 14 countries, and ranged from 0.11% to 1.0%.
  • We believe it is feasible to collect global surgery indicators across the South Pacific, a diverse geographical region encompassing high-income and low-income countries.
  • Such metrics will allow direct comparison between similar nations, but more importantly provide baseline data that providers and politicians can use in advocacy national health planning.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 2012 Dec 15;380(9859):2163-96 [23245607.001]
  • [Cites] Br J Surg. 2016 Oct;103(11):1453-61 [27428044.001]
  • [Cites] Trop Med Int Health. 2012 Nov;17(11):1405-8 [22973827.001]
  • [Cites] Lancet Glob Health. 2015 Apr 27;3 Suppl 2:S13-20 [25926315.001]
  • [Cites] World J Surg. 2016 Nov;40(11):2591-2597 [27255941.001]
  • [Cites] Lancet. 2015 Aug 8;386(9993):569-624 [25924834.001]
  • [Cites] Lancet Glob Health. 2015 Apr 27;3 Suppl 2:S38-44 [25926319.001]
  • [Cites] Anaesth Intensive Care. 2016 May;44(3):420-4 [27246944.001]
  • [Cites] World J Surg. 2015 Apr;39(4):856-64 [24841805.001]
  • [Cites] Lancet. 2012 Dec 15;380(9859):2197-223 [23245608.001]
  • [Cites] PLoS Med. 2016 May 17;13(5):e1002023 [27186645.001]
  • [Cites] World J Surg. 2015 Sep;39(9):2115-25 [26239773.001]
  • [Cites] Lancet. 2015 Apr 27;385 Suppl 2:S27 [26313074.001]
  • [Cites] Lancet. 2012 Dec 15;380(9859):2095-128 [23245604.001]
  • [Cites] Lancet Glob Health. 2016 Sep;4(9):e597-8 [27539799.001]
  • [Cites] ANZ J Surg. 2012 May;82(5):318-24 [22507204.001]
  • [Cites] Surgery. 2015 Jul;158(1):17-26 [25958067.001]
  • [Cites] World J Surg. 2017 Jan;41(1):7-9 [27600709.001]
  • [Cites] Pan Afr Med J. 2017 Aug 03;27:246 [28979647.001]
  • [Cites] Int J Equity Health. 2013 Jul 03;12:49 [23822552.001]
  • [Cites] ANZ J Surg. 2017 Jun;87(6):436-440 [27647706.001]
  • [Cites] Qual Saf Health Care. 2009 Apr;18(2):121-6 [19342526.001]
  • [Cites] N Engl J Med. 2009 Jan 29;360(5):491-9 [19144931.001]
  • [Cites] Trop Doct. 2014 Jul;44(3):128-34 [24821618.001]
  • [Cites] World J Surg. 2016 Nov;40(11):2620-2627 [27283189.001]
  • (PMID = 29225948.001).
  • [ISSN] 2059-7908
  • [Journal-full-title] BMJ global health
  • [ISO-abbreviation] BMJ Glob Health
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; disease and standardisation of rates / indices of healthd / public health / surgery
  •  go-up   go-down


96. Plöthner M, Klora M, Rudolph D, Graf von der Schulenburg JM: Health-Related Genetic Direct-to-Consumer Tests in the German Setting: The Available Offer and the Potential Implications for a Solidarily Financed Health-Care System. Public Health Genomics; 2017 Jun 23;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Health-Related Genetic Direct-to-Consumer Tests in the German Setting: The Available Offer and the Potential Implications for a Solidarily Financed Health-Care System.
  • BACKGROUND: The global genetic direct-to-consumer (DTC) market will reach a volume of USD 230 billion in 2018.
  • In November 2016, we updated the information of the webpages in terms of country, language, types of health-related tests, additional offer of non-health-related DTC test, information about sensitivity and specificity, certification and accreditation, costs as well as reference to German Act on Genetic Testing.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 S. Karger AG, Basel.
  • (PMID = 28641282.001).
  • [ISSN] 1662-8063
  • [Journal-full-title] Public health genomics
  • [ISO-abbreviation] Public Health Genomics
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; Direct-to-consumer genetic testing / Germany / Health-care system / Health-related offer
  •  go-up   go-down


97. Leblebicioglu H, Arends JE, Ozaras R, Corti G, Santos L, Boesecke C, Ustianowski A, Duberg AS, Ruta S, Salkic NN, Husa P, Lazarevic I, Pineda JA, Pshenichnaya NY, Tsertswadze T, Matičič M, Puca E, Abuova G, Gervain J, Bayramli R, Ahmeti S, Koulentaki M, Kilani B, Vince A, Negro F, Sunbul M, Salmon D, ESGHV (part of ESCMID): Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries. Antiviral Res; 2017 Dec 05;150:9-14

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries.
  • BACKGROUND: Treatment with direct acting antiviral agents (DAAs) has provided sustained virological response rates in >95% of patients with chronic hepatitis C virus (HCV) infection.
  • However treatment is costly and market access, reimbursement and governmental restrictions differ among countries.
  • We aimed to analyze these differences among European and Eurasian countries.
  • Countries were evaluated according to their income categories by the World Bank stratification.
  • RESULTS: Experts from 26 countries responded to the survey.
  • All countries had national guidelines except Albania, Kosovo, Serbia, Tunisia, and UK.
  • Transient elastography was available in all countries, but reimbursed in 61%.
  • PegIFN/RBV was reimbursed in 54% of the countries.
  • No DAAs were available in four countries: Kazakhstan, Kosovo, Serbia, and Tunisia.
  • CONCLUSION: Prevalence of HCV is relatively higher in lower-middle and upper-middle income countries.
  • DAAs are not available or reimbursed in many Eurasia and European countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier B.V. All rights reserved.
  • (PMID = 29217468.001).
  • [ISSN] 1872-9096
  • [Journal-full-title] Antiviral research
  • [ISO-abbreviation] Antiviral Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Availability of hepatitis C diagnostics / Therapeutics in European and Eurasia countries
  •  go-up   go-down


98. Ciccia R: A two-step approach for the analysis of hybrids in comparative social policy analysis: a nuanced typology of childcare between policies and regimes. Qual Quant; 2017;51(6):2761-2780

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There is growing awareness around these issues, but empirical research often still relies on methodologies aimed at classifying countries in a limited number of unambiguous types.
  • In the first step, parental leave policies are analysed using three methods-direct, indirect, and combinatory-to identify and describe specific hybrid forms at the level of policy analysis.
  • Clearly shows that many countries display characteristics normally associated with different types (hybrids and sub-types) .

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29070917.001).
  • [ISSN] 0033-5177
  • [Journal-full-title] Quality & quantity
  • [ISO-abbreviation] Qual Quant
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Child care / Comparative social policy / Fuzzy set ideal type analysis / Gender equality / Hybrids, typology / Welfare regime
  •  go-up   go-down


99. Cattaneo D, Fossati A, Resnati C, Galli M, Gervasoni C: Generics for the Treatment of Hepatitis C in Monoinfected and HIV-coinfected Patients: Pros and Cons. AIDS Rev; 2017 Oct-Dec;19(3):167-172
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The treatment of hepatitis C virus in monoinfected and HIV-coinfected patients has greatly changed over recent years as a result of the introduction of direct-acting antiviral agents (DAAs), which have revolutionized clinical outcomes and led to sustained virological response rates above 90-95%.
  • However, the cost of branded DAAs is still too high for many developing countries, and many patients are still left without therapy.
  • In this context, the availability of generic DAAs certainly provides a major opportunity for further cost savings in industrialized countries and will ensure broader access to treatment elsewhere.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28926562.001).
  • [ISSN] 1698-6997
  • [Journal-full-title] AIDS reviews
  • [ISO-abbreviation] AIDS Rev
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


100. Long NP, Lim DK, Mo C, Kim G, Kwon SW: Development and assessment of a lysophospholipid-based deep learning model to discriminate geographical origins of white rice. Sci Rep; 2017 Aug 17;7(1):8552

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • By using direct infusion-mass spectrometry-based targeted lipidomics, 17 lysoglycerophospholipids were simultaneously characterized within minutes per sample.
  • Unsupervised data exploration showed a noticeable overlap of white rice between two countries.
  • The model accurately discriminated white rice from two countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Food Chem. 2008 Jul 15;109(2):470-5 [26003374.001]
  • [Cites] J Agric Food Chem. 2011 Oct 12;59(19):10435-41 [21916514.001]
  • [Cites] Ecology. 2007 Nov;88(11):2783-92 [18051647.001]
  • [Cites] Mol Syst Biol. 2016 Jul 29;12 (7):878 [27474269.001]
  • [Cites] Front Plant Sci. 2016 Sep 22;7:1419 [27713752.001]
  • [Cites] Food Chem. 2013 Aug 15;139(1-4):1133-45 [23561219.001]
  • [Cites] Plant Signal Behav. 2011 Nov;6(11):1720-31 [22041989.001]
  • [Cites] J Pharm Biomed Anal. 2016 May 30;124:120-8 [26942336.001]
  • [Cites] Mol Pharm. 2016 Jul 5;13(7):2524-30 [27200455.001]
  • [Cites] J Agric Food Chem. 2017 Mar 29;65(12 ):2628-2634 [28245645.001]
  • [Cites] Crit Rev Food Sci Nutr. 2008 Jun;48(6):553-98 [18568860.001]
  • [Cites] Food Chem. 2013 Dec 15;141(4):3504-9 [23993513.001]
  • [Cites] Metabolomics. 2017;13(2):12 [28090198.001]
  • [Cites] J Agric Food Chem. 2010 Mar 24;58(6):3801-7 [20170108.001]
  • [Cites] J Environ Sci (China). 2013 Jan 1;25(1):144-54 [23586309.001]
  • [Cites] Health Psychol Behav Med. 2014 Jan 1;2(1):723-734 [25750814.001]
  • [Cites] Neural Netw. 2015 Jan;61:85-117 [25462637.001]
  • [Cites] Food Chem. 2015 Oct 1;184:154-9 [25872438.001]
  • [Cites] Cell Mol Life Sci. 2012 Oct;69(19):3225-43 [22885821.001]
  • [Cites] Anal Chim Acta. 2015 Jul 23;885:1-16 [26231889.001]
  • [Cites] J Assoc Physicians India. 2009 Feb;57:127-33 [19582980.001]
  • [Cites] Trends Biotechnol. 2004 May;22(5):245-52 [15109811.001]
  • [Cites] Nucleic Acids Res. 2009 Jul;37(Web Server issue):W652-60 [19429898.001]
  • [Cites] J Agric Food Chem. 2014 Jul 16;62(28):6600-7 [24953871.001]
  • [Cites] Brief Bioinform. 2016 Jul 29;:null [27473064.001]
  • [Cites] Anal Chim Acta. 2015 Jun 16;879:10-23 [26002472.001]
  • (PMID = 28819110.001).
  • [ISSN] 2045-2322
  • [Journal-full-title] Scientific reports
  • [ISO-abbreviation] Sci Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down






Advertisement